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Regular participation intense intense physical activity induces 
characteristic physiological ECG and echocardiographic changes. These 
are well described in Caucasian athletes (WA). Male black athletes 
(MBAs) demonstrate a higher prevalence of repolarisation anomalies 
and a greater maximal left ventricular wall thickness (mLVWT). The 
longitudinal significance of this is unclear. There is no published data on 
female black athletes  (FBAs).
 
Methods
Between 1996 and 2010, 1144 elite BAs (21% female) underwent a 
standard pre-participation screen, including a 12-lead ECG and 2-D 
trans-thoracic echocardiogram. These were compared with 2059 similar 
WAs (12% female), 259 sedentary black controls (BCs; 54% female), 
and 52 black patients with hypertrophic cardiomyopathy (HCM). Any 
healthy subject exhibiting a mLVWT of >11mm (females) or >13mm 
(males), underwent comprehensive examination to look for phenotypic 
features of HCM. Male athletes were followed up for 69.7±29.6 months.
Results
BAs demonstrated a greater mLVWT (Females 9.2±1.2mm vs. 
8.6±1.2mm, P<0.001: Males 10.6 ±1.6mm vs. 10.0±1.2, P<0.001) than 
WA and BC subjects. Eight FBA (3%) exhibited a mLVWT >11mm (12 to 
13mm) compared with none of the FWA. T wave inversions (TWI) were 
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present in 82.7% of HCM patients, 22.8% MBAs, 14% FBAs, 10.1% 
BCs, 3.7% MWA and 2% FWA (P<0.001). The major determinant of TWI 
in healthy subjects was black ethnicity. In BAs, TWI were confined 
predominately to the anterior leads (V1-4). Anterior TWI were infrequent 
amongst BCs (4.2%) and HCM patients (3.8%). TWI in the lateral leads 
were frequently  seen amongst HCM patients(79.6%), but rare in all 
healthy individuals. During follow-up, one MBA survived a cardiac arrest, 
and two athletes (one MBA and one MWA) were diagnosed with HCM. 
 
Conclusion
Systematic physical exercise in BAs is associated with greater LV 
hypertrophy and higher prevalence of TWI than in similar WAs. However, 
a mLVWT >13mm (females) or >16mm (males) or deep TWI in the 
inferior/lateral leads are rare and warrant investigation.
3
Table of Contents Page 
Number
Abstract 2 - 3
Table of Contents 4 - 10
List of Tables 11 - 12
List of Figures 13 - 14
List of Abbreviations 15 - 16
Chapter 1 – Introduction and Literature Review 17 - 65
1.1 Introduction 17 - 21
1.2 The Echocardiographic appearance of the Athletes Heart 21 - 33
1.2.1 The Left Ventricle 22 - 23
1.2.2. The Upper Limit of Left Ventricular Wall Thickness 23 - 26
1.2.3. Left Ventricular Cavity Size 26 - 28
1.2.4. Determinants of Left Ventricular Hypertrophy  28 - 30
1.2.5. The Right Ventricle 31 - 32
1.2.6. The Atria 32 - 33
1.3. The Electrocardiographic Appearance of the Athletes 
Heart
34 - 44
1.3.1. Common findings in the Athletes ECG 34 - 36
1.3.2. Repolarisation Changes 36 - 38
1.3.3. Demographic Factors affecting the appearance of the 
Athletes ECG
38 - 44
1.3.3.1. Ethnicity 39 - 42
1.3.3.2. Gender 42 - 44
1.4 Differentiation between Physiology and Pathology 44 - 55
1.4.1 Left Ventricular Hypertrophy 45 - 54
  4
1.4.1.2 Impact of athlete demographics on the 
diagnosis of HCM
46 - 47
1.4.1.3 Role of trans-thoracic echocardiography in the 
diagnosis of HCM
47
1.4.1.4 Structural markers of HCM at 
Echocardiography
47 - 49
1.4.1.5 Functional markers of HCM at 
Echocardiography
49 - 51
1.4.1.6 Further assessment of LVH in the athlete 52 - 54
1.4.2 Repolarisation anomalies 54 - 55
1.5. Pre-participation Screening 55 - 63
1.5.1. Methods of pre-participation Screening 57 - 59
1.5.2. The pre-participation screening of Black Athletes 60 - 63
1.6 Aims and Objectives 64 - 65
Chapter 2 – Methodology 66 - 79
2.1 Setting 66 - 67
2.2 Study Design 67 - 76
2.2.1 Subjects 67 - 71
2.2.1.1 Athletes 68
2.2.1.2 Sedentary Controls 69
2.2.1.3 Black patients with Hypertrophic 
Cardiomyopathy
70 - 71
2.2.2 Health Questionnaire 71 - 72
2.2.3 Demographic data collection 72
2.2.4 Clinical Examination 73
2.2.5 12-lead Electrocardiogram 74 - 75
2.2.6 Trans-thoracic Echocardiography 75 - 76
5
2.3 Further Evaluation  and Follow-up 76 - 78
2.3.1 Exercise Stress Testing 77
2.3.2 48-Hour ECG Monitoring 77
2.3.3 Cardiac Magnetic Resonance Imaging 77 - 78
2.4 Statistical Analysis 78 - 79
Chapter 3-5 - Results 80 - 119
Chapter 3 -  !Subject Characteristics 80 - 91
3.1 Female Subject Demographics 80 - 85
3.1.1 Black Female Athlete Demographics 80
3.1.2 White Female Athlete Demographics 81 - 82
3.1.3 Female Control subject Demographics. 83
3.1.4 Female Athletes versus Control Subjects 84 - 85
3.2 Male Subject Demographics 85 - 88
3.2.1 Black Male Athlete Demographics 85 - 87
3.2.2 White Male Athlete Demographics 87 - 88
3.2.3 Black Male Sedentary Control Subjects 88
3.3 Patients with Hypertrophic Cardiomyopathy 88 - 89
3.4 Screening Questionnaire results 90
3.5 Examination Findings 90
3.6 Conclusion 91
Chapter 4 – Trans-thoracic echocardiography in Elite female 
athletes – The Impact of Ethnicity and Regular Sporting 
Activity.
92 - 106
4.1. Left Ventricular Dimensions 92 - 101
6
4.1.1 – Female Control Subjects 92 - 95
4.1.2 – Female Black Athletes versus Black Female Control 
Subjects
95 - 96
4.1.3 - White Female Athletes vs. White Female Controls 97 - 98
4.1.3 – Black Female Athletes vs. White Female Athletes 99 - 101
4.2 Left Ventricular Hypertrophy in Female Athletes 102 - 103
4.3 Determinants of Left Ventricular Hypertrophy in Athletes 104
4.4 Reliabi l i ty of Left Ventricular Wall Thickness 
Measurements in Athletes
104
4.5 Other Cardiac Dimensions 104 - 106
4.5.1 Left Atrial Diameter 105 - 106
4.5.2 Aortic Root Diameter 106
Chapter 5 – The 12-Lead ECG in Elite Black Female Athletes – 
the Impact of Ethnicity and Regular Sporting Activity. 
107 - 119
5.1 Baseline Electrocardiographic Findings 107 - 113
5.1.1 Control Subjects 107 - 109
5.1.2 Black Athletes versus Control Subjects 109 - 110
5.1.3 White Athletes versus Control Subjects 110 - 112
5.1.4 Black versus White Athletes 112 - 113
5.2 Repolarisation Anomalies 114 - 118
5.2.1 Control subjects 114
5.2.2. Athletes versus Control subjects 115
5.2.3 Black vs. white athletes 116 - 117
5.2.4 Determinants of Repolarisation Anomalies 118
5.3 Correlation between ECG and Echocardiogram 118
5.4 Subsequent investigations 119
7
Chapter 6 – The Significance of Repolarisation Anomalies in 
Black Male Athletes 
120 - 140
6.1 The 12-Lead ECG in Male Subjects 120 - 134
6.1.1 Baseline Electrocardiographic Findings 120 - 125
6.1.1.1 Baseline ECG in Healthy Subjects 121 - 124
6.1.1.2 Baseline ECG findings in Subjects with HCM 124 - 125
6.1.2 Repolarisation changes – Prevalence and Distribution 125 - 128
6.1.2.1 Black Male Athletes vs. White Male Athletes 126 - 127
6.1.2.2 Black Male athletes vs. Black Sedentary 
Controls vs. Black HCM patients 
128
6.1.3 ST-segment morphology 129 - 130
6.2 The Echocardiographic Appearance In Male Subjects 131 - 134
6.2.1 Athletes vs. Controls 132 - 133
6.2.2 Black vs. White Male athletes 133 - 134
6.2.3 The Echocardiogram in Black patients with 
Hypertrophic Cardiomyopathy
134
6.3 Further Testing 134 - 136
6.3.1 Further Testing results 136
6.4 Determinants of repolarisation changes in athletes 137
6.5 Clinical Significance of Repolarisation Changes 138 - 140
6.6 Other significant findings in Male Athletes 140
Chapter 7 – Discussion 141 - 172
7.1 Introduction 141 - 143
7.2 Cardiac Structural Adaptation in Black Female Athletes 143 -145
 7.2.1 Left Ventricular Wall Thickness in Black Female 
athletes
143 - 144
7.2.2 Black Athletes with Left Ventricular Hypertrophy 144 - 145
8
7.2.3 Other Cardiac Dimensions in Black Athletes 145
7.3 The Electrocardiographic appearance in Black Female 
Athletes 
146 - 149
7.3.1 Differences in Electrocardiographic Repolarisation 
between Black and White Athletes
147 - 149
7.4 Cardiac Adaptation to Exercise in Black Male Athletes 149 - 155
7.4.1 Ethnic differences in Repolarisation Changes amongst 
Elite Male Athletes
151
7.4.2 The distribution of Repolarisation Changes amongst 
black athletes
151 - 155
7.4.2.1 The Anterior Pre-cordial Leads 151 - 153
7.4.2.2 The Inferior Leads 153 - 154
7.4.2.3 The Lateral Leads 154 - 155
7.4.3 ST Segment Shift 155
7.5 Trans-Thoracic Echocardiography in Black Male Athletes 156 - 159
7.5.1 Measures of Left Ventricular Wall Thickness 156 - 158
7.5.2 Other measures of Cardiac Chamber size and 
Function
158 - 159
7.6 Implications for Pre-Participation Screening 160 - 169
7.6.1 Differentiation of Physiological Left Ventricular 
Hypertrophy from Hypertrophic Cardiomyopathy
160 - 162
7.6.2 A Bedside Clinical Algorithm for the Differentiation of 
Left Ventricular Hypertrophy in Black Athletes
161 - 163
7.6.3 Interpretation of the 12-lead ECG in Black Athletes 163 - 165
7.6.4 The Impact on Pre-Participation screening of Black 
Athletes & Recommendations.
166 - 168
7.7 Potential Mechanisms for Ethnic Differences in Cardiac 
Adaptation
169 - 172
7.7.1 Structural differences 169 - 171
7.7.2 Electrical Differences 171 - 172
9
7.8. Conclusion 172
Chapter 8 – Limitations of this Study and Suggestions for 
Further Research
173 - 176
References 177 - 193
Acknowledgements 194 - 195
Publications and Prizes 196 - 199
Appendices 200 - 240
Appendix A - CRY Information Sheet for study participants 200 - 202
Appendix B - CRY consent form for study participants 203 - 204
Appendix C - Screening Questionnaire 205 - 207
Appendix D - Rawlins et al. Ethnic Differences in 
physiological cardiac adaptation to intense physical exercise 
in h igh ly t ra ined female a th le tes . C i rcu la t ion . 
2010;121:1078-1085
208 - 215
Appendix E - Rawlins et al. Left Ventricular Hypertrophy in 
Athletes. Eur J Echo. 2009;10:350-356
216 - 222
Appendix F - Papadakis et al. The prevalence, distribution, 
and clinical outcomes of electrocardiographic repolarization 
patterns in male athletes of African/Afro-Caribbean origin. 
Eur H J. 2011 Sep;32(18):2304-13
223 - 232
Appendix G - Papadakis et al. Prevalence and significance 
of T-wave inversions in predominantly  Caucasian 






Table 1.1 Causes of sudden cardiac death amongst young 
athletes aged under 25
19
Table 1.2 – Common Findings in the resting ECG in the Athlete 35
Table 1.3 - Echocardiographic indices used in the differentiation 
between physiological and pathological left ventricular 
hypertrophy.
51
Table 3.1 Demographic characteristics of Black and White 
female Athletes
82
Table 3.2 Demographic characteristics of Black and White 
female Control subjects
83
Table 3.3 Demographic characteristics of Black female athletes 
and controls
84
Table 3.4 Demographic characteristics of White female athletes 
and controls
85
Table 3.5 Demographic characteristics of Male athletes and 
controls
87
Table 3.6 Demographic and clinical characteristics of black 
patients with HCM.
89
Table 4.1 Comparison of echocardiographic cardiac dimensions 
between female black and white control subjects
94
Table 4.2 Comparison of echocardiographic cardiac dimensions 
between female black athletes and black control subjects
96
Table 4.3 Comparison of echocardiographic cardiac dimensions 
between female White athletes and White control subjects
98
Table 4.4 Comparison of echocardiographic cardiac dimensions 
between black and white elite female athletes
100
11
Ta b l e 4 . 5 D e m o g r a p h i c , e c h o c a r d i o g r a p h i c a n d 
electrocardiographic features of Black Athletes with left 
ventricular hypertrophy. 
103
Table 5.1 Comparison of electrocardiographic parameters 
between Black and White female sedentary control subjects.
108
Table 5.2 Comparison of electrocardiographic parameters 
between female black athletes and sedentary control subjects
110
Table 5.3 Comparison of electrocardiographic parameters 
between female white athletes and sedentary control subjects.
111
Table 5.4 - Comparison of electrocardiographic parameters 
between black and white female elite athletes.
113
Table 5.5 Prevalence of repolarisation anomalies amongst 
female athletes and control subjects.
115
Table 6.1 – Electrocardiographic characteristics in healthy male 
subjects.
123
Table 6.2 – Electrocardiographic characteristics in patients with 
HCM
125
Table 6.3 Comparison of standard echocardiographic 
parameters in male black athletes, male white athletes and black 
male control subjects.
132
Table 6.4 The echocardiographic characteristics of black 
patients with HCM
135






Figure 1.1 Probe positioning bias 23
Figure 1.2 Distribution of left ventricular wall thickness in 3,500 
highly trained athletes 
25
Figure 1.3 Distribution of left ventricular wall thickness in 720 
elite adolescent athletes 
26
Figure 1.4 - Distribution of left ventricular wall thickness in 300 
highly trained black male athletes
30
Figure 1.5 Distribution of left atrial dimensions in 1777 highly 
trained athletes
33
Figure 1.6 - A normal Athletes ECG 36
Figure 1.7 – 12-lead ECG taken from a Caucasian male junior 
tennis player demonstrating a juvenile ECG pattern
38
Figure 1.8 - 12-lead ECG from an elite black male athlete 
showing deep T wave inversions and convex ST segment 
elevation in the anterior pre-cordial leads.
39
Figure 1.9 Annual Incidence Rates of Sudden Cardiovascular 
Death in the Veneto Region of Italy.
59
Figure 3.1 Sporting disciplines in black and white male athletes 85
Figure 4.1 Histogram showing the distribution of maximal left 
ventricular wall thickness in black and white female athletes.
101
Figure 4.2 Distribution of left atrial diameter in female elite 
athletes.
106




Figure 5.2 – Spectra of ECG observations in black female 
athletes
117
Figure 6.1 – Series of ECGs demonstrating typical repolarisation 
changes in black male individuals.
127
Figure 6.2 - Histograms demonstrating the prevalence and 
distribution of repolarisation anomalies in black athletes, 
controls, and patients with HCM.
129
Figure 6.3 - Examples of common ECG ST-segment 
morphologies in leads V1-3 & V4-6 amongst black athletes
130
Figure 6.4 – Histogram demonstrating the distribution of 
maximal left ventricular wall thickness in black and white male 
athletes. 
133
Figure 6.5 – ECG and echocardiographic findings in athletes 
identified with Hypertrophic Cardiomyopathy
139
Figure 7.1 – 12-lead ECGs taken from a young black male 





A wave - Late diastolic mitral valve inflow peak velocity
A’- Late annular diastolic peak velocity (lateral mitral annulus)
Ao - Aortic annulus diameter 
ARVC - Arrhythmogenic Right Ventricular Cardiomyopathy 
AV - Atrio-Ventricular node, 
BA - Black Athlete
BC - Black Control Subject
BSA - Body Surface Area 
CMR - Cardiac Magnetic resonance
DBP - Diastolic Blood Pressure
E wave - Early diastolic mitral valve peak inflow velocity
E:A - Ratio of peak Early diastolic mitral inflow velocity to peak late diastole 
mitral inflow velocity
E Decel - E wave deceleration time
E`- Early diastolic annular peak velocity (lateral mitral annulus)
E:E` - Ratio of peak early  diastolic mitral inflow velocity to peak early diastolic 
mitral annular velocity 
EF - Ejection Fraction 
FBA - Female black athlete
FWA - Female White Athlete
HR - Resting Heart rate
HCM - Hypertrophic Cardiomyopathy 
ICD - Implantable Cardioverter Defibrillator
IVSd - Maximal left ventricular septal wall thickness in end-diastole 
IVRT - Isovolumic relaxation time (left ventricle)
15
LA - Left Atrial diameter
LA Enlargement - Voltage criterion for left atrial enlargement 
LAE - Voltage criterion for left atrial enlargement
LDR – Long Distance Running 
LVED - Maximal left ventricular cavity dimension in end-diastole 
LVES - Maximal left ventricular cavity dimension in end-systole 
LV - Left Ventricle
LVEDP - Left ventricular end diastolic pressure
LVH - Left Ventricular Hypertrophy
LVM - Left ventricular mass 
LVWT - Left Ventricular Wall Thickness in end-diastole
MBA – Male Black Athlete
mLVWT - Maximal left ventricular wall thickness in end diastole
MWA - Male White Athlete
PASP - Pulmonary artery systolic pressure
PTWd - Left ventricular posterior wall thickness in end-diastole 
RA Enlargement - voltage criteria for right atrial enlargement
SAM - Systolic anterior motion of the anterior mitral valve leaflet
S’ - Systolic annular peak velocity (lateral)
SBP – Systolic Blood Pressure 
STE - ST segment Elevation.
T-wave Inv - Distribution of T-wave inversions
UK - United Kingdom
US - United States of America
WA - White Athlete
16
Chapter 1 – Introduction and Literature Review
1.1 Introduction
The systematic and regular participation in intense physical activity  results in 
central and peripheral cardiovascular adaptation to facilitate the generation of 
the large and sustained increases in cardiac output to enhance the extraction of 
oxygen in exercising muscles for aerobic glycolysis. Collectively, these 
physiological cardiac adaptations have been termed “the athletes heart”.1 
Specifically, both electrical and structural physiological cardiac remodelling 
occurs, which characteristically  regresses following cessation of regular training. 
Most athletes exhibit alterations in both parasympathetic and sympathetic 
autonomic tone in combination with modest increases in left ventricular mass, 
which is reflected in increased left ventricular chamber size and wall thickness.
The phenomenon of the athletes heart was first recognised in Norwegian cross 
country skiers as early as 1899,2 and since then many thousands of athletes 
being have been studied to describe the features of this physiological process. 
The characterisation of the athletes heart has been facilitated by improvements 
in both echocardiography3-7 and electrocardiography8-11allowing a detailed 
description of the cardiac adaptation to physical training to gradually emerge. 
The majority of these studies have been cross sectional in design and focused 
on male Caucasian athletes aged 18-35 years. The data has described the 
magnitude of cardiac enlargement, and identified determinants of cardiac size 
amongst this population. These have subsequently been used to develop 
algorithms to allow the differentiation between physiological cardiac adaptation 
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and cardiomyopathy. Clearly  distinction is crucial as world-wide, 
cardiomyopathies are the leading cause of exercise related sudden cardiac 
death amongst young athletes (Table 1.1). This includes both hypertrophic 
cardiomyopathy (HCM), the leading cause of exercise related sudden cardiac 
death amongst young athletes in the United States,12 and arrhythmogenic right 
ventricular cardiomyopathy (ARVC), the commonest cause of exercise related 
sudden cardiac death in the Vento region of Italy.13
With the aim of reducing the incidence of exercise related sudden cardiac death 
in young athletes, pre participation cardiac screening using both resting 12-lead 
ECG and 2-D trans-thoracic echocardiography is becoming increasingly 
widespread throughout the sporting community. Pre-participation cardiac 
screening has been endorsed by international sporting organisations, such as 
the International Olympic Committee (IOC),14 the Federation Internationale de 
Football Association (FIFA),15 and by  Cardiac societies, including the European 
Society of Cardiology (ESC).16,17 Vital to this process, is a clear and accurate 
understanding of the physiological athletes heart to enable the correct 
identification of potentially lethal cardiac conditions and prevent an erroneous 
diagnosis in a healthy individual.
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Table 1.1 Causes of sudden cardiac death amongst young athletes aged under 25 in 
the United States between 1986 and 2007 – Adapted from Maron et al12






Arrhythmogenic right ventricular cardiomyopathy 4.3%
Ion channelopathies (long QT and Brugada syndromes) 3.6%
Mitral valve prolapse 3.4%
Myocardial Bridging 3.3%
Premature coronary artery disease 3.3%
Aortic stenosis 2.4%
Marfan’s syndrome 2.7%
Idiopathic dilated cardiomyopathy 2.0%
Wolff-Parkinson-White syndrome 1.6%
Others* 4.9%
* Other causes of death include: Congential heart disease (0.9%), Myocardial infarction 
(0.9%), Kawasaki Disease (0.7%), Sickle cell trait (0.7%), sarcoidosis (0.6%), stroke 
(0.4%), cardiac tumour (0.1%), conduction system disease (0.3%), and miscellaneous 
(not specified) (0.3%).
With the aim of reducing the incidence of exercise related sudden cardiac death 
in young athletes, pre participation cardiac screening using both resting 12-lead 
ECG and 2-D trans-thoracic echocardiography is becoming increasingly 
widespread throughout the sporting community. Pre-participation cardiac 
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screening has been endorsed by international sporting organisations, such as 
the International Olympic Committee (IOC),14 the Federation Internationale de 
Football Association (FIFA),15 and the  by Cardiac societies, including the 
European Society  of Cardiology (ESC).16,17 Vital to this process, is a clear and 
accurate understanding of the physiological athletes heart to enable the correct 
identification of potentially lethal cardiac conditions and prevent an erroneous 
diagnosis in a healthy individual.
Recent data has suggested that the ethnicity of an athlete is an important 
determinant of the appearances of both ECG18 and echocardiogram19 when 
taken during a standard pre-participation screen. In particular, male athletes of 
African/Afro-Caribbean origin occasionally  demonstrate physiological ECG and 
echocardiographic abnormalities that may overlap  with the appearances 
observed in conditions such as HCM and ARVC. Specifically these include 
repolarisation anomalies in the 12-lead ECG, such as T wave inversions and 
convex ST segment elevation in the anterior pre-cordial leads, and left 
ventricular hypertrophy observed on trans-thoracic echocardiography.  These 
studies have however been limited to male athletes who participate in a small 
number of sports. There is no data available in the literature on female black 
athletes, and no longitudinal data that describes the significance of these 
cardiac appearances over time. Given that there has been a dramatic increase 
in the numbers of black athletes competing in international sporting events and 
therefore undergoing pre-participation cardiac screening, further data on both 
female and male black athletes is needed to ensure the accurate interpretation 
of the 12-lead ECG and echocardiogram in this burgeoning population. 
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The following sections will summarise data describing the echocardiographic 
and electrocardiographic characteristics of the athlete’s heart, and the current 
understanding with respect to the impact of demographic factors, including 
ethnicity and gender, on these appearances. The impact of these physiological 
changes on pre-participation screening for cardiac causes of sudden cardiac 
death during sport will then be discussed. 
1.2 – The Echocardiographic appearance of the Athletes Heart
During intense sporting activity, the cardiac output may be required to rise from 
5l/min at rest, to over 40l/min at peak exertion.20,21 To enable this augmentation 
of cardiac output, the heart undergoes both structural and functional 
modification. Structurally, changes include an increase in both ventricular5 and 
atrial size,22 along with functional enhancement of myocardial relaxation and 
corresponding indices of diastolic function.23 
There have been a large number of studies that have utilised trans-thoracic 
echocardiography to describe the characteristics of physiological cardiac 
adaptation to exercise. The bulk this data has focused on the structural and 
functional properties of the left ventricle at rest and have been conducted 
predominately in Caucasian male subjects, aged over 20 years old. The data 
derived has been used to develop algorithms that aim to facilitate the 
differentiation between physiological cardiac adaptation and pathological 
causes of sudden cardiac death during sport. Given the availability and ease of 
use, trans-thoracic echocardiography  is often used as a first line investigation if 
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an abnormality is detected in either the clinical history, examination or the 12-
lead ECG. 
The following section describes the normal appearance of the athletes’ heart as 
observed in routine trans-thoracic echocardiography as well as the impact of 
demographic factors on the cardiac dimensions observed.
1.2.1 The Left Ventricle
In response to systematic training, the left ventricle undergoes physiological 
enlargement and increases in mass, when compared to sedentary individuals. 
This is reflected in an increase in maximal left ventricular wall thickness (LVWT) 
4-6 and left ventricular internal diastolic cavity diameter (LVED).5,7,24
Measures of left ventricular mass (LVM) utilising traditional M-mode and 2-D 
echocardiography have demonstrated that athletes consistently develop relative 
left ventricular hypertrophy when compared to sedentary controls.4,6,25 Small 
increases in left ventricular wall thickness and left ventricular cavity can result in 
a large (>45%) increase in left ventricular mass. These differences are 
maintained when values are corrected for body mass, surface area and height.
The calculation of LV mass using 2-D measures of left ventricular wall thickness 
and cavity size makes several assumptions, which introduce inherent 
inaccuracies into results. Error in the measure of LV wall thickness is magnified 
within the equation as a cubed function is used to calculate the mass value,. 
Hence small intra- and inter- observer variability can produce a large variation in 
22
calculated mass. In addition probe positioning bias (Figure 1.1) account for the 
poor correlation between 2-D echocardiography  and the current gold standard 
technique – cardiac magnetic resonance scanning.26,27 It is for this reason, that 
absolute measures of left ventricular wall thickness and cavity size are used 
routinely in clinical practice to establish the degree of left ventricular 





1.2.2 Upper Limit of Left Ventricular Wall Thickness in Athletes
A large amount of data has been published on the quantification and description 
of the physiological left ventricular hypertrophic response to exercise using 
maximal left ventricular wall thickness (LVWT) as a surrogate for left ventricular 
mass. These have been used to establish upper limits of left ventricular 
hypertrophy in male and female athletes to facilitate the differentiation between 
athletes heart and hypertrophic cardiomyopathy (HCM). 
Figure 1.1 - Probe positioning Bias: The probe in position A is aligned to measure the 
LVWT across the LV axis. In contrast, the probe in position B, only a small distance 
away, measures a greater value, due to it mal-aligned orientation. ie B> A and Bi> Ai. 
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An early meta-analysis of 59 M-mode studies involving almost 1500 highly 
trained male Caucasian athletes demonstrated a 15-20% increase in left 
ventricular septal and posterior wall thickness respectively, when compared to 
sedentary control subjects. However, in terms of absolute values, the mean 
LVWT in athletes was between 10-11mm and fell within the range accepted for 
sedentary individuals, outside of that seen in pathological hypertrophic disease 
states.5
More recent two-dimensional echocardiographic studies in large cohorts of 
highly trained athletes have indicated that the vast majority  of athletes have a 
maximal LVWT of <12mm, which is within the established normal limits for the 
general population. However, a small minority of male athletes exhibit measures 
of LVWT that may overlap with that seen in morphologically mild HCM. In an 
Italian study of 947 male Caucasian Olympic athletes, 1.7% of athletes had a 
wall thickness exceeding 12mm.4 Similarly, in a British study of 3500 highly 
trained Caucasian male athletes, 1.5% of athletes had a maximal LVWT of 
>12mm (Figure 1.2).28 The maximal LVWT in both studies was 16mm. therefore 
it would be reasonable to infer that a a LVWT > 16mm may be representative of 
pathological LVH, although there are isolated reports of a maximal left 
ventricular wall thickness of up to 19mm in some endurance athletes. 29,30
24
Figure 1.2 Distribution of left ventricular wall thickness in 3,500 highly  trained athletes 
demonstrating that 1.7% athletes exhibit a maximal left ventricular wall thickness of > 
12mm. Reproduced from Basavarajaiah et al with permission from the American 
College of Physicians28. Copyright 2008.
With respect to female athletes, less data is available. In one of the few studies 
pertaining specifically to women that examined the echocardiogram of 600 
Italian  female Olympic athletes, the maximal LVWT recorded was 12mm.31 
Similarly, a meta analysis of the echocardiographic appearances of 890 female 
athletes reported an upper limit for maximal left ventricular wall thickness 
cardiac of 12mm.32  Unlike male athletes, there is currently no data in the 
literature reporting physiological left ventricular hypertrophy (LVH) in women 
which overlaps with that seen in morphologically mild HCM (i.e. of 13mm or 
greater). Therefore, according to current data, describing exclusively  Caucasian 
athletes, a maximal LVWT of greater than 12mm in any female athlete should 
be considered pathological hypertrophy.
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The majority of studies evaluating the echocardiographic features of athletes 
have focused on subjects aged 18-35 years old. There is far less data on those 
adolescent athletes aged <18 years of age, in whom pre-participation screening 
may have the greatest impact. The largest published study compared over 720 
adolescent athletes with 250 age matched sedentary controls. The investigators 
demonstrated that athletes had a 13% relative increase in maximal left 
ventricular wall thickness compared to controls.  In terms of absolute values, 
only 4% of athletes exhibited a maximal LV wall thickness of greater than 
12mm, with the upper limit of physiological LVH being reported as 14mm in this 
population.6(Figure 1.3).
Figure 1.3 Distribution of left ventricular wall thickness in 720 elite adolescent athletes 
(■) compared to 250 sedentary  control subjects matched for age, size and sex (□). 
Reproduced from Sharma et al with permission from the American College of 
Physicians.6 Copyright 2002.
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1.2.3 Left Ventricular Cavity size
The increase in cardiac mass that occurs in response to regular exercise is 
reflected not only in left ventricular wall thickness, but also in left ventricular 
end diastolic cavity diameter (LVED). In a meta-analysis of over 1450 athletes, 
athletes in all sports demonstrated a significantly greater LVED, when 
compared to sedentary controls.55 
In terms of absolute values of LVED, in the majority of athletes the dimensions 
are within normal limits for the general population. In a population of 1300 elite 
male and female athletes, with a mean age of 24 years, 55% had an LV cavity 
size of less than 54mm, within the normal limits for the general population. Of 
the remaining 45%, 14% had a maximal LVED of greater than 60mm. All had 
normal indices of both diastolic and systolic function. These athletes were 
predominately male (97%), and had a substantially  larger body surface area 
when compared to athletes without LV cavity dilatation (2.12m2 ±0.20 v.s. 
1.82m2 ±  0.21 P<0.001).  No athlete had an LV cavity  diameter of greater than 
66mm.33
With respect to female athletes, published data is sparse. In a population of 600 
Italian elite female athletes, the observed mean maximal LV cavity amongst this 
group was 11% smaller (P<0.001) when compared to a similar population of 
738 male athletes. In contrast to male athletes, 8% of female athletes (n=47) in 
this study had a maximal LV cavity size of >54mm (the accepted upper limit of a 
normal sedentary individual), and only  1% (n=4) had a maximal LV cavity size 
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of >60mm, compared to 45% of male athletes in the comparison group.31 Again, 
the maximal absolute value of LV cavity size was 66mm.
The effect of age on LV cavity size has been addressed in a single study 
comparing 900 adolescent mixed male and female adolescent athletes to age 
matched sedentary  controls. Overall, athletes demonstrated an 8% relative 
increase in maximal LV cavity size. With respect to absolute values, 18% 
exhibited a maximal LV cavity size of >54mm, with the upper limit of values 
being 60mm.34 
1.2.4 Determinants of Left Ventricular Hypertrophy in Athletes
In addition to age and gender, as described above, there are additional factors 
which affect the magnitude of physiological LVH in athletes. These include body 
size, the type of sporting discipline in which the athlete participates in, and the 
ethnicity of the athlete.
The sporting discipline in which an athlete participates is an important 
determinant of the magnitude of observed left ventricular hypertrophy. In 
particular, athletes competing in  endurance sport with a high isometric and 
isotonic component such as rowing, canoeing , swimming, cycling and ultra-
endurance running exhibit the greatest increase in maximal left ventricular wall 
thickness. Amongst 947 Italian athletes, all athletes with LVH (n=15;1.7%) 
participated in rowing, canoeing or cycling.4 Amongst over 3000 British athletes, 
LVH was also observed in athletes participating in swimming, professional 
football, rugby and tennis.28 Importantly, in contrast to the widely held 
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misconception, purely isometric sports such as weight lifting or wrestling rarely 
exhibit a maximal left ventricular wall thickness of greater than 12mm.5  Within 
any sporting discipline, the size of the athlete is an important determinant of 
measurement; a body surface of greater than 2.0m2 increases the probability of 
identification of echocardiographic LVH. 
More recently, the effect of an athlete’s ethnicity upon the magnitude of left 
ventricular wall thickness has been recognised. A number of studies have been 
published suggesting that Afro-Caribbean/African (black) male athletes exhibit a 
significantly greater magnitude of left ventricular hypertrophy when compared to 
white male athletes of similar size and age who participate in identical sports. 
The first to suggest this was Lewis et al, who conducted 2-D trans-thoracic 
echocardiography on 265 collegiate athletes, participating predominately in 
American Football (48%). They reported that 11% of the black athletes they 
studied had a maximal LVWT of > 13mm, within the range seen in 
morphologically  mild HCM35. This has been followed with data from 
Basavarajaiah et al who compared 300 highly trained black athletes with a 
population of 300 highly trained white athletes, of similar size, age and 
participating in a similar range of ball, racquet and endurance sports, as well as 
a group  of 150 sedentary  control subjects.  They reported that 18% of black 
athletes have a maximal LVWT of greater than 13mm, compared with only 4% 
white athletes, and none of the control subjects (P<0.001).  In addition, 3% of 
the black athletes demonstrated a maximal LVWT of >15mm, compared with 
none of the white athletes (Figure 1.4)19. A  further study  by Magaleski et al, on 
1290 American football players, reported trans-thoracic echocardiographic data 
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limited to 205 of their subjects. Within their study  population, 4% had a maximal 
LVWT of >13mm18. 
Figure 1.4 Distribution of left ventricular wall thickness in 300 highly trained black male 
athletes and 300 white male athletes of similar age, size and sporting calibre 
demonstrating that a significantly  higher proportion of black athletes exhibit a wall 
thickness >12 mm compared with white athletes (8% (line A) vs. 3% (line B), P<0.001). 
Reproduced from Basavarajaiah et al with permission from the American College of 
Physicians19. Copyright 2008.
In summary, a maximal left ventricular wall thickness of greater than 13mm may 
be present in 4-18% of black athletes, when compared to 1.8-4% of similar 
caucasian individuals.. However, these studies are confined to male athletes, all 
of whom were over 20 years of age There is currently no echocardiographic 
data evaluating any ethnic differences with respect to female athletes or those 




1.2.5 The Right Ventricle
The geometrical structure of the right ventricle makes imaging using trans-
thoracic echocardiography technically  challenging, with a high intra- and inter-
observer variability on measures of RV cavity  size. Early  echocardiographic 
studies examined both male36 and female37 athletes, who compete in a number 
of endurance events. These demonstrated that, in general, athletes have a 
greater transverse right ventricular diameter when compared to sedentary 
controls. A more comprehensive assessment of  echocardiographic right 
ventricular morphology in a cohort of 650 endurance and strength athletes has 
recently published data. Amongst endurance athletes, there was a significant 
increase in transverse right heart diameters compared to both strength athletes 
and controls. In addition, significant increases in right ventricular outflow tract 
diameter and right atrial area were also observed38.
With respect to markers of right ventricular function amongst the 650 individuals 
studied, there were no significant differences observed between the athlete 
cohorts and sedentary  controls. Amongst endurance athletes however, a wider 
range of tricuspid regurgitant velocities, pulmonary artery systolic pressures 
(PASP) and mean pulmonary artery pressures were observed. This did not 
reflect an increase in pulmonary vascular resistance, which was normal in all 
subjects. The authors suggested an upper physiological limit of 40mmHg for 
estimated PASP amongst endurance trained athletes, reflecting the 
physiological right ventricular chamber enlargement and increase in stroke 
volume.38
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The right ventricle has also been studied in detail with cardiac magnetic 
resonance scanning, which offers a significant improvement over 2-D trans-
thoracic echocardiography in terms of definition of the free wall and trabecular 
structures. An MRI study conducted on 27 male endurance athletes suggested 
that RV remodeling in response to exercise mirrors that seen in the LV, with an 
increase in mass, end-diastolic dimensions, and stroke volume. Importantly, the 
ratio of RV to LV size was maintained – leading the authors to conclude that the 
athletes’ heart syndrome results in balanced remodeling of both ventricles.39 
This is supported by the echocardiographic data and should be considered 
when assessing athletes, particularly  those participating in endurance events, 
during pre-participation screening.
1.2.6 The Atria
Cardiac remodeling in response to exercise is not confined to the ventricular 
cavities. In order to facilitate the increase in stroke volume during intense 
physical activity, the left atrium is required to accommodate an increase in blood 
volume. Correspondingly, left atrial dilatation is a common finding amongst 
athletes. This is usually  in proportion with any left ventricular dilatation. In a 
study of 1777 elite Italian athletes, <2% had a maximal LA diameter of greater 
than 45mm (Figure 1.5). The authors concluded that the upper limit of 
physiological LA dilatation in this adult population was 50mm.22 It was 
associated with participation in dynamic endurance sports such as cycling or 
rowing, both of which involve prolonged activity of large muscle groups – 
leading to significant increases in cardiac pre-load 40. 
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In contrast, amongst 1000 adolescent elite athletes, the upper limit of LA 
diameter was 45mm.41 This may  be an indication of the consequences of longer 
term participation in dynamic endurance sports, with older athletes 
demonstrating greater left atrial diameters. Importantly, left atrial dilation was 
again associated with LV cavity diameter. The presence of a dilated left atrium 
with a normal LV cavity size, and left ventricular hypertrophy, should raise the 
suggestion of an increase in LV filling pressures, and a potential pathological 
explanation for this – such as hypertrophic cardiomyopathy – should be sought.
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Figure 1.5 Distribution of transverse left atrial dimensions in 1777 highly trained 
athletes. Data are shown seperately for female (grey bars) and male (black bars) 
athletes. Twenty percent had an enlarged left atrium (range 40-50mm) including 
2% with a left atrial dimension of >45mm. Reproduced by permission of the 
American College of Cardiology - Copyright 2005.
1.3 – The Electrocardiogram in the Athlete
In addition to the structural changes described above, electrical and functional 
remodelling occurs in response to regular participation in physical activity, 
reflected in the appearance of the 12-lead surface ECG.8 In particular, 
alterations in parasympathetic and sympathetic tone are induced by training. 
These are fundamental to the physiological cardiac adaptive process8 allowing 
an increase in both the efficiency of cardiac contraction and a sustained cardiac 
output. 
As a consequence of the alterations in autonomic tone, in certain 
circumstances, the normal appearance of the athletes ECG may mimic that 
seen in cardiomyopathy, ion channel disease and other structural heart disease. 
Therefore, the correct interpretation of the 12-lead surface ECG in the athlete is 
essential and forms a central part of the recommendations for pre-participation 
screening endorsed by the ESC,14,17the IOC,14 and FIFA.15
1.3.1 – Common Findings on the Resting 12-lead ECG (Table 1.2)
Common findings on the resting 12 lead ECG include sinus bradycardia 
(present in up  to 80% of trained athletes),10 sinus arrhythmia (52%) and 1st 
degree heart block (5%) (Figure 1.6) These are considered to be secondary to 
increased vagal tone, although alterations to the intrinsic properties of the SA 
and AV node have also been described and may contribute.43
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Table 1.2 – Common Findings in the resting ECG in the Athlete9
ECG Finding Frequency (%)
Sinus Bradycardia 80%
Sinus Arrhythmia 52%








AV= atrio-ventricular node, “Giant” = T wave voltage >0.2mV, LVH = left ventricular 
hypertrophy, LA Enlargement = Voltage criteria for left atrial enlargement, RA 
Enlargement = voltage criteria for right atrial enlargement, ST = ST segment elevation.
An increase in QRS complex voltages, particularly across the precordial leads is 
observed in up to 60% of athletes. This can only in part be attributed to an 
increase in cardiac size, as there is a poor correlation between the commonly 
used voltage criteria for cardiac hypertrophy (Sokolow-Lyon, Cornell) and 
cardiac dimensions observed on trans-thoracic echocardiography. Several other 
factors affect QRS voltage including the distance between the heart and the 
chest wall which is influenced by chest wall size, pectoral hypertrophy  and the 
presence or absence of breast tissue.  
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Figure 1.6 A normal Athletes ECG – taken from a young professional cyclist during 
routine pre-participation screening. His ECG demonstrates sinus bradycardia, voltage 
criteria for left ventricular hypertrophy, and “giant” (T wave >0.2mV) precordial T-waves.
Other common findings in athletes include the presence of incomplete right 
bundle branch block (29% of highly trained athletes),9 and voltage criteria for 
left and right atrial enlargement, present in 14% and 16% of adolescent athletes 
respectively.9(figure 1.6) The sensitivity  and specificity of such voltage scores is 
also poor, with only 0.3% of 347 adult athletes with echocardiographic evidence 
of left atrial enlargement having positive voltage criteria.22 
1.3.2 Repolarisation Changes
Amongst athletes, early repolarisation changes are common consist 
predominately of J point and ST segment elevation, and increased T wave 
voltages (>0.2mV or “giant” T waves). These changes are present in between 
40-50% of individuals,9 and reflect alterations in autonomic tone affecting the 
timing sequence between depolarisation and repolarisation. In general, these 
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are considered benign (Figure 1.6), in the absence of symptoms  or any specific 
family history of sudden cardiac death.
However, it is the presence of other repolarisation changes – in particular T 
wave inversions and ST segment depression – that may be attributed to athletic 
adaptation but may overlap  with phenotypic manifestations of cardiomyopathy,
44,45 ion channel disorders,46,47 and anabolic steroid abuse.48 These are unusual 
findings in athletes, being present in only 3-4% of Caucasian adolescent49 and 
adult athletes11. The juvenile ECG pattern consisting of T wave inversions 
beyond V1 (V1-V3) usually  resolves by the age of 16 years old. In general, 
Caucasian athletes who demonstrate such an ECG appearance should 
undergo thorough evaluation before the findings should be attributed to 
physiological adaptation (Figure 1.7)
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Figure 1.7 – 12-lead ECG taken from a 15-year old Caucasian male junior elite tennis 
player demonstrating T-wave inversions in the anterior leads (V1-V3), consistent with 
the juvenile ECG pattern. His trans-thoracic echocardiogram was entirely normal. 
The appearance of the normal resting 12 lead ECG – including the presence of 
repolarisation anomalies (i.e. T wave inversions), voltage criteria for ventricular 
hypertrophy and left or right atrial enlargement - is affected by  a number of 
demographic factors.
1.3.3 Demographic factors affecting the appearance of the Athletes ECG
In a similar pattern to the data relating to trans-thoracic echocardiography, the 
majority of data from which the appearance of a normal athletes ECG has been 
determined, relates to adult Caucasian male subjects. However, the effect of a 
variety of demographic factors upon the range of normal ECG patterns 
observed has been recognised. These are mentioned briefly above, and include 
the athletes’ ethnicity, sex, age, and body size.
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1.3.3.1 Ethnicity
Historically, racial differences in the appearance of the 12-lead ECG have been 
recognised, with a number of observational papers in the 1950’s that suggest 
that J-point and ST-segment elevation may be part of the normal ECG in young 
black men,50-52. They also describe bizarre repolarisation patterns that may 
simulate myocardial infarction or phenotypic manifestations of both hypertrophic 
cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy52 (a 
condition yet to be described at the time these papers were written) (Figure 
1.8). This concept has recently been revisited by  a number of papers examining 
the ECG in a range of black male athletes. 
Figure 1.8 - 12-lead ECG taken from a male African endurance athlete, a medallist at 
the 2008 Bejing Olympics. Note the deep T-wave inversions and convex ST segment 
elevation in the anterior pre-cordial leads (V1-V3). He subsequently  underwent further 
evaluation which did not reveal any underlying cardiac abnormalities.
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The first of these examined the ECG appearance in 289 male American 
footballers. They  noted that 39 players demonstrated significant ST-T wave 
changes that mimicked ischaemia, and 22 of these (representing 7.6% of the 
total athletes studied) were black. The authors were unable to subsequently 
assess athletes with echocardiography due to the circumstances in which the 
study was conducted, but concluded that these represented normal ethnic 
variation.53 This was followed by a larger and more comprehensive study, again 
in male American football players. From a population of 1282 athletes, 835 were 
described as black. They reported ST segment and/or T wave abnormalities 
occurring in 20.5% of black individuals, compared to 9.4% of white athletes 
(P<0.001). They noted no differences in the frequency of voltage criteria for left 
or right ventricular hypertrophy. The athletes with an ECG suggestive of 
cardiomyopathy or ischaemia underwent trans-thoracic echocardiography, but 
no athlete was subsequently diagnosed with a cardiac condition.54 More 
recently, a further study of 1,959 male athletes, again American footballers, of 
which 1,321 (67%) were black, reported that 5.8% of black players had an ECG 
appearance that was deemed “markedly abnormal” by the investigators, when 
compared to only 1.8% of similar white players. The term “markedly  abnormal” 
encompassed T wave inversions, left or right axis deviation, the presence of 
pathological Q waves, and significant inter-ventricular conduction delay. Only 33 
of the 88 athletes with abnormal ECGs underwent subsequent 
echocardiographic examination, the numbers studied being insufficient to draw 
any correlations between ECG and echocardiographic appearance.18 The 
authors of all these studies concluded that that in the majority of cases, these 
changes are benign and represent normal ethnic variation. 
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All these studies are limited in that they report results in athletes who participate 
in only a single sport – American football, which has little relevance to the wider 
sporting community in countries other than the US. All athletes are male, aged 
over 20, and have an average height of 1.84±0.07 m and weight of 103±18 kg. 
It is sport in which females do not participate at all in any numbers. In all these 
studies, one should also consider the use of illicit performance enhancing drugs 
(in particular, the use of anabolic steroids), whose use in the National Football 
Leagues (NFL) over the period in time in which the earlier studies were 
conducted, was widespread.55 
The only data regarding the appearance of the athletes ECG in black athletes 
available upon sports other than American football, is from an 
echocardiographic study of 300 black and 300 white male athletes from 
Basavarajaiah et al.19They report that amongst athletes with left ventricular 
hypertrophy (i.e. a maximal LVWT of >12mm), black athletes had a higher 
prevalence of voltage criteria for left ventricular hypertrophy (37 (68%) vs. 5 
(40%); p<0.001), ST segment elevation (46 (85%) vs. 7 (62%); p<0.001), and T 
wave inversions (7 (12%) vs. none (0%); p<0.001). The distribution of T wave 
inversions observed was confined to leads V1-V4 and was present in 4 of the 9 
athletes that demonstrated a maximal LVWT of ≥15mm. T-wave inversions were 
not present in any white athlete with LVH. The determinants of T wave 
inversions were not studied in depth in this paper, but the athletes participated 
in a wide variety of sporting disciplines (including boxing, basketball, track 
athletics, and football) and were of similar size to controls and black athletes 
without T wave inversions. However, again this was confined to male athletes, 
over the age of 18.
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With respect to female black athletes, there is currently no specific data 
available in the literature. 
1.3.3.2 Gender
In general, females have a lower lean body mass, and tend to exhibit smaller 
quantitative electrocardiographic changes when compared to males. Males 
exhibit higher voltages and longer complex/interval durations e.g. PR interval, 
QRS duration and QT interval.17
Overall, there is limited data available with respect to the female athletes ECG 
across the demographic spectrum, as the majority of studies assessing cardiac 
adaptation in response to exercise have been conducted predominantly  in 
Caucasian male subjects.
There are few specific studies in the literature that examine the appearance of 
the ECG in the female athlete. Through cohort studies that examine both male 
and female athletes (in smaller numbers), one can determine that Caucasian 
female athletes seem to exhibit a lower prevalence of ECG abnormalities when 
compared to similar male subjects. The first of these to report was from a 
Norweigen cohort of 1299 physical education students, of which 617 (47%) 
were Female.56 Overall, male athletes had lower heart rates, with increased 
voltages and a higher prevalence of voltage criteria for LVH when compared to 
similar females. No distinction was attempted amongst this group between 
normal and abnormal, other than for conduction disease (e.g. the presence of 
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an accessory pathway), where there were no specific differences noted 
between the sexes. Pelliccia et al reported ECG findings in 1005 highly trained 
Italian athletes, 25% of which were female.11 They found that a significantly 
lower proportion of female athletes had “distinctly  abnormal ECG’s”, 8% vs. 
17% (p<0.001). The vast majority of female athletes studied had entirely  normal 
ECGs (78% vs. 55%; P<0.001). This has been followed by two large studies 
conducted in Italy, reporting results based upon an unselected group of 
individuals who attended one of the 19 clinics in Italy who conduct  the 
mandatory annual pre-participation screening required to compete in any 
sporting activity. Pelliccia at al reported data on a population of 32,652 
individuals, 6602 (20%) of which were female. Of these, 9.6% exhibited an ECG 
deemed “markedly  abnormal” by the investigators, compared to 12.4% of males 
(P<0.001).57 Sofi et al reports data on 30,065 individuals, 6495 (21%) of whom 
were female.58 In total, a lower proportion of athletes (6%) were deemed to 
have a “markedly abnormal ECG”, based on the same criteria as Pelliccia. With 
respect to gender differences, again, a significantly lower proportion of women 
had abnormal ECG’s when compared to men (Women 3.7% vs. Men 6.7%; 
p<0.001). However, when considers the individual abnormalities, a similar 
percentage of men and women demonstrated significant ST-T wave alterations 
(0.5% vs. 0.5%;p=0.9), which included T-wave inversions. 
With respect to female adolescent athletes (i.e. those under 18 years old), only 
a few data is available. In a study of 1000 adolescent predominantly Caucasian 
athletes, of which 270 (23%) were female, voltage criteria for LVH, right and left 
atrial enlargement and partial right bundle branch block, were more common in 
male athletes than female athletes, with only 5% of female athletes 
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demonstrating Solokow-lyon voltage criteria compared to 60% of male athletes 
(p<0.001).9 Papadakis et al, in a similar population of 1710 largely  Caucasian 
adolescent athletes49 observed that only 1 of the 296 female athletes studied 
(0.3%) demonstrated significant T wave inversions, compared to 66 (4.7%) of 
male athletes studied (p<0.001).
All the studies above have been conducted in predominately Caucasian 
athletes with no specific data available with respect to cardiac adaptation in 
black female athletes of any age. 
1.4 Differentiation between Physiology and Pathology
The data described in the above sections describes the impact of physical 
conditioning  on the appearance of both the echocardiogram and ECG in the 
athlete. The ability of a physician to accurately  interpret these investigations  is 
the mainstay of an effective pre-participation cardiac screening program. The 
clear differentiation between physiology and pathology is essential to allow 
appropriate intervention to minimise the risk of sudden cardiac death in an 
individual with a cardiac disorder, and conversely prevent an erroneous 
diagnosis in an otherwise healthy young person.
Hypertrophic cardiomyopathy  (HCM) and arrythmogenic right ventricular 
cardiomyopathy (ARVC) are the commonest causes of sudden cardiac death in 
the United States59 and Italy13 respectively. Therefore, the identification of 
features of either condition, notably left ventricular hypertrophy on 
echocardiography and/or electrocardiographic repolarisation anomalies, in an 
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individual at cardiac screening requires further thorough evaluation. Both 
findings can be the consequence of physiological adaptation, but careful 
assessment is necessary before they are attributed to this benign process. The 
following sections will describe current methods that are employed in the 
differentiation between athletic adaptation and cardiomyopathy as seen on the 
12-lead ECG and trans-thoracic echocardiogram. 
1.4.1 Left Ventricular Hypertrophy
As detailed above, the finding of left ventricular hypertrophy (a maximal left 
ventricular wall thickness of 13-16mm) in an athlete may occur in up to 4% of 
caucasian athletes and up to 18% of black athletes. This measure overlaps with 
vales observed in 10-15% of patients with morphologically mild HCM28. The 
majority of such findings can be attributed to physiological conditioning, 
however careful examination of the echocardiographic and clinical parameters 
should be undertaken to exclude pathological forms of myocardial hypertrophy. 
The vast majority of individuals with HCM find themselves unable to excel in 
sport due in part to the limitations in cardiac function imposed by this condition. 
However, there is marked morphological and functional heterogeneity, and 
outstanding athletic achievement is possible in some individuals.
The differentiation between pathological and physiological hypertrophy is 
usually clear, however may challenge even the most able cardiologist. The 
approach taken should be systematic, with a detailed history (including a 
comprehensive family tree and demographic assessment), physical 
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examination, 12-lead ECG and trans-thoracic echocardiography. If the 
diagnosis is unclear, then further imaging with cardiac magnetic resonance 
scanning, cardiopulmonary exercise testing , and screening for causal genetic 
mutations may be required in equivocal cases.
1.4.1.2 Impact of athlete demographics on the diagnosis of HCM 
When assessing an athlete with mild LVH, careful consideration of an athlete’s 
race and sex should be undertaken whilst establishing the diagnosis. The 
impact of both these demographic variables on the process of physiological 
adaptation has been described in section 1.2.
Precise details on the relative incidence of HCM in different ethnic groups is not 
available in the current literature, but expert consensus does not currently 
recognise a racial predilection.42,60 HCM has an estimated prevalence of 1 in 
500 amongst western populations, based upon a number of epidemiological 
studies61 62. In general, these report data on mainly caucasian subjects, with 
only a small proportion of the study population comprising Afro-Caribbean 
individuals.. Amongst a large cohort of patients diagnosed with HCM in one US 
registry, Afro-Caribbean patients represent only  8% of the cohort. This data 
however is likely  to be affected by the various socio-economic factors that 
impact the availability of healthcare in the US63.
Similarly, the majority of genetic mutations identified as causing the HCM 
phenotype are inherited in an autosomal dominant fashion.42 There does not 
appear to be an overall gender preference, and both males and females are 
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affected by the condition in equal numbers. Therefore, the diagnosis of HCM in 
a black athlete, male or female, is at present established on guidelines based 
on predominately caucasian subjects. Given the data presented in section 1.2, 
care should be taken to examine the echocardiogram and 12-lead ECG for 
features of HCM beyond absolute measures of left ventricular wall thickness.
1.4.1.3 Role of Trans-thoracic Echocardiography in the diagnosis of HCM  
Trans-thoracic echocardiography is an essential tool in the differentiation 
between pathological and physiological LVH in the highly trained athlete. It 
allows rapid and non invasive assessment of the myocardial structure and 
function, with information on the magnitude and distribution of left ventricular 
hypertrophy, associated left ventricular outflow obstruction, and indices of 
systolic and diastolic function. The presence of, or alterations in, these 
important structural and functional measures can be essential in establishing 
the diagnosis of a cardiomyopathy in an athlete. 
1.4.1.4 Structural Markers of HCM at Echocardiography
The discrimination between pathological and physiological hypertrophy should 
take into account the full echocardiographic study, rather than a single measure 
of left ventricular wall thickness in isolation. The upper limit of physiological 
hypertrophy in athletes is considered to be 16mm, and the data that support’s 
this have been described in section 1.2.2. Therefore, the identification at 
echocardiography of LVH of greater than 16mm, in any cardiac segment, should 
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be considered to be pathological and further investigation should be 
undertaken. 
Physiological LVH is homogeneous, symmetrical and athletes rarely  exhibit 
differences of >2mm between adjacent LV myocardial segments. The ratio of 
inter-ventricular septal wall thickness to the LV posterior wall thickness in end-
diastole is <1.5.64 In contrast, almost any pattern of hypertrophy is possible in 
HCM, and contiguous portions of left ventricle may vary  significantly in the the 
magnitude of LVH. Of note, 60% of individuals with HCM exhibit asymmetrical 
septal hypertrophy, with a further 10% demonstrate hypertrophy confined purely 
to the LV apex.60 
The left ventricular cavity size often the most useful additional measure. Almost 
all athletes with physiological LVH have concomitant enlargement of the left 
ventricular cavity, with only a minority exhibiting normal left ventricular 
dimensions.24 HCM is characterised by disparity between the magnitude of LVH 
and the left ventricular cavity size, with LVH occurring at the expense of left 
ventricular cavity  size. Most individuals with HCM have a small left ventricular 
cavity  (<45mm).42 A  dilated ventricle is a marker of end stage disease; a 
consequence of progressive myocardial fibrosis, increased LVEDP, and 
associated with impaired systolic and diastolic function and accompanied by 
significant functional limitation.
Approximately one quarter of individuals with HCM exhibit basal, dynamic left 
ventricular outflow tract obstruction at rest65 and up to 70% develop  obstruction 
with exercise, the majority due to systolic anterior motion (SAM) of the anterior 
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mitral valve leaflet against the inter-ventricular septum.66 This phenomenon has 
been attributed to several factors, including the presence of asymmetrical septal 
hypertrophy, anteriorly displaced papillary muscles, redundant mitral valve 
leaflets, a narrow LVOT and hyper-dynamic systolic function. The demonstration 
of SAM and associated LVOT obstruction at rest or immediately after exercise 
in an athlete with LVH is considered consistent with the diagnosis of HCM.65 
1.4.1.5 Functional Markers of HCM at Echocardiography
In an athlete with physiological LVH, conventional indices of diastolic function 
(mitral valve inflow Doppler and pulmonary vein Doppler measurements) are 
normal. These individuals have a compliant ventricle that is capable of efficient 
left ventricular filling to maintain a high stroke volume at approaching maximal 
heart rate.67 In contrast, individuals with HCM have an increase in myocardial 
stiffness as a consequence of myocyte disarray, myocardial fibrosis, and 
impaired sarcoplasmic calcium kinetics - all resulting in impaired myocardial 
relaxation. Hence, early passive left ventricular filling is blunted and impaired. 
This is reflected in a reversal of the E/A ratio, prolongation of the E-deceleration 
time (>240 msec) or isovolumic relaxation times (>90 msec), and reversed S/D 
ratio during pulmonary vein Doppler.68 
More recent studies utilizing colour coded and pulsed tissue Doppler 
echocardiography have provided more sensitive and specific methods of 
differentiating physiological LVH from HCM.69,70 Measurement of myocardial 
velocity gradients from digitised M-mode colour Doppler reveals that individuals 
with HCM exhibit impaired myocardial filling during the early rapid filling phase 
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of diastole and display  reduced left ventricular posterior wall myocardial velocity 
gradients when compared to athletes. In a small study comparing comparing 
individuals with HCM (n=25) and athletes with physiological LVH (n=21), 
suggests that a myocardial velocity  gradient of <7 s-1 measured in early 
diastole may be a sensitive and specific marker in differentiating physiological 
from pathological LVH.71
Assessment of longitudinal cardiac function with pulsed tissue Doppler at the 
level of the mitral valve annulus has shown that individuals with morphologically 
mild HCM, including those individuals with normal mitral inflow Doppler 
measurements (E/A), exhibit lower early diastolic velocities (Ea or E’) when 
compared with athletes. An E’ of <9m/s suggests pathological LVH, with a 
sensitivity approaching 90%.23 In addition, an E/E’ ratio may be useful,70 with an 
E/E’ of >12 being indicative of an increase in left atrial filling pressures - a 
recognized pathophysiological feature of HCM. However, the majority  of trained 
athletes exhibit an E/E’ of <8 as a consequence of the increase in left 
ventricular compliance and associated low filling pressures. (Table 1.3)   
Indices of systolic function are conventionally based on the percentage change 
in left ventricular volume between systole and diastole. As a consequence of 
the small left ventricular cavity  size and modest changes in the absolute volume 
of the LV, the percentage change (ejection fraction) in LV volume in patients 
with HCM may be high. When one considers other, more subtle, indices of 
systolic function - including pulsed tissue Doppler studies - many individuals 
with HCM have impaired longitudinal and radial systolic function. In general, the 
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identification of a peak systolic velocity  of <9cm/s at the mitral valve annulus in 
an athlete with LVH should suggest pathological substrate.72(Table 1.3)
Table 1.3 Echocardiographic indices used in the differentiation between 
physiological and pathological left ventricular hypertrophy.
Structural Markers Of HCM Functional Makers of HCM
Maximal LVWT > 16mm E/A reversal (ratio <1.0)
Asymmetric Hypertrophy (>2mm) E Decel >240 msec
Small (<45mm) LV cavity IVRT >90 msec
SAM ± LVOT gradient at rest Myocardial Velocity gradient < 7 s-1
Dilated LA E’ (lateral) < 9m/s
E/E’ >12
Peak S’ < 9cm/s
Abbreviations - A = late diastolic mitral valve inflow peak velocity, E = early 
diastolic mitral valve peak inflow velocity, E Decel = E wave deceleration time, E’ = 
early diastolic annular peak velocity (lateral mitral annulus), E:E`=ratio of peak 
early diastolic mitral inflow velocity to peak early diastolic mitral annular velocity 
HCM = hypertrophic cardiomyopathy, IVRT = Isovolumic relaxation time, LVWT = left 
ventricular wall thickness, LV = left ventricle, LA = left atrium, LVOT = left ventricular 
outflow tract, SAM = Systolic anterior motion of the mitral valve, S’ = systolic annular 
peak velocity (lateral)
1.4.1.6 Further assessment of LVH in the athlete
The trans thoracic echocardiogram is an essential part of the assessment of an 
individual in one whom the diagnosis of HCM is suspected. No single 
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echocardiographic parameter should be taken in isolation to be diagnostic, but 
should form part of a comprehensive clinical assessment, including the clinical 
history, examination and 12-lead ECG. The ECG changes that may be present 
in HCM will be discussed in section 1.4.2.
Despite this, the cause of LVH in the athlete may remain equivocal. There are 
further, less widely available non-invasive clinical investigations that may prove 
invaluable to the clinician required to assess an athlete with LVH.
The measure of peak oxygen consumption during an exercise test can be a 
useful method of differentiating physiological from pathological LVH. Athletes 
participating in endurance sports have a large peak oxygen consumption. A 
peak oxygen consumption of > 50ml/kg/min (or 120% of that predicted for age) 
in an athlete with mild LVH favours physiological adaptation.73 In contrast, most 
individuals with HCM have a sub-normal peak oxygen consumption irrespective 
of the magnitude of LVH and function capacity of the individual. The 
combination of impaired myocardial relaxation, associated with myocardial 
fibrosis, a small left ventricular cavity size, exercise related myocardial 
ischemia, and dynamic left ventricular outflow tract obstruction results in an 
innate inability to generate the large and sustained increases in stroke volume 
and cardiac output required in elite sport.
Additional imaging with cardiac magnetic resonance (CMR) imaging can 
provide valuable data on cardiac structure and function in addition to trans-
thoracic echocardiography. With respect to cardiac structure, CMR provides 
better definition of the cardiac apex and antero-lateral wall, allowing 
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demonstration of LVH in these segments that may not clearly be seen using 
trans-thoracic echocardiography (TTE)74 In particular, the use use of gadolinium 
enhancement to identify and quantify regional myocardial fibrosis can be very 
helpful in the differentiation between physiology and pathology. Approximately 
50% of individuals with pathological LVH due to HCM exhibit significant 
myocardial fibrosis75 which is not seen in athletes with physiological LVH. The 
identification of fibrosis strongly favours of a pathological form of hypertrophy. 
Given the diverse appearances and manifestations of HCM, there is no one 
isolated investigation that will identify all individuals with HCM. it may be 
necessary to subject the athlete in question to a period of detraining - usually 
around 3 months - followed by comprehensive re-assessment. Physiological 
LVH should regress, whereas pathological hypertrophy should persist, albeit to 
a lesser extent. This is associated with anxiety  as well as potentially 
jeopardizing fitness and future team selection. It should therefore be only 
advised if the athlete fully understands the implications involved and cooperates 
fully, as even a limited training may cloud the ability to make a clear diagnosis. 
The differentiation between pathological and physiological LVH may be 
extremely difficult, particularly in athletes of Afro-Caribbean ancestry, amongst 
whom little information exists regarding the spectrum of electrocardiographic 
and echocardiographic appearances in response to physical activity. More data 
is required to enable clinicians to make an accurate and correct diagnosis, and 
allow afro-caribbean  athletes to continue to excel at sport. 
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1.4.2 Repolarisation anomalies
The pre-participation screening program advocated by the ESC16,17 and IOC14 
include a 12-lead ECG as part of the assessment of an athlete. The presence 
of repolarisation anomalies (including ST segment depression and T-wave 
inversions in 2 or more contiguous leads) in an ECG is often the trigger for the 
athlete concerned to undergo further investigation to exclude a 
cardiomyopathy44 16,45, ion channel disease46 or other cause of sudden cardiac 
death during sport.
Amongst caucasian athletes, such repolarisation anomalies are present in 
3-4% of male adult and adolescent athletes. As has been discussed in section 
1.3.3, the prevalence of significant T-wave inversions is significantly lower in 
caucasian female athletes, and considerably higher amongst male black 
athletes. There is currently  no published data available on the ECG 
appearance in black female athletes. Given their relative rarity, current 
guidance suggests thorough evaluation of any athlete exhibiting such an ECG 
appearance in order to exclude occult cardiac disease.
Data on the significance of such ECG anomalies is currently  only available 
relating to male caucasian athletes. In a longitudinal study of 123 adult male 
athletes with deep T wave inversions, who presented at routine cardiac 
screening, 39 (32%) had echocardiographic and clinical evidence of cardiac 
disease. Of the remaining 84 athletes, who had no immediately demonstrable 
evidence of cardiac disease, 81 were followed up for a mean of 9 years (+/- 7 
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yrs.; range 1-27). Of these, 5 athletes (6%) subsequently developed a 
cardiomyopathy, with one death and one aborted cardiac arrest as a 
consequence of ventricular fibrillation due to ARVC and HCM respectively. The 
remaining 70 athletes did not develop  any pathological cardiac conditions 
during the period of follow-up. This data suggests that the presence of 
repolarisation anomalies, such as deep  T wave inversions, in a caucasian 
athlete may represent occult cardiac disease, and as such, the individuals 
should remain under periodic surveillance.  
As has been discussed in section 1.3.3, significantly greater numbers of black 
male athletes exhibit T wave inversions on the resting 12-lead ECG. These are 
predominately confined to the anterior precordial leads (Figure 1.8). there is 
currently no data available with respect to the long term significance of such 
ECG changes, and whether a proportion of such individuals may harbor a 
cardiomyopathy.  
1.5 Pre-Participation Cardiac Screening of Athletes 
The sudden cardiac death of a young athlete during a sporting event is a tragic 
and thankfully unusual event. Estimates vary with respect to the precise 
incidence. Data from the United States reports an incidence of 0.5 per 100,000 
per year.59 However, this is retrospective, based on collating mortality data from 
sporting institutions and media reports and likely therefore to represent an 
underestimate. Further retrospective data from the database of the NCAA 
(National Collegiate Athletic Association), reports an incidence of  sudden 
cardiac death of 1 in 43700 participants per year amongst collegiate level 
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athletes, assessed over a 5 year period.76  Prospective data from Northern Italy 
suggests an overall incidence of 2.1 deaths per 100,000 per year.13 The 
incidence in the UK is unknown, as no systematic registry of deaths during 
sporting activity exists.
These events are often highly visible and generate considerable media and 
public interest. The causes of these deaths are multiple (Table 1.1) and include 
cardiomyopathies, inherited anomalies of the coronary  arteries, and ion 
channel diseases. With advances in management and treatment of these 
conditions, once identified sudden death may be preventable. Given this fact, 
many sporting organisations, including FIFA,15 the IOC,14 the LTA (Lawn Tennis 
Association), and IRB (International Rugby Board)  have advocated pre-
participation screening for all athletes who are engaged in international 
competition. They are supported in this by international cardiac societies such 
as the ESC17. However, the diversity and low population prevalence of the 
conditions that need to be identified means that a large number of athletes 
need to be screened to identify a small number of individuals who harbour a 
serious cardiac disorder.  
In common with most western countries, the UK does not advocate a 
compulsory state sponsored pre-participation screening program. The majority 
of data examining the efficacy of such a system is derived from Italy, where 
state sponsored pre-participation screening has been written into the statute 
books since the late 1970s. Pre-participation screening is also advocated in the 
United States at a collegiate athlete level77 – but to a lesser extent than in Italy. 
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Hence, the bulk of data available regarding the efficacy of such screening 
programs has been derived from these two countries.  
1.5.1 Methods of pre-participation screening
The evidence that supports the use of pre-participation screening has been 
collated in both the US and Italy. However, the two countries have adopted 
differing approaches to the identification of conditions that may pre-dispose a 
young individual to sudden cardiac death during intense physical activity.
The American model of pre-participation screening comprises a focused 
history, assessed by means of a health questionnaire particularly concerned 
with cardiac symptoms and family history of cardiac disease, and a clinical 
examination.77This approach has a low sensitivity and specificity  for the 
identification of occult cardiac disease which may pre-dispose an individual to 
sudden cardiac death during sport. 80% of victims during exercise are 
asymptomatic prior to the lethal event, and the majority  of causes are not 
identifiable on examination alone. This is highlighted by a retrospective 
analysis of a series of 134 sudden cardiac deaths over a 10 year period in the 
U.S. 115 had undergone pre-participation screening, with a focused history and 
clinical examination, with only a single athlete correctly  diagnosed at the time 
of screening.59 
Current legislation in Italy mandates an annual pre-participation cardiac screen 
for all athletes that participate in any organised sporting event. This legislation 
has been in place since 1976, and has resulted in Italian physicians developing 
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unique experience in the pre-participation screening of athletic individuals. The 
screening process used involves a focused history, examination and 12-lead 
ECG. The addition of the ECG to the screening protocol increases both the 
sensitivity and specificity of the screening process. It facilitates the 
identification of cardiomyopathies with 95% of individuals with HCM, and 80% 
of individuals with ARVC, having electrocardiographic abnormalities.78,79 In 
addition, the diagnosis of ion-channel disorders and accessory pathways are 
dependant upon electrocardiography.79 All are recognised causes of sudden 
death during sporting activity.12,59
Evidence to justify to addition of a 12-lead ECG to a history and examination 
has come from several prospective large demographic studies examining the 
efficacy of the Italian programme. With respect to the identification of 
cardiovascular disease, amongst a population of over 33,000 screened in the 
Vento region of Northern Italy  over 17 years, 1.8% (n=621) were identified with 
a cardiac condition and subsequently excluded from sport. Of these, 0.07% 
(n=22) were diagnosed with HCM, all of whom remained alive at follow-up. The 
majority of athletes excluded were as the result of hypertension, valvular heart 
disease, or cardiac conduction disease.  The same Italian group  have 
published data examining the efficacy of their screening program, described 
ac ross th ree t ime pe r iods – wh ich they have te rmed “p re -
screening” (1979-1981), “early screening” (1982-1992), and “late 
screening” (1993-2004). They demonstrated a reduction in sudden deaths 
during sport from 3.6/100,000 person-years in 1979-80, to 0.9/100,000 person 
years in 2003-2004 (Figure 1.9). The reduction in mortality  can be explained by 
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a reduction in observed deaths primarily due to cardiomyopathy, including 
AVRC and HCM.13 
Figure 1.9 Annual Incidence Rates of Sudden Cardiovascular Death in Screened 
Competitive Athletes vs Non-athletes in the Veneto Region of Italy (1979-2004), 
demonstrating the efficacy of the addition of an ECG to the pre-participation screening 
protocol. Corrado et al13
If therefore the ECG (and subsequent echocardiogram) is to be used as tool to 
identify latent pathology in athletes, then it is vital that the sports cardiology 
community has a clear and accurate understanding of what constitutes a 
normal ECG across the athletic demographic spectrum.
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1.4.2 The Pre-Participation screening of Black Athletes
Currently, when assessing a young black athlete, a physician is required to 
extrapolate data derived from a population which is non-representative for the 
vast majority of athletes in the United Kingdom or Western Europe.  There is no 
data available on the ECG or echocardiogram in female black athletes to allow 
accurate assessment of these individuals and differentiate physiological 
adaptation from pathological causes of sudden cardiac death during sport. 
There is also no data on the longitudinal significance of the ECG changes that 
have been described in black male athletes,18,53,54, and it is currently unclear if 
a proportion of these individuals may harbor an occult cardiomyopathy.
Worldwide sporting organizations14,15 and international cardiac societies17 are 
increasingly recommending and requiring pre-participation cardiac screening 
for all athletes prior to competing in international sporting events, irrespective 
of their nationality. This is as a result of partly an increased understanding of 
the disease processes that may lead to sudden death in sport and advances in 
the therapy of such conditions60, and partly due to the relative success of 
systematic pre-participation screening programs in countries such as Italy.13 
Along with the increase in pre-participation cardiac screening seen across 
sporting disciplines, there has been an overall increase in the numbers of black 
participants in elite sport. Within western countries, black athletes form an 
increasingly large percentage of all athletes representing their respective 
nations. For example, at the Beijing Olympics 2008, over 80% of all track and 
field medals were won by  athletes of African/afro-Caribbean ancestry. In 
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particular, female black athletes won 72% of track medals at these games.80 
This is in addition to the rise of African teams competing with great success at 
international level in a variety  of sports – in particular football, basketball, rugby 
and athletics. Within American sport, black players predominate within the 
National Football League (the NFL), and the National Basketball Association 
(the NBA), where 70% and 85% respectively, of players are black. Within 
female professional sport, two black female players have dominated the game 
of tennis for the last decade (the Williams sisters) and have inspired a new 
wave of black female players into the game. Similarly, in international track 
athletics, black male and female athletes have come to predominate in the 
upper levels of competition across both sprinting and distance running 
disciplines.
In general, the numbers of black participants in all sports (both male and 
female) over the coming decades is predicted to rise. In particular, the numbers 
of black female participants in organised competitive sport is expected to 
increase dramatically. US federal legislation - known as Title IX, has meant that 
sporting scholarships within the US collegiate system has to be seen to be 
divided equally between both male (who currently dominate college sport) and 
females. As a direct consequence, there has been increased opportunity for 
women of all races to participate in a wide range of sporting disciplines. 
Female participation in collegiate sport has risen by 450% across a 27 year 
period (1977-2006), and this trend has continued.81 Certain sports, such as 
swimming, are actively targeting the black community  to increase participation 
– currently  at low levels.82 The rise in black female athletes will be mirrored by 
an increase those undergoing pre-participation screening. 
61
There is currently  no data within the scientific literature on the normal 
electrocardiographic or echocardiographic appearances in black female 
athletes. If data from white athletes is incorrectly  applied to this population, 
then there is a risk of inaccuracies in the identification and diagnosis of 
conditions that may predispose an individual to sudden cardiac death during 
sporting activities. If an incorrect diagnosis is made, and that female athlete 
subsequently  excluded from further sporting participation, then there is 
potential for significant harm, both financially and psychologically. The 
converse is also true, with black female athletes who may harbour potentially 
life threatening disease placed at further risk by continued participation in 
sporting activity.
There is also limited data on the relationship  between the ECG and 
echocardiographic appearances of male black athletes and potential causes of 
sudden death during sport - in particular. cardiomyopathy. The small volume of 
data currently available has concluded that the ECG repolarisation changes 
and echocardiographic LVH seen amongst black male athletes can be 
attributed to the physiological effect of training. There is no large scale 
descriptive or longitudinal data to confirm or refute this hypothesis. Black 
athletes with such ECG and echocardiographic anomalies may be falsely 
reassured that they do not have an occult cardiomyopathy.
It is crucial that cardiologists develop a clear and accurate understanding of the 
physiological adaptive processes that accompany  regular systematic physical 
training. This should be across the demographic spectrum, with recognition that 
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ethic differences exist in the presentation of cardiac disease. Physicians will 
then be better placed to correctly assess individual athletes and prevent 
unnecessary exclusion of athletes, whilst identifying those at genuine 
increased risk of sudden death during sport. 
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1.5 Aims and Objectives
There are current deficiencies in the scientific literature with respect to the 
physiological manifestations of athlete’s heart in black (African/Afro-Caribbean) 
athletes. In particular, there has been no published data on either the ECG or 
echocardiogram amongst female elite black athletes. There is also no data 
assessing the significance of the ECG and echocardiographic appearances 
that have been described amongst black male athletes.
 
This thesis aims to address this issue by examining the characteristics of 
physiological cardiac adaptation in a large unselected cohort of elite female 
and male athletes of African/Afro-Caribbean origin, and comparing them to 
both sedentary controls, similar cohorts of unselected Caucasian athletes, and 
a cohort of black patients who have the diagnosis of hypertrophic 
cardiomyopathy.  Therefore the objectives of this study are to:
1. Describe the normal range of trans-thoracic echocardiographic 
appearances amongst female elite black athletes 
2. Describe the electrocardiographic appearances seen in female elite 
black athletes
3. Correlate the electrocardiographic appearance amongst these two 
group of athletes with the trans-thoracic echocardiographic appearance
4. Compare the electrocardiographic and electrocardiographic 
appearances of a large cohort of male black athletes and a cohort of 
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black patients with HCM, in particular the significance of T-wave 
inversions..
5. Assess the longitudinal significance of the electrocardiographic and 
echocardiographic appearance in black male athletes.
Overall, the objective is to provide information regarding the normal 
appearance of the athlete’s heart in black athletes, in order to facilitate the 
clear and accurate pre-participation screening of these individuals for causes of 
sudden cardiac death during sport. 
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Chapter 2 - Methodology
2.1: Setting
This study was part of a collaborative programme between the United Kingdom 
and France designed to investigate cardiac adaptation in black athletes. 
Neither country  has a mandatory pre-participation cardiac screening program. 
However, certain international and national sporting organisations such as the 
International Olympic Committee14, the Federation Internationale de Football 
Association (FIFA)15, the Union Cycliste International (UCI), and the 
International Rugby board (IRB) require pre-participation cardiac screening for 
all athletes who compete at events endorsed by these governing bodies. In 
addition athletes who are not affiliated with these organisations but participate 
in the Commonwealth games are also required to undergo mandatory pre-
participation screening. 
Over the period of the study, our collaborative group  (in conjunction with the 
charity Cardiac Risk in the Young (CRY) and the University Rennes Sports 
Institute) has been responsible for the majority  of cardiac screening carried out 
on elite athletes in both the United Kingdom and France. In the United 
Kingdom this is conducted at national sporting training camps, King’s College 
Hospital (2007-2010), University  Hospital Lewisham, and St Georges Hospital 
(2010 onwards). In France, the majority of athlete assessment takes place at 
the Sports Medical Institute of the University Hospital Rennes, under the 
supervision of Prof. F Carre. The data presented here represents the sum of all 
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available athletes that have been assessed as part of the ongoing work of the 
group across both countries between 2006 and 2010.
2.2 – Study Design
This study  was undertaken as a prospective cohort study, examining the ECG 
and echocardiographic appearances of a group of elite African/Afro-Caribbean 
athletes. The findings were compared to a similar group  of elite Caucasian 
athletes, a similar group of sedentary  African/Afro-Caribbean sedentary  control 
subjects, and a group  of patients who had been diagnosed with hypertrophic 
cardiomyopathy.
Ethical approval for this work was granted by the ethics committee at the 
University  Hospital Lewisham and South East Thames ethics committee’s and 
in France, by the University Rennes Ethics Board. Information sheets were 
provided to all athletes, controls, and HCM patients at least 24 hours prior to 
the assessment that clearly explained the screening process (Appendix A). 
Medical staff were available to answer any specific questions that the subjects 
may have prior to the assessment taking place. All study participants provided 
written consent for the evaluation.(Appendix B)
  
2.2.1: Subjects
Between 1996 and 2010, 3185 consecutive athletes, 399 sedentary control 
subjects and  155 patients with hypertrophic cardiomyopathy  underwent 
assessment with a health questionnaire, focused cardiac examination, 12-lead 
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ECG and 2-dimensional echocardiogram. Amongst the athletes and controls, 
the assessment was part of a standard pre-participation cardiac screening. In 
the individuals with HCM, the assessment  formed part of the standard ongoing 
clinical assessment in a number of outpatient clinics run from a tertiary 
cardiology referral centre in South London. 
2.2.1.1 Athletes
An athlete was defined as an individual who participates and competes in a 
singular sporting discipline on a regular basis.  
Athletes were recruited from consecutive screenings organised on behalf of 
various national sporting governing bodies – including the FA, the IRB, the 
British Olympic Association (BOA), the Comite National Olympique et Sportif 
Francais, and the Lawn Tennis association (LTA). All athletes were fully 
consented to participate at the time of screening.  All athletes competed at 
regional, national or international level. All athletes underwent at least one 
standard pre-participation cardiac evaluation.
In total, 440 female athletes and 2745 male athletes were assessed, in both 
the U.K. and in France. 
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2.2.1.2 Sedentary controls 
A sedentary control subject was defined as an individual who performs less 
than 2 hours per week of regular purposeful physical activity.
Sedentary controls were recruited from the voluntary cardiac screening 
program run by the charitable body, Cardiac Risk in the Young (CRY). The 
service offered is freely available to the general public, irrespective of their 
athletic prowess or participation. The standard CRY screening in the majority of 
cases comprises a focused history, examination and ECG, with an 
echocardiogram only if indicated. In total, 7326 individuals underwent cardiac 
screening between 2006 and 2010. Any potential selection bias was minimised 
by considering only  consecutive individuals who attended screening events 
offering both ECG and echocardiography as cardiac investigations. All controls 
were consented to participate at the time of screening, and all groups were 
assessed using identical screening protocols. Further selection criteria included 
an ethnic background defined as white or black (African/Afro-Caribbean), age 
14 to 35 years old, the absence of cardiac symptoms, drug history  , or family 
history of sudden cardiac death or cardiomyopathy. In total, 399 individuals 
where included in the analysis, 119 black male controls, 140 black female 
controls, and 140 white female controls. For the purposes of this study, 
individuals hailing from other ethnic groups (e.g. asian or chinese descent) 
were excluded.
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2.2.1.3 Hypertrophic Cardiomyopathy patients
Between 2001 and 2010, 155 new patients with hypertrophic cardiomyopathy 
were seen and assessed in one of three specialist cardiomyopathy clinics in 
South London. These institutions include Kings College Hospital, University 
Hospital Lewisham, and St Georges Hospital. The particular demographic 
characteristics of the community served by these hospitals comprises of a 
substantial proportion of individuals of African/Afro-Carribean descent. In some 
areas, this approaches 30%, compared to a national average of under 2%.
These clinics, therefore, offered a unique environment to identify  black 
individuals, both male and female, that are affected by HCM. The majority  of 
patients diagnosed with HCM were referred originally from primary care 
following symptoms (including chest pain, palpitations, and breathlessness), 
the identification of a new cardiac murmur, or for screening in the context of a 
family history of HCM or sudden cardiac death. A further cohort of patients 
were referred from local district hospitals seeking a specialist opinion.  
The diagnosis of HCM was made based upon the AHA/ESC consensus 
statement. 42,60 In general, the condition was identified based on a maximal 
end-diastolic left ventricular wall thickness of greater than 15mm in any 
myocardial segment, in the absence of a cardiac or systemic cause, or the 
identification of relative left ventricular hypertrophy (a maximal left ventricular 
wall thickness between 12 and 15mm) with electrocardiographic abnormalities 
consistent with HCM (repolarisation abnormalities, extreme leftward axis 
deviation, of left bundle branch block) and the identification of HCM in a first 
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degree relative. Only  patients with African/Afro-Caribbean ancestry  were 
considered for this analysis. Patients who had previous been subjected to 
therapy that may induce significant ECG changes - most notably  repolarisation 
anomalies - such as septal myomectomy or pacemaker insertion were 
excluded, as were patients who had a concurrent diagnosis of myocardial 
ischaemia that may have affected the pattern of the 12-lead ECG. A total of 52 
patients, 32 mean and 20 women, fulfilled the inclusion criteria and were 
included in this analysis.
2.2.3. Health Questionnaire
The health questionnaire (appendix C) has been designed to specifically 
assess symptoms that may be the result of previously unrecognised 
pathological cardiac disease.83 It asks for information on past medical and drug 
history, family history  -including established risk factors for the development of 
atherosclerosis (hypertension, diabetes, and hypercholesterolaemia), and 
information on any specific incidences of sudden death in young family 
members (either as a result of a specific cardiac cause or unexplained). 
Any athlete or control with specific cardiac symptoms which raised suggestion 
of occult cardiac disease, or family  history of sudden cardiac death or a 
hereditary disease which may predispose an individual to sudden cardiac 
death during sport, were excluded from further analysis and investigated 
appropriately in a tertiary cardiology clinic. 
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All subjects were then asked to define their main sport in which they  participate 
(if any) and state the number of hours that total training in an average week. A 
sedentary control subject was defined on the basis of this self reported figure. 
To be considered as sedentary, an individual had to state that they participated 
in less than 2 hrs per week of regular sporting activity. 
2.2.3 Demographic Data Collection
Each subject’s age at the time of screening, height and weight were recorded. 
The subjects were requested to remove excess clothing and all footwear. 
Height was measured using a standard stadiometer, and recorded (to the 
nearest cm). The subject’s weight was then recorded to the nearest kilogram. 
Weight was measured using a scale (Seca, Hamburg, Germany) that had been 
calibrated regularly. Body surface area (BSA) was calculated using the formula 
– BSA (m2) = 0.20247 x Height(m)0.725 x Weight(kg)0.425 .84
 
The subject were asked to self define their ethnicity, with terms including black 
African, black Afro-Caribbean, black British, black French, white British, white 
Irish and white French. These were then collated – with the term “black” in this 




Each subject underwent a focused cardiac examination, including blood 
pressure measurement, and auscultation of the precordium, according to the 
ESC consensus statement on pre-participation screening. 17
Blood pressure was measured using a manual sphygmomanometer at rest. If 
elevated, then this was repeated on three occasions and an average taken, in 
an attempt to account for any potential hypertensive stress response. Athletes 
or controls with persistent hypertension were referred to their general 
practitioner for ongoing monitoring and investigation as appropriate. 
Results were documented, and any athlete or control with examination findings 
clearly  consistent with an occult cardiac disease were excluded from further 
analysis and investigated appropriately in a tertiary centre cardiology clinic. 
Of the full cohort of 3584 individuals without a diagnosis of cardiomyopathy, 22 
athletes (all male) were excluded based on systolic blood pressure readings of 
greater than 140mmHg or diastolic blood pressure readings of greater than 
90mmHg. 
2.2.5 12-Lead Electrocardiogram
 A standard 12-lead electrocardiogram (EKG) was performed during quiet 
respiration in a supine position using a Philips Pagewriter Trim III ((Philips, 
Bothel, Washington) recorder.87  The electrodes were placed carefully to 
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ensure consistency, and ECGs were recorded at a paper speed of 25 mm/s. 
Heart rate and QRS axis were calculated. A significant left QRS axis was 
defined as a frontal axis between -30o and -90o .P, Q-, R-, S-, and T-wave 
voltages; ST-segments; QRS duration; PR interval; and QT-interval were 
measured in each lead using callipers. Pathological Q-waves were defined as 
being greater than 0.04s in duration or ≥25% of the height of the following R-
wave. The QT-interval was corrected for the heart rate (QTc) using the Bazzet’s 
formula.54 Electrocardiographic LVH was defined using the Sokolow–Lyon 
voltage criterion.88 Electrocardiographic criteria for left and right atrial 
hypertrophy were defined according to the European Society of Cardiology 
(ESC) consensus statement on pre-participation screening.16,17 
ST segment shift and T wave inversions were considered as repolarisation 
anomalies. ST segment deflection was considered significant if ≥1mV in 2 or 
more contiguous leads. Similarly, T wave inversion of ≥-0.1mV in 2 or more 
contiguous leads was considered significant - excluding that seen in lead aVR, 
V1 and lead III in isolation. Biphasic T waves were considered abnormal if the 
negative portion exceeded -0.1mV. If present, the distribution of T wave 
inversions was classified into one of three groups:
• T wave inversions affecting the Anterior leads (V1-V4)
• T wave inversions affecting the inferior leads (II, III, aVF)
• T wave inversions affecting the lateral leads (I, aVL, V5, V6)
Deep T wave inversions were defined as a maximal negative deflection of 
-0.2mV or greater, in at least one lead, in an ECG that demonstrates significant 
T-wave inversions (i.e. in 2 or more contiguous leads).
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All ECGs were read and interpreted by myself, and validated by two senior 
physicians, in the UK and France, both of whom are highly experienced in 
sports cardiology and the diagnosis and management of HCM.
2.2.6 Trans-thoracic Echocardiography 
A full 2-dimensional echocardiogram was conducted on each subject by one of 
3 experienced sports cardiologists (the majority  by myself) using GE Vivid I 
(General Electric, Tirat Carmel, Israel), Philips Sonos 7500, or Philips CPX50 
(Philips, Bothel, Washington) cardiac ultrasound equipment. Standard views of 
the heart were obtained, and analysed according to the protocol specified by 
the European Society of echocardiography.89 Left ventricular (LV) wall 
thickness was measured in the 2-dimensional para-sternal short axis, at the 
levels of the mitral valve and papillary muscles; the greatest measurement 
being defined as the maximal LV wall thickness (maximal LVWT). Left 
ventricular diameter was measured in the para-sternal long axis using an M-
mode positioned at the tips of the mitral valve leaflets, according to the ESC 
protocol.89 If the M-mode cursor could not be positioned on axis, then a 2-D 
image was used for assessment. Left atrial diameter was measured in the the 
para-sternal long axis at end-diastole. Aortic annular size was also measured 
using an M-mode cursor, positioned parallel to the cusps of the aortic valve in 
the para-sternal long axis.89 Left ventricular mass (LVM) was calculated using 
the formula of Devereux.90 Left ventricular ejection fraction was calculated from 
left ventricular volumes using Simpson’s rule91. Assessment of diastolic 
function included traditional pulsed wave Doppler across the mitral valve,67 and 
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tissue Doppler velocity imaging of the septal and lateral mitral valve annulus.70 
Echocardiographic files were saved to compact disc or digital video disk as 
numeric files to preserve anonymity. 
All measurements where repeated by an experienced senior cardiologist, 
blinded to the identity of the subject.
2.3 Further Evaluation and follow-up
All subjects with left ventricular hypertrophy (maximal LVWT of > 11 mm) or  T 
wave inversions in 2 contiguous leads underwent further clinical evaluation with 
treadmill exercise testing, 48hr Holter monitoring and where appropriate, 
cardiac magnetic resonance imaging to check for the broader phenotypic 
features of the variety  of cardiac diseases that may pre-dispose individuals to 
sudden cardiac death during sport. 59
Several athletes underwent repeat cardiac evaluation over the time period of 
the study, in accordance with the screening policies of their sporting 
organisations. The timetable of such evaluations was dictated according purely 
by the sporting organisation concerned, and was irrespective of baseline 
results.
2.3.1: Exercise stress testing
An upright treadmill stress test was performed using the standard Bruce 
Protocol.92 EKG and blood pressure (BP) were recorded at 1min intervals. 
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Subjects were exercised to volitional exhaustion and assessed specifically for 
the development of ischaemic changes, abnormal or flat BP response and 
arrhythmias. An abnormal blood pressure response was defined as a rise in 
systolic blood pressure from resting baseline to peak exercise of less than 
25mmHg or a fall of 10mmHg or more from baseline, or the peak blood 
pressure attained.93
2.3.2: 48-Hour ECG monitoring
48 hour ambulatory ECG monitoring was performed to check specifically for 
supra-ventricular and/or ventricular tachy-arrhythmias.94 Athletes were 
encouraged to continue usual day-to-day life activities including exercise during 
the investigation.
2.3.3: Cardiac Magnetic Resonance Imaging
Cardiac magnetic resonance imaging was performed with a Siemens Sonata 
1.5T (Erlangen, Germany) using steady-state, free precession breath-hold 
cines (TE/TR 1.6/3.2 ms, flip  angle 60°) in long-axis planes and sequential 
7mm short-axis slices (3mm gap) from the atrioventricular ring to the apex. 
Late gadolinium enhancement images were acquired 10 minutes after 
intravenous gadolinium-DTPA (Schering, 0.1mmol/kg) in identical short-axis 
planes using an inversion-recovery gradient echo sequence. Inversion times 
were adjusted to null normal myocardium (typically 320 to 440 ms; pixel size 
1.7 x 1.4mm). Late gadolinium enhancement images were phase swapped to 
exclude artefact. Ventricular volumes and function were measured for both 
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ventricles using standard techniques95,96 and analyzed using semi-automated 
software (CMR tools, Cardiovascular Imaging Solutions, London, UK). All 
volumes and masses were indexed for age and BSA
2.4: Statistical Analysis!
Data are expressed as mean ±  standard deviation (SD), with percentages were 
appropriate. Variables were tested for normality using the Kolmogoriv-Smirnov 
test. Statistical analyses to assess group  differences were performed using 
unpaired Students t-test or one-way ANOVA and Mann-Whitney U or Kruskal-
Wallis tests for normally  and non-normally distributed variable respectively. To 
test group differences in proportions, Fisher’s exact test was used, calculated 
from a 2 x 2 contingency  table using SPSS version 12 (Chicago, IL, USA). A p 
value of <0.05 was considered significant for all statistical analyses.
For continuous variables, a stepwise multivariable linear regression model was 
constructed to assess the relationship  between LVWT and LVM, as dependant 
variables, with age, height, weight, body  surface area, ethnicity, country of 
screening and hours trained as predictors.
For binary variables, a binary logistic regression model was constructed to 
assess any relationship  between T-wave inversions or ST segment elevation 
as dependant variables, and age, height, weight, BSA, country of screening, 
number of hours trained, ethnicity, maximal LVWT, and end diastolic left 
ventricular cavity diameter as independent variables.
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Averaged coefficients of variance for intra-observer and inter-observer 
variability were calculated for values of maximal left ventricular wall thickness. 
No attempt was made to re-test, as the the observed variability in measures 
was low - see chapter 4, section 4.4. 
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Chapter 3 – Subject Characteristics
In total, 3562 individuals underwent assessment as part of this study. The 
subject characteristics will be presented below, divided according to gender.
3.1 Female Subject Demographics
In total, 240 consecutive female black and 200 Caucasian athletes and 140 
consecutive black and 140 Caucasian sedentary female control subjects 
underwent assessment.
3.1.1 Black Female Athlete Demographics
Two hundred and forty consecutive black female athletes were recruited from a 
variety of sporting disciplines. These included athletics (25%), basketball, 
(20%), football/soccer (16%), netball (18%) and martial arts( 13%) (Table 3.1). 
They reflect the typical sports in which black female athletes participate in 
Western Europe.  
The demographics of the black female athlete group is presented in table 3.1. 
Of the 240 black athletes, 70% (n=169) originated from the UK, and the 
remainder from France. On average, each athlete participated in their chosen 
sporting discipline for 13.7±3.4 hrs (8-24hrs) per week. All athletes competed at 
regional, national or international level.
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3.1.2 White Female Athlete Demographics
Two hundred consecutive white female athletes were recruited from the same 
sporting disciplines as the black athletes (Table 3.1). In general, the athletes 
were recruited from the same clubs and teams as the black athletes, and 
therefore participated in similar training programes. 
White female athletes were similar in age, height and weight to the black 
female athlete group (Table 3.1).  Of the two hundred white female athletes, 
70% (n=140) were studied in the UK, with the remainder in France, an identical 
proportion as within the black female athletic group. On average, each athlete 
participated in their chosen sporting discipline for 14.4±6.1hrs (8-36hrs) per 
week. All Caucasian female athletes participated at a similar competitive level 
to the black female athlete group – with each athlete having competed at 
regional, national or international level. 
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Age (years) 21±4.6 (14-35) 20±4.0 (14- 35) 0.18
Weight (kg) 66±10.8 (39-106) 64±8.4 (45-92) 0.06
Height (m) 1.71±8.3 (150-192) 1.70±7.7 (151-191) 0.07
BSA (m2) 1.78±0.17 (1.31-2.21) 1.73±0.18 (1.33-1.96) 0.10
Resting SBP (mmHg) 110±19 (120-80) 111±13 (120-80) 0.80
Resting DBP (mmHg) 65±12 (85-40) 66±12 (89-40) 0.94
Training/week (Hours) 13.7±3.4 (8-24) 14.4±6.1 (8, 36) 0.41
Sporting discipline 
Athletics (%) 25 23 0.58
Basketball (%) 20 18 0.63
Football (Soccer) (%) 16 20 0.26
Netball (%) 18 18 1.00
Martial arts (%) 13 11 0.56













Data expressed as mean±standard deviation (limits) or percentages (%), as 
appropriate.
Abbreviations –BSA – Body  Surface Area, DBP – Diastolic Blood Pressure, LDR – 
Long Distance Running, SBP – Systolic Blood Pressure.
82
3.1.2 Female Control subject Demographics
One hundred and forty consecutive black female sedentary control subjects 
and 140 female sedentary  white control subjects were recruited from CRY 
screening clinics, conducted within the UK. All controls participated in less the 
two hours of sporting activity per week (Table 3.2). When comparing control 
groups, both black and white female sedentary subjects were similar and 
comparable in all demographic characteristics. (Table 3.2).
Table 3.2 Demographic Characteristics of Black and White Female Control 
Subjects
White Controls Black Controls P Value
Age (yrs) 20±5.3 (14-35) 21±6.6 (14-35) 0.07
Height (cm) 168±6.6(154-187) 1.69±6.9 (1.5-1.87) 0.08
Weight (Kg) 64±13.6(37-106) 65±13.4 (42-109) 0.6
BSA (m2) 1.71±0.17(1.3-2.1) 1.74±0.17(1.3-2.2) 0.34
SBP(mmHg) 111±15 (120-80) 113±13(120-80) 0.29
DBP (mmHg) 65±12 (87-40) 65±15 (80-40) 0.94
Training/week (hrs) 1.22±0.83(0-2) 1.1±0.85(0-2) 0.57
Data expressed as mean±standard deviation (limits) or percentages (%), as 
appropriate.
Abbreviations –BSA – Body  Surface Area, DBP – Diastolic Blood Pressure, LDR – 
Long Distance Running, SBP – Systolic Blood Pressure.
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3.1.3 Female Athletes versus Control subjects
When compared to their respective control groups, both black and white female 
athletes were similar in age, height, weight, and body  surface area. There were 
no significant differences in systolic or diastolic blood pressure between the 
athlete and control groups. (Table 3.3 – White female athletes vs. white female 
controls, Table 3.4 – Black female athletes vs. black female controls). 
By definition, both groups of athletes spent a significantly  greater amount of 
time engaging in physical activity when compared to sedentary controls. (Table 
3.3/3.4)
Table 3.3 Demographic characteristics of black female athletes and controls
Black Athletes Black Controls P Value
Age (yrs) 21±4.6 (14-35) 21±6.6 (14-35) 0.37
Height (cm) 1.71±8.3 (1.5-1.92) 1.69±6.9 (1.5-1.87) 0.07
Weight (Kg) 66±10.8 (39-106) 65±13.4 (42-109) 0.18
BSA (m2) 1.78±0.18 (1.3-2.2) 1.74±0.17(1.3-2.2) 0.06
SBP(mmHg) 110±19 (120-80) 113±13 (120-80) 0.40
DBP (mmHg) 65±12 (85-40) 65±15 (80-40) 0.32
Training/week (hrs) 13.7±3.4 (8-24) 1.1± 0.85 (0-2) <0.0001
Data expressed as mean±standard deviation (limits) or percentages (%), as 
appropriate.
Abbreviations –BSA – Body  Surface Area, DBP – Diastolic Blood Pressure, LDR – 
Long Distance Running, SBP – Systolic Blood Pressure.
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Table 3.4 Demographic characteristics of white athletes and controls
White Athletes White Controls P Value
Age (yrs) 20±4.0 (14- 35) 20±5.3 (14-35) 0.46
Height (cm) 1.70±7.7 (151-191) 168±6.6(154-187) 0.27
Weight (Kg) 64±8.4 (45-92) 64±13.6(37-106) 0.97
BSA (m2) 1.73±0.18 (1.33-1.96) 1.71±0.17(1.3-2.1) 0.49
SBP(mmHg) 111±13 (120-80) 111±15 (120,80) 0.90
DBP (mmHg) 66±12 (89-40) 65±12 (87-40) 0.34
T r a i n i n g / w e e k 
(hrs)
14.4±6.1 (8, 36) 1.22±0.83(0-2) <0.001
Data expressed as mean±standard deviation (limits) or percentages (%), as 
appropriate.
Abbreviations –BSA – Body  Surface Area, DBP – Diastolic Blood Pressure, LDR – 
Long Distance Running, SBP – Systolic Blood Pressure.
3.2 Male Subject Demographics
In total, 904 black male athletes, 1829 white male athletes, and 119 black male 
control subjects underwent assessment as part of this study.  
3.2.1 Black male Athlete demographics
Black male athletes were recruited from a variety of sporting disciplines (Figure 
3.1). In total, 25 sporting disciplines were studied, including soccer (41%), track 
and field athletics (18%), boxing (15%) and martial arts (9%)(Figure 3.1). 
These sports reflect the typical participation levels in western europe. Black 
male athletes exercised for a longer period of time per week than white male 
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athletes  (15.2 ± 6.1 vs 13.1± 6.2 hrs/week). (Table 3.5). Every effort was made 
to recruit athletes from the same teams/coaching organisations in order to 
ensure that similar training programmes were pursued by athletes from 
different ethnic backgrounds, participating in the same sport. 
When compared to white male athletes and black male controls, black athletes 
were older (with 95% being over 16 yrs old; Black males 22.5±5(14-35) yrs vs 
white male athletes 17.4 ± 4.1 (14-35 yrs); p<0.001)), and had a higher body 
surface area. (Table 3.5) Systolic and diastolic blood pressure and was also 
higher in black male athletes than in white male athletes (Table 3.5). 
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Figure 3.1 Sporting Disciplines expressed as percentage of the total black (Black bars) 
and white (grey  bars) athlete cohorts respectively. *Track and Field events. **<1%  of 
the total cohort. White athletes: Biathlon n=15; speed skating n=10; Gaelic Football 
n=7; badminton n=5. Black athletes: weight lifting n=6; American Football, n=5; 
gymnastics n=5; fencing n=5.








N= 904 1819 119
Age (yrs) 22.5 ± 5.0 
(14-35)
17.4 ± 4.1 
(14-35)
18.6 ± 6.0 
(14-35)
<0.001 a,b,c
BSA (m2) 1.92 ± 0.2 
(1.3-2.8)
1.87 ± 0.24 
(1.27-2.8)





116.5 ± 13.1 
(80-140)
111.8 ± 11.0 
(82-145)





71.2 ± 11.5 
(40-90)
68.9 ± 9.6 
(40-89)






15.2 ± 6.1 
(8-36)
13.1 ± 6.2 
(8-30)
<0.001 a,b,c
aStatistically significant difference between black athletes and white athletes
bStatistically significant difference between black athletes and black controls
cStatistically significant difference between white athletes and black controls.
3.2.2 White male athlete demographics
In total, 1819 consecutive white male athletes were recruited from a variety of 
sporting disciplines which is summarised in figure 3.1. In general, white male 
athletes were recruited from the same teams/training organisations as black 
male athletes. The distribution of sporting disciplines and rates of participation 
reflects general participation levels by black and white male individuals across 
the UK and France. All athletes participated at regional, national or 
international level in their chosen sporting discipline.
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The demographic characteristics of the cohort of white male athletes is shown 
in Table 3.5. When comparing white athletes  to black controls, white male 
athletes were younger but of similar body surface area. White male athletes 
also exhibited lower levels of both systolic and diastolic blood pressure (Table 
3.5). 
3.2.3 Black male sedentary control subjects 
In total, 119 consecutive black sedentary control subjects were assessed over 
the study period. All subjects participated in less  than 2 hours of regular 
physical activity per week. Their demographic characteristics  are summarised 
in table 3.5.
Black male sedentary individuals were younger than black athletes, but older 
than white athletes  (Table 3.5). They exhibited a lower body surface area, but 
higher systolic and diastolic blood pressure where compared to black male 
athletes (Table 3.5).  
3.3 Patients with Hypertrophic Cardiomyopathy
In total, 52 consecutive black patients with hypertrophic cardiomyopathy 
underwent assessment using the standardised cardiac screen described in 
chapter 2. the demographic and clinical characteristics  are summarised in table 
3.6.  
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The average age of diagnosis  was 48.1 ± 17.1 yrs, and the majority of patients 
were male(61.5%). All were diagnosed and assessed in the UK in one of 3 
specialist cardiomyopathy clinics in South East London. 
A minority of patients had a family history of Hypertrophic cardiomyopathy or 
sudden cardiac death (34.6%). 5.8% of individuals seen had an ICD in situ, 
implanted as a consequence of an aborted sudden cardiac death or clinical 
features that suggest a high risk of such an event occurring (according the 
ACC/ESC task force criteria). Over 50% of patients were on some form of 
pharmacotherapy to alleviate symptoms and/or to treat arrhythmias (Table 3.6)




Demographic and Clinical characteristics (%)
Age at diagnosis (years) 48.1 ± 17.1
Gender (males) 61.5
Family history of HCM/SCD 34.6
Patients on Treatment 51.9
B-Blockers 26.9




ICD* in situ 5.8
*ICD - Implantable Cardiac Defibrillator
89
3.5 Screening Questionnaire Results
 
All athlete and control subjects (male and female) were assessed using the 
same standardised health questionnaire (Appendix C). 
No healthy athlete or control subject documented symptomatic information that 
could be consistent with a history of occult cardiac disease, either via 
questionnaire or upon further questioning during the screening process. None 
volunteered any significant past medical history, and no subject was prescribed 
any regular cardiac medication. 
No healthy  subject (i.e. without a diagnosis of hypertrophic cardiomyopathy) 
reported any family history of sudden cardiac death or cardiomyopathy. 
No individual reported any family history of hypertension, hypercholesterolemia 
or diabetes in first degree family members. No attempt was made to further 
question the individuals assessed beyond the questionnaire unless this 
highlighted an area of concern. 
3.6 Examination findings
No athlete or healthy control had any significant findings on physical 
examination. None had any signs consistent with any potential inherited 
causes of sudden cardiac death. The majority of athletes and controls were 
normo-tensive, with a blood pressure of <140/80. 5 individuals, all male, were 
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All athletes and control subjects were subject to the same initial screening 
protocol, based on clinical history and examination. No individual without a 
prior diagnosis of cardiomyopathy  demonstrated any clinical findings that would 
be consistent with occult cardiac disease that may put an individual at risk of 
sudden death during sporting activity. 
91
Chapter 4 – Trans-thoracic echocardiography in Elite female athletes – 
The impact of ethnicity and sporting participation.
This chapter aims to describe the characteristics of cardiac adaptation in elite 
black female athletes, as seen on trans-thoracic echocardiography. The 
echocardiographic findings in two hundred and forty elite black female athletes 
were compared with 200 similar Caucasian female athletes, 140 sedentary 
black female control subjects, and 140 sedentary white female controls, a total 
of 720 female subjects. The demographic characteristics of both athlete and 
control groups are described in detail in Chapter 3
4.1. Left Ventricular Dimensions 
This first section describes the echocardiographic dimensions and functional 
characteristics of the left ventricle in both female athletes and female control 
subjects.
4.1.1 – Control Subjects (Table 4.1)
Both black and white female control subjects exhibited similar left ventricular 
dimensions. There was no significant difference seen in maximal left ventricular 
cavity  diameter in either diastole (Table 4.1). With respect to measures of left 
ventricular size, both groups had similar values of inter-ventricular septal wall 
thickness, posterior wall thickness, and maximal left ventricular wall thickness. 
Calculated values of left ventricular mass were also similar between the two 
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groups  (Table 4.1). None of the control subjects had evidence of left 
ventricular cavity enlargement (>54mm) at end-diastole.
All control subjects had normal indices of systolic and diastolic function. There 
were no demonstrable differences in either between black and white control 
subjects. 
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Table 4.1 Comparison of echocardiographic cardiac dimensions between black 






Ao (mm) 25.7±3.8 (19-32) 24.9±3.4(19-32) 0.46
LA (mm) 30±4.2 (22-38) 31±4.7(20-40) 0.69
LVED (mm) 44.7±3.9(34-52) 45.5±4.1(36-52) 0.32
LVES (mm) 28.2±3.9(22-36) 29±3.9(21-37) 0.41
IVSd (mm) 8.1±1.4(6-11) 8±1.1(6-11) 0.73
PTWD (mm) 7.9±1.2(6-11) 7.8±1(6-11) 0.65
Max LVWT (mm) 8.4±1.4(6-11) 8.1±1.1(6-11) 0.33
LVM (g) 143±34(61-206) 145±31(73-206) 0.75
E wave (m/s) 0.93±0.15(0.5-1.2) 0.92±0.2(0.5-1.42) 0.74
A wave (m/s) 0.44±0.16(0.2-0.9) 0.48±0.13(0.2-1) 0.17
E/A ratio 2.3±0.77(0.6-4.5) 2.04±0.69(0.7-4.5) 0.12
E` (m/s) 0.21±0.03 (0.27-0.15) 0.22±0.05(0.25-0.12) 0.45
A` (m/s) 0.06±0.04 (0.14- 0.02) 0.07±0.03(0.13-0.02) 0.52
E:E` 4.42±0.74 (5.62-1.87) 4.37±0.68(5.71-1.79) 0.23
EF (%) 65±7.2 (46-76) 65±8.4(48-79) 0.75
Data expressed as mean±standard deviation (limits). 
Abbreviations for Table 4.1/4.2/4.3/4.4
A wave=late diastolic mitral valve inflow peak velocity; A`=late annular diastolic peak 
velocity  (lateral mitral annulus); Ao=Aortic annulus diameter; E wave=early  diastolic 
mitral valve peak inflow velocity; E`=early diastolic annular peak velocity (lateral mitral 
annulus); E:E`=ratio of peak early  diastolic mitral inflow velocity  to peak early  diastolic 
mitral annular velocity; EF=Ejection Fraction; continued on following page.
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Abbreviations for Table 4.1/4.2/4.3/4.4 continued
IVSd=maximal left ventricular septal wall thickness in end-diastole; LA=left atrial 
diameter; LVED=maximal left ventricular cavity  dimension in end-diastole; 
LVES=maximal left ventricular cavity  dimension in end-systole; LVM=left ventricular 
mass; Max LVWT=maximal left ventricular wall thickness in end-diastole; PTWd=left 
ventricular posterior wall thickness in end-diastole.
4.1.2 – Black female athletes versus Black female control subjects (Table 
4.2)
When compared to sedentary  control female subjects, black female athletes 
demonstrated a significant increase in left ventricular inter-ventricular septal 
wall thickness, posterior wall thickness, and maximal left ventricular wall 
thickness (Table 4.2). Overall, there was an 11% difference in maximal left 
ventricular wall thickness between black athletes and sedentary  control 
subjects.
Calculated left ventricular mass was significantly greater in black athletes than 
black control subjects (Table 4.2) amounting to a 31% difference between the 2 
groups. With respect to measures of left ventricular cavity diameter, black 
athletes demonstrated a significantly larger end diastolic  and end systolic 
diameters compared with controls. 
Both athletes and controls exhibited normal indices of both systolic and 
diastolic function, with no demonstrable differences between the two groups.
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Table 4.2 Comparison of echocardiographic cardiac dimensions between 






Ao (mm) 27.2±2.9 (23-38) 25.7±3.8 (19-32) 0.04
LA (mm) 35.3±4.7 (21-45) 30±4.2 (22-38) <0.001
LVED (mm) 48.6 ±3.9 (39-60) 44.7±3.9(34-52) <0.001
LVES (mm) 30.8±4.0 (21-44) 28.2±3.9(22-36) 0.003
IVSd (mm) 9.0±1.3(6-13) 8.1±1.4(6-11) 0.002
PTWD (mm) 8.7±1.3(6-12) 7.9±1.2(6-11) 0.01
Max LVWT 
(mm)
9.2±1.2 (6-13) 8.3±1.4(6-11) 0.002
LVM (g) 187.2±42 (95-322) 143±34(60-214) <0.001
E wave (m/s) 0.89±0.2 (0.6-1.36) 0.92±0.15(0.5-1.2) 0.59
A wave (m/s) 0.41±0.1 (0.2-1.1) 0.44±0.16(0.2-0.9) 0.71
E/A ratio 2.3±0.8 (1.1-5.5) 2.05±0.69(0.7-4.5) 0.17
E` (m/s) 0.22±0.03 
(0.13-0.25)
0.21±0.03 (0.15-0.27) 0.39
A` (m/s) 0.07±0.03 
(0.02-0.16)
0.06±0.04 (0.02-0.14) 0.45
E:E` 4.41±0.71 (2.3-5.61) 4.42±0.74 (1.87-5.62) 0.76
EF (%) 67±6.7 (41-78) 65±7.2 (46-76) 0.32
Data expressed as mean±standard deviation (limits)
Abbreviations for Table 4.2 - see pages 95/96 (as per table 4.1)
96 
97
4.1.3 - White Female athletes versus White Female controls (Table 4.3)
In a similar pattern to that observed amongst black athletes, white athletes 
exhibited a significantly greater inter-ventricular septal wall thickness , 
posterior wall thickness , and maximal left ventricular wall thickness, when 
compared to the group  of sedentary control subjects (Table 4.3). This 
represents a 6% difference in maximal left ventricular wall thickness.
Calculated left ventricular mass was 19% greater amongst white athletes 
when compared to sedentary controls .  Measure of left ventricular cavity size 
in both diastole and systole were greater in athletes than controls (Table 4.3). 
All indices of systolic and diastolic function were normal in both groups, with 
no differences evident between athletes and sedentary control subjects. 
Amongst athletes, the peak E and A wave velocity was lower when compared 




Table 4.3 Comparison of echocardiographic cardiac dimensions between 






Ao (mm) 26.4±3.5 (17-33) 24.9±3.4(19-32) 0.002
LA (mm) 32.5±2.1 (21-47) 31±4.7(20-40) 0.08
LVED (mm) 48.2±3.5 (40-62) 45.5±4.1(36-52) <0.001
LVES (mm) 30.5 ±4.7 (20-44) 29±3.9(21-37) 0.02
IVSd (mm) 8.4±1.2 (6-11) 8±1.1(6-11) 0.046




LVM (g) 172.3±42 (86-293) 145±31(73-206) <0.001
E wave (m/s) 0.90±0.2 (0.53-1.33) 0.92±0.2(0.5-1.42) 0.07
A wave (m/s) 0.44 ±0.1(0.2-0.9) 0.48±0.13(0.2-0.9) 0.001
E/A ratio 2.2±0.8 (1.1-5.5) 2.04±0.69(0.7-4.5) 0.01
E` (m/s) 0.23±0.03 (0.28, 
0.17)
0.22±0.05(0.25-0.12) 0.45
A` (m/s) 0.06±0.03 (0.13, 
0.03)
0.07±0.03(0.13-0.02) 0.57
E:E` 4.46±0.74 (5.55, 
1.96)
4.37±0.68(5.71-1.79) 0.19
EF (%) 66±6.9 (44, 76) 65±8.4(48-79) 0.43
Data expressed as mean±standard deviation (limits). 
Abbreviations for Table 4.3 - see pages 95/96 (as per table 4.1)
98 
99
4.1.3 – Black Female athletes versus White Female athletes (Table 4.4)
Black athletes demonstrated a greater maximal left ventricular wall thickness 
compared with white athletes amounting to a 7% difference between the two 
groups. Calculated LVM was also greater in black athletes vs. white athletes, 
with a 9% difference overall between the ethnic groups.  Black athletes also 
demonstrated a significant increase in inter-ventricular septal wall thickness 
compared to white athletes. There was no significant difference in posterior 
wall thickness measurements between the groups. 
The range of left ventricular wall thickness observed amongst white athletes 
and both white and black control groups was 6-11mm, compared to the range 
seen amongst black athletes of 6-13mm. In total, 3% of black athletes had a 
maximal left ventricular wall thickness of >11mm. The distribution of maximal 
left ventricular wall thickness amongst athletes is shown in figure 4.1.
There was no significant difference between the ethnic groups with respect to 
left ventricular chamber size, either in diastole (black 48.6 ±3.9mm (39-60) 
vs. white 48.2±3.5mm (40-62); P=0.93), or systole (black 30.8±4.0 (21-44) vs. 
white 30.5 ±4.7 (20-44); P=0.47). Twenty black athletes (8%) and 12 white 




Table 4.4 Comparison of echocardiographic cardiac dimensions between 






Ao (mm) 27.2±2.9 (23-38) 26.4±3.5 (17-33) 0.21
LA (mm) 35.3±4.7 (21-45) 32.5±2.1 (21-47) <0.0001
LVED (mm) 48.6 ±3.9 (39-60) 48.2±3.5 (40-62) 0.93
LVES (mm) 30.8±4.0 (21-44) 30.5 ±4.7 (20-44) 0.47
IVSd (mm) 9.0±1.3(6-13) 8.4±1.2 (6-11) <0.001
PTWD (mm) 8.7±1.3(6-12) 8.4±1.2 (6-11) 0.14
Max LVWT 
(mm)
9.2±1.2 (6-13) 8.6±1.2(6-11) <0.0001
LVM (g) 187.2±42 (95-322) 172.3±42 (86-293) 0.008
E wave (m/s) 0.89±0.2 (0.6-1.36) 0.90±0.2 (0.53-1.33) 0.49
A wave (m/s) 0.41±0.1 (0.2-1.1) 0.44 ±0.1(0.2-0.9) 0.076
E/A ratio 2.3±0.8 (1.1-5.5) 2.2±0.8 (1.1-5.5) 0.15
E` (m/s) 0.22±0.03 (0.13-0.25) 0.23±0.03 (0.17-0.28) 0.40
A` (m/s) 0.07±0.03 (0.02-0.16) 0.06±0.03 (0.03-0.13) 0.43
E:E` 4.41±0.71 (2.30-5.61) 4.46±0.74 (1.96-5.55) 0.39
EF (%) 67±6.7 (41-78) 66±6.9 (44-76) 0.48
Data expressed as mean±standard deviation (limits). 
Abbreviations for Table 4.4 - see pages 95/96 (as per table 4.1)
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Figure 4.1 Histogram showing the distribution of maximal left ventricular wall 
thickness in black  (black bars) and white (grey  bars) female athletes. Three percent 
of black athletes demonstrated a maximal left ventricular wall thickness of >11mm 























4.2 Left Ventricular Hypertrophy in Female Athletes
The distribution of maximal left ventricular wall thickness is shown in figure 
4.1. This passed statistical tests for normal distribution. None of the white 
athletes or control subjects demonstrated a maximal LVWT of >11mm. In 
contrast, 8 black athletes (3.3%) exhibited a maximal LVWT >11mm (12-13 
mm) and were considered to exhibit LVH. The demographic, 
echocardiographic and electrocardiographic features of the 8 black athletes 
with LVH are shown in table 4.5. 
The pattern of LVH in all the black female athletes was homogeneous, with a 
difference of <2mm between adjacent segments. All athletes with left 
ventricular hypertrophy exhibited a normal LV diastolic cavity size (Table 4.5). 
None of the athletes with LVH exhibited dynamic left ventricular outflow 
obstruction.97
There were no statistically  significant differences in age, weight and BSA 
between black athletes with left ventricular hypertrophy and those without, 
respectively (Table 4.5). 
All athletes with left ventricular hypertrophy underwent further investigation 
with an exercise stress test, 48 hour holter monitoring and a cardiac magnetic 
resonance scan. The results of these investigations will be discussed in 
chapter 5, section 5.4. However, there was 100% concurrence between 
echocardiography and cardiac magnetic resonance for the identification of 
left ventricular hypertrophy across multiple modalities. 
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 Table 4.5 Demographic, Echocardiographic and Electrocardiographic 














































































































































































































































































































































































































































































































4.3 Determinants of left ventricular hypertrophy in athletes
The results of a multivariable linear regression model, assessing the 
relationship  between maximal left ventricular wall thickness and age, BSA, 
ethnicity and number of hours trained, demonstrated that ethnicity  was the 
strongest independent predictor of maximal LVWT (β =0.263 (CI=0.29-0.855; 
P<0.001)), with age being the only other significant factor (β=-0.155 
(CI=-0.07--0.01; P=0.006)).  There was no relationship between sporting 
discipline and LVH.
4.4 Reliability of Left Ventricular Wall Thickness Measurements in 
Athletes
The averaged coefficients of variance between intra-observer and inter-
observer reliability for maximal left ventricular measurements were 4 % and 
6.2 % respectively. No attempt was made to re-test, as the the observed 
variability in measures was low  
4.5 Other Cardiac dimensions
The following section describes the impact of ethnicity and sporting 
participation on the dimensions of other cardiac structures, in particular left 




4.5.1 Left Atrial Diameter
Black female athletes demonstrated a significant increase in left atrial 
diameter when compared to black controls (Table 4.3) There were however 
no significant differences in left atrial diameter between black and white 
control subjects (Table 4.1), nor between white athletes and white control 
subjects (Table 4.2). Both distributions passed tests for normality. 
Black athletes also exhibited a sigificantly greater left atrial diameter when 
compared to white athletes. (Table 4.4). The distribution of left atrial diameter 
is summarised in figure 4.2. Only  2.5% of caucasian athletes had an LA 


















Figure 4.2 Histogram showing distribution of left atrial diameter in female elite black 
(purple bars) and white (blue bars) athletes. Black athletes had a 9% increase in left 
atrial diameter when compared to similar white athletes.
4.5.2 Aortic Root Diameter
There was no significant difference in aortic annulus diameter between black 
and white control subjects (Table 4.1). Both groups of athletes demonstrated 
a statisically significant increase in aortic annulus diameter when compared 
to their respective sedentary control subjects (Table 4.2 & Table 4.3). There 
was however no significant overall difference in annulus diameter between 
the ethnic groups of athletes. (Table 4.4).
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Chapter 5 – The 12-Lead ECG in Elite Black Female Athletes – the 
Impact of Ethnicity and Regular Physical Activity.
This chapter aims to describe the spectrum of electrocardiographic 
appearances that may be found in elite black female athletes. Given that all 
subjects underwent both 12-lead ECG and 2-D trans-thoracic 
echocardiography; this enables correlation between the two investigations, 
used most commonly in cardiac screening.  
As in chapter 4, comparisons will be made between the two control groups of 
sedentary subjects, followed by comparison between both groups of athletes 
with their respective controls and each other. Section 5.1 will examine the 
baseline ECG findings, with section 5.2 describing the differences the in 
repolarisation complex between black and white individuals. Following this, 
the ECG appearances in black and white athletes will be correlated to their 
trans-thoracic echocardiogram.
5.1 Baseline Electrocardiographic Findings 
The following section will describe the baseline ECG findings across the 
study cohort. The presence 
5.1.1 Control Subjects (Table 5.1)
Black control subjects exhibited a small but significant increase in heart rate 
at rest, when compared to white control subjects (Table 5.1). When compared 
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to white sedentary controls, Black control subjects had a longer PR interval, 
with a shorter QRS duration, and QT interval – both uncorrected and 
corrected (Table 5.1).  Black control subjects demonstrated a more leftward 
axis than white control subjects.(Table 5.1) 
Table 5.1 Comparison of electrocardiographic parameters between Black 







Heart rate (bpm) 76 ± 9.5 (56-95) 71 ± 10.9(47-96) 0.02
PR interval (ms) 152 ± 20 (116-208) 139 ± 19 (96-198) <0.001
QRS Duration (ms) 83 ± 10 (66-142) 89 ± 9 (60-112) <0.001
QT interval (ms) 367 ± 25 (338-418) 399 ± 27 (332-486) <0.001
QTc (Bazzets) (ms) 403 ± 25 (338-458) 413 ± 20(372-484) 0.003
Axis (Degrees) 52 ± 30(-30-108) 60 ± 24 (-22-102) 0.04
LAE (%) 4.3 4.3 1.00
RAE(%) 1.4 4.3 0.28
LVH Voltage (%) 8.6 5.7 0.49
Partial RBBB (%) 2.9 8.1 0.11
Data expressed as mean±standard deviation (limits) or percentages (%), as 
appropriate.
Abbreviations for Table 5.1 Bpm=beats per minute; LAE=voltage criterion for left 
atrial enlargement;QTc=corrected QT interval; RAE=voltage criterion for right atrial 
enlargement; RBBB=right bundle branch block
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There were no significant differences in the incidence of voltage criteria for 
left atrial hypertrophy, right atrial hypertrophy or left ventricular hypertrophy 
between the two groups. Partial right bundle branch block was a more 
common finding amongst white controls, but this failed to reach statistical 
significance (Table 5.1). 
None of the control subjects exhibited pathological Q waves, ST segment 
depression, left bundle branch block, or epsilon waves.
5.1.2 Black Athletes versus Control Subjects (Table 5.2)
Black athletes exhibited a significantly lower resting heart rate than sedentary 
black control subjects (Table 5.2). Black athletes also had a small, but 
significant increase in PR interval. QRS duration was similar between the two 
groups. There was a significant difference observed in the resting QT interval, 
but this was not apparent once this had been corrected for heart rate (Table 
5.2). Black control subjects also demonstrated a more leftward axis than 
black athletes (Table 5.2).
Black athletes demonstrated a significantly higher incidence of voltage 
criteria for left atrial hypertrophy compared with controls. There was however 
no significant difference in the incidence of voltage criteria for right atrial 
hypertrophy or left ventricular hypertrophy between the two groups. The 
prevalence of partial right bundle branch block was significantly higher 
amongst black athletes compared to controls (Table 5.2). 
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Table 5.2 Comparison of electrocardiographic parameters between female 






Heart rate (bpm) 61 ± 8.3 (44-85) 76 ± 9.5 (56-95) <0.001
PR interval (ms) 162 ± 25 (112-246) 152 ± 20 (116-208) 0.04
QRS Duration (ms) 84 ± 10 (43-105) 83 ± 10 (66-142) 0.29
QT interval (ms) 400 ± 32 (330-475) 367 ± 25 (338-418) <0.001
QTc (Bazzets) (ms) 404 ± 42 (358- 465) 403 ± 25 (338-458) 0.61
Axis (Degrees) 67 ± 14 (32-89) 52 ± 30(-30-108) 0.001
LAE (%) 12.5 4.3 0.01
RAE(%) 5 1.4 0.09
LVH Voltage (%) 8 8.6 0.85
Partial RBBB (%) 14 2.9 <0.001
Data expressed as mean±standard deviation (limits) or percentages (%), as 
appropriate.
Abbreviations for Table 5.2 Bpm=beats per minute; LAE=voltage criterion for left 
atrial enlargement;QTc=corrected QT interval; RAE=voltage criterion for right atrial 
enlargement; RBBB=right bundle branch block
5.1.3 White athletes versus Control Subjects (Table 5.3)
In a similar pattern to that seen in black athletes, white athletes exhibited a 
significantly lower resting heart rate compared to sedentary white control 
subjects (Table 5.3). In addition, white athletes demonstrated an increase in 
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PR interval compared to sedentary control subjects. There were no 
significant differences in QRS duration, QT interval (both uncorrected and 
corrected) and QRS axis between athletes and sedentary controls (Table 
5.3). 
Table 5.3 Comparison of electrocardiographic parameters between female 






Heart rate (bpm) 60 ± 9.5 (35-85) 71 ± 10.9(47-96) <0.0001
PR interval (ms) 149 ± 23 (88-228) 139 ± 19 (96-198) <0.0001
QRS Duration (ms) 87 ± 10 (66-120) 89 ± 9 (60-112) 0.15
QT interval (ms) 415 ± 33 (290- 447) 399 ± 27 (332-486) 0.09
QTc (Bazzets) (ms) 407 ± 41 (285-474) 413 ± 20(372-484) 0.16
Axis (Degrees) 65 ± 32 (-26-129) 60 ± 24 (-22-102) 0.06
LAE (%) 10 4.3 0.06
RAE(%) 4 4.3 1.0
LVH Voltage (%) 12 5.7 0.059
Partial RBBB (%) 14 8.1 0.086
Data expressed as mean±standard deviation (limits) or percentages (%), as 
appropriate.
Abbreviations for Table 5.3 Bpm=beats per minute; LAE=voltage criterion for left 
atrial enlargement;QTc=corrected QT interval; RAE=voltage criterion for right atrial 




Amongst white athletes, voltage criteria for both left atrial and left ventricular 
hypertrophy, and partial right bundle branch block were a more frequent 
finding than in sedentary  controls. These differences did not however reach 
statistical significance. There was no difference in the incidence of voltage 
criteria for right atrial hypertrophy between white athletes and sedentary 
control subjects (Table 5.3).  
5.1.4 Black versus White Athletes (Table 5.4)
Black athletes demonstrated a greater PR interval than white athletes, 
whereas white athletes revealed a slightly  greater QRS duration compared 
with black athletes (Table 5.4).  
There were no significant differences between black athletes and white 
athletes with respect to QRS axis, QT interval (both uncorrected and 
corrected), voltage criteria for LVH, right or left atrial hypertrophy or 
incomplete right bundle branch (Table 5.4). 
None of the athletes exhibited pathological Q waves (> 40 msec wide or 
exceeding in depth 25% of the height of the proceeding R wave), ST 
segment depression, left bundle branch block, or epsilon waves. The 




Table 5.4 - Comparison of electrocardiographic parameters between black 






Heart rate (bpm) 61±8.3 (44-85) 60±9.5 (35-85) 0.26
PR interval (ms) 162±25 (112-246) 149±23 (88-228) <0.001
QRS Duration (ms) 84±10 (43-105) 87±10 (66-120) 0.0072
QT interval (ms) 400±32 (330-475) 415±33 (290- 447) 0.17
QTc (Bazzets) (ms) 404±42 (358- 465) 407±41 (285-474) 0.28
Axis (Degrees) 67±14 (32-89) 65±32 (-26-129) 0.66
LAE (%) 12.5 10 0.45
RAE(%) 5 4 0.65
LVH Voltage (%) 8 12 0.16
Partial RBBB (%) 14 14 0.89
Data expressed as mean±standard deviation (limits) or percentages (%), as 
appropriate.
Abbreviations for Table 5.4 Bpm=beats per minute; LAE=voltage criterion for left 
atrial enlargement;QTc=corrected QT interval; RAE=voltage criterion for right atrial 
enlargement; RBBB=right bundle branch block
113
114
5.2 Repolarisation Anomalies (Table 5.5)
The repolarisation anomalies that will be considered in the following section 
will be the presence of J point ST segment elevation or depression and T 
wave inversions in 2 or more contiguous leads.    
5.2.1 Control subjects 
Black control subjects exhibited a higher prevalence of T wave inversions 
than sedentary white subjects, but this difference did not reach statistical 
significance. (Table 5.5) 
Amongst black control subjects, T wave inversions were distributed equally 
across both the inferior (n=6) and anterior leads (n=6). This differed slightly 
from the distribution pattern observed in white controls, with T wave 
inversions being predominately seen in the inferior leads (n=4, 67%) rather 
than the anterior leads (n=2, 33%). In no control subject (black or white) did 
the maximum T wave voltage exceed -0.2mV – i.e. “deep” T wave inversions.
In total, 10 black sedentary control subjects (7.1%) and 12 (8.5%) white 
sedentary control subjects demonstrated J point ST segment elevation 
(P=0.82). In all subjects this was confined to the anterior pre-cordial leads – 
i.e. leads V1-V4.  
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5.2.2. Athletes versus Control subjects
When compared to sedentary  black controls, black athletes exhibited a 
higher prevalence of J point ST segment elevation than black sedentary 
control subjects - but this did not reach statistical significance(Table 5.5). In 
contrast, white control subjects demonstrated a significantly higher 
prevalence of J point ST segment elevation when compared to white athletes 
(White controls n=12 (8.5%) vs. white athletes n=2 (1%); P<0.001). Amongst 
all female athletes and control subjects, ST elevation was confined to the 
anterior pre-cordial leads (V1-V4).
Table 5.5 Prevalence of repolarisation anomalies amongst Female 












10 (7.1%) 26 (11%) 12 (8.5%) 2 (1%) <0.001a,b
T-wave Inv 
(N=, %)
12 (8.5%) 34(14%) 6 (4.3%) 9 (4.5%) <0.001a
a Statistically significant between black athletes and white athletes
b Statistically significant between white athletes and white controls
Black athletes demonstrated a higher prevalence of contiguous T wave 
inversions when compared to sedentary black control subjects. However, this 
failed to reach statistical significance (Table 5.5; P=0.14).  There was no 
difference observed in the prevalence of contiguous T wave inversions 
between white athletes and white control subjects (Table 5.5).
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5.2.3 Black versus white athletes 
Black athletes demonstrated a higher prevalence of ST segment elevation 
compared with white athletes (Table 5.5). Black athletes also exhibited a 
higher prevalence of contiguous T wave inversions compared with white 
athletes (Table 5.5; Figure 5.1). In black athletes T wave inversions were 
confined to leads V1-V3 and exceeded -0.2 mV (deep T wave inversions) in 6 
(2.5%) individuals (Figure 5.2; C). In contrast, white athletes only showed T 
wave inversions in leads III and aVF (i.e. in the inferior leads) and none 
exhibited deep T wave inversions. 
Figure 5.1 Pie charts comparing ECG anomalies in black and white athletes. Black 
athletes exhibited a higher prevalence of ST segment elevation and T wave 
inversions than white athletes. Abbreviations – LVH Volt – Voltage criteria for Left 
Ventricular Hypertrophy, LAE – Voltage criteria for left atrial enlargement, RAE – 
Voltage criteria for right atrial enlargement, ST Elev  – ST segment elevation, T wave 

















Figure 5.2 – Spectra of ECG observations in black female athletes revealing 
Sokolow-Lyon voltage criteria for LVH and elevated J point in the lateral leads (A), 
partial right bundle branch block with accompanying convex ST elevation in leads V1 
through V3 (B), and convex ST-segment elevation and deep T-wave inversions in 
leads V1 through V3.
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5.2.4 Determinants of Repolarisation Anomalies
The results of a binary logistic regression model, with the dependant 
variable being the presence of T wave inversions, demonstrated that 
black ethnicity  was the only  significant independent predictive factor 
(β=1.94, S.E.=0.417; P=0.003). This means that a black female athlete is 
approximately  7 times more likely to exhibit T wave inversions than a 
similar white athlete. Black ethnicity was also the strongest independent 
predictive factor (β=1.29, S.E. =349; p<0.001) when ST segment 
elevation was used as a dependent variable in the model. This equates to 
a 3.5 times chance of a black athlete having significant ST elevation if 
compared to a white athlete. In addition, athlete height in both races 
having a weak additional effect (β=0.042, S.E.=0.021; P=0.043). 
5.3 Correlation between ECG and Echocardiogram
There was a weak correlation between the presence of T wave inversions 
and magnitude of LVWT and LVM in both groups of athletes (maximal 
LVWT; P=0.039, LVM; P=0.041). However, there were no significant 
differences in absolute values of maximal LVWT between any athletes or 
controls with T wave inversions and those without (black controls; P=0.76, 
black athletes; P=0.12, white controls; P=0.78, white athletes; P=0.07). 
The identification of T wave inversions did not predict the presence of LVH 
or increased LV cavity size. There was no relationship  between the 
presence of Sokolow-Lyon voltage criteria for LVH on the ECG and 




All athletes or controls who exhibited echocardiographic left ventricular 
hypertrophy and/or deep  T wave inversions were referred for further 
investigations, as detailed in chapter 2, section 2.3.  All athletes that were 
identified with either of the above findings underwent the full compliment 
of investigations. 
Twelve black athletes underwent an exercise stress test, 48 hour Holter 
monitoring and a CMR scan.  None of the 12 athletes demonstrated any 
phenotypic features of HCM or any other form of cardiomyopathy. 
Specifically, none of the 12 athletes exhibited flat BP responses to 
exercise,93 or >1000 ventricular extra-systoles/non-sustained ventricular 
tachycardia94 or late gadolinium enhancement (to indicate myocardial 
fibrosis),98 apical hypertrophy98  and right ventricular wall motion 
abnormalities,99 on exercise testing, 48-hour Holter monitor and the CMR 
scan respect ively. There was 100% concurrence between 
echocardiography and CMR for the identification of left ventricular 
hypertrophy in all black athletes with echocardiographic LVH. 
None of the white athletes or control subjects demonstrated 




Chapter 6 - The Significance of Repolarisation Anomalies in Black 
Male Athletes
The following section, will attempt to describe the significance of the 
repolarisation anomalies that have previously been reported in cohorts of 
black male athletes.18,19,53,54 As described in chapter 2, a large cohort of 
black and white male athletes were studied using both ECG and 
echocardiography and compared to a cohort of black male control 
subjects and a cohort of  black patients with hypertrophic cardiomyopathy 
that underwent a similar series of investigations.
The ECG and echocardiographic appearances in the male athletes will be 
described first, followed by the control group, and finally the cohort with 
hypertrophic cardiomyopathy. Comparisons will be made between the 
athlete cohort, the control cohort and the hypertrophic cardiomyopathy 
group. Finally, this chapter will report the results on the longitudinal follow-
up  of the athlete cohort and in doing so, assess the significance of the 
ECG and echocardiographic appearances observed.
6.1 The 12-Lead ECG In Male Subjects
6.1.1 Baseline Electrocardiographic findings 
The baseline ECG findings across the cohort of healthy individuals are 




6.1.1.1 Baseline ECG findings in Healthy Male Subjects (Table 6.1)
White athletes had a lower resting heart rate when compared to black 
athletes, with a greater proportion exhibiting significant sinus bradycardia, 
(HR <60bpm)(Table 6.1). Black athletes however had a longer PR interval 
at rest (168 ms Vs. 156 ms; p<0.001), and a significantly higher 
prevalence of first degree heart block when compared to white male 
athletes (Table 6.10. There were also small, but statistically  significant, 
differences in  QRS duration and corrected QT interval between black and 
white athletes (Table 6.1). 
The incidence of partial right bundle branch block (RBBB) was 
significantly higher in black athletes , but complete RBBB was more 
commonly observed amongst white healthy individuals. The overall 
incidence of full RBBB was however low in both groups (Table 6.1).
When compared to black sedentary control subjects, black male athletes 
had a significantly  lower resting heart rate. Only 20% of black sedentary 
individuals had a resting sinus bradycardia compared to over 60% of 
black athletes. Similarly, the  resting PR interval and the incidence of first 
incidence of first degree heart block was significantly greater amongst 
black athletes. 
With respect to voltage criteria for cardiac chamber enlargement, 
electrocardiographic left ventricular hypertrophy was seen less frequently 
in black athletes than in either white athletes or black sedentary control 
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subjects (Table 6.1). In contrast, left and right atrial enlargement was 
observed significantly more frequently  amongst black athletes than in 
white athletes or sedentary controls.  
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Table 6.1 Electrocardiographic characteristics in healthy  male  subjects: 
















Sinus bradycardia 47.1 60.7 20.2 <0.001 <0.001
PR interval (ms) 168 ±28 156 ± 27 153 ±19 <0.001 <0.001
1o AV Block 11.2 3.6 2.5 <0.001 0.003
QRS Duration (ms) 88 ± 13 96±10 89 ± 9 <0.001 0.42
QTc (ms) 393 ± 26 404 ± 20 400 ± 18 <0.001 0.005
Partial RBBB 24.7 12.3 5.00 <0.001 <0.001
RBBB 0.3 1.2 0 0.03 0.53
Left-axis deviation 1.1 0.6 2.5 0.10 0.20
Right-axis deviation 0.1 0.9 0 0.01 0.72
Pathological Q-
waves
0.9 0.4 0 0.152 0.31
LA enlargement 8.6 2.8 5.9 <0.001 0.17
RA enlargement 6.3 0.3 2.5 <0.001 0.066
LVH 23.2 36.8 39.5 <0.001 <0.001
RVH 13.3 2.6 4.2 <0.001 <0.001
Inverted T waves 22.8 3.7 10.1 <0.001 0.003
T-wave inversions in 
V1-V4
12.7 1.9 4.2 <0.001 0.007
T-wave inversions 
inferior leads
6 1.5 2.5 <0.001 0.12
T-wave inversions in 
lateral leads
4.1 0.3 3.4 <0.001 0.70
Deep T-wave 
inversions
12.1 1 1.7 <0.001 0.002
ST-segment 
elevation
63.2 26.5 65.5 <0.001 0.61
ST-segment 
depression
0.4 0 0 0.01 0.47
Data expressed as mean±standard deviation (limits) or percentages (%), as 
appropriate. Abbreviations - See Page 125
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Abbreviations for Table 6.1 AV - atrio-ventricular node, LA enlargement - 
Voltage criteria for left atrial enlargement, LVH - Voltage criteria for left 
ventricular hypertrophy, QTc - Corrected QT interval, RA enlargement - 
Right atrial Voltage criteria for right atrial enlargement, RBBB - right 
bundle branch block, RVH - Voltage criteria for right ventricular 
hypertrophy.
6.1.1.2. Baseline ECG findings in Subjects with HCM
The baseline ECG characteristics in the cohort of patients with HCM are 
summarized in table 6.2. No attempt has been made to compared 
baseline ECG intervals between the cohorts due to the use of medications 
in the HCM cohort that affect heart rate and myocardial function, altering 
these parameters and making comparison invalid. 
With respect to voltage criteria for chamber enlargement, both left 
ventricular hypertrophy and left atrial enlargement were observed 
significantly more frequently amongst the individuals with HCM that in 
either groups of athletes or control subjects (LVH HCM 53.8% vs. BA 
23.2% vs. WA 36.9% vs. BC 39.5%; P<0.001).  Pathological Q waves and 
left axis deviation were also observed significantly  more frequently in the 
HCM cohort, compared to both the athlete and controls groups. The 




Table 6.2 Electrocardiographic characteristics in patients with HCM. 
ECG Characteristics % Patients
LVH (Sokolow and Lyon) 53.8
LA enlargement 44.2
Pathological Q waves 11.5
Left-axis deviation 11.5
Inverted T-waves 82.7
T-wave inversions leads V1-V4 3.8
T-wave inversions in inferior leads 1.9
T-wave inversions in lateral leads 76.9
Deep T wave inversions 69.2
ST segment elevation 9.6
ST segment Depression 50
Data expressed as % of total cohort
Abbreviations for Table 6.2 - LA enlargement - left atrial enlargement, LVH - Voltage 
criteria for left ventricular hypertrophy.
6.1.2 Repolarisation changes - Prevalence and Distribution
In the following section, the aim is to describe the prevalence and 
distribution of anomalies affecting the repolarisation phase and the ST 
segment of the ECG complex. Firstly, racial differences between the black 
and white athlete groups will be considered, before comparing the black 




6.1.2.1 Black Male Athletes vs. White Male athletes
Both ST segment elevation and T-wave inversions were observed more 
frequently  in black male athletes than in white athletes (Table 6.1). T wave 
inversions, including deep T-wave inversions, were present in 22.8% of 
black athletes compared to 3.7% of white athletes.
T-wave inversions amongst black athletes were predominately  observed 
in the anterior leads (12.7%; Figure 6.1A, Figure 6.2). T wave inversions 
in the lateral leads were observed significantly less frequently, with only 
4.1% of black athletes demonstrating such changes.
ST segment depression was rare in both groups, being absent amongst 
white athletes, and seen in just 0.4% of black athletes. ST segment 
elevation was observed more frequently amongst black male athletes 
than in white athletes.
6.1.2.2 Black Male athletes vs. black sedentary controls vs. black 
HCM patients
There were no differences in the prevalence of ST segment elevation 
between black  athletes and black sedentary controls. However, ST 
segment elevation was observed significantly more frequently in healthy 
individuals than in individuals with hypertrophic cardiomyopathy  (BAs 
63.2% vs. BC 65.5% vs. HCM 9.6%, P<0.001)(Figure 6.2A). In contrast, 
ST segment depression was virtually absent in athletes and controls, but 
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was common amongst individuals with HCM (BAs 0.4% vs. BCs 0% HCM 
50%, Figure 6.1C).
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(A) Black long distance 
runner with convex ST 
segment elevation and 
deep T wave inversions 
in leads V1-V3,
(B) Black sedentary 
individual with 
widespread ST-
segement elevation of 
the concave /saddle 
shaped and hight take 
off pattern,
(C) Black hypertrophic 
cardiomyopathy patient 
with ST-segment 
depression and deep T 
wave inversions in the 
lateral leads. 
Figure 6.1 A series of ECGs demonstrating typical repolaristation changes 
in black male individuals.     
128
Individuals with HCM exhibited a significantly higher prevalence of T wave 
inversions (including deep  T-wave inversions) compared with athletes and 
controls (BAs 22.8% vs. BCs 10.1% vs. HCM 82.7%; P<0.001; Figure 
6.2A).  With respect to the distribution of T-wave inversions, amongst 
black athletes these were observed significantly more frequently in the 
anterior chest leads when compared to both black control subjects and 
black patients with hypertrophic cardiomyopathy (BAs 12.7% vs. BCs 
4.2% vs. HCM 3.8%; P=0.006; Figure 6.2B). In contrast, black patients 
with HCM had a significantly higher prevalence of T wave inversions in 
the lateral leads (BAs 4.1% vs. BCs 3.4% vs. HCM 76.9%; P<0.001; 
Figure 6.2B). all groups exhibited a similar prevalence of T wave inversion 
in the inferior leads (BAs 6% vs. BCs 2.5% vs. HCM 1.9%; P=0.21; Figure 
6.2B).
6.1.3 ST-segment morphology
A variety of ST segment morphologies were noted amongst black 
athletes. These included convex ST-segments, concave/saddle-shaped 
and high take off patterns (figure 6.3). The concave ST-segment pattern 
was more prevalent in black athletes than in black control subjects and 
white athletes (BAs 38.4% vs. BCs 6.7% vs. WAs 2.7%; P<0.001). Of 
note, the majority  (64.3%) of T wave inversions across the anterior leads 

































































Black Athletes Black Controls Black HCM 
P<0.001 P<0.001 P<0.001 P<0.001
P=0.006 P=0.212 P<0.001
Figure 6.2: (A) Histogram demonstrating the prevalence of repolarisation 
changes as a percentage (%) of the total cohort in black athletes, black controls 
and black patients with Hypertrophic Cardiomyopathy. (B) Histogram 
demonstrating the distribution of T-wave inversions as percentage (%) of the total 
cohort in the three groups.
130130 
Figure 6.3 - Examples of common ECG ST-segment morphologies in leads V1-3 
& V4-6 amongst black athletes (A) - Concave J point ST elevation with a “high 
take off”  pattern, (B) Convex Dome shaped ST-elevation, (C) Convex ST 
elevation associated with T wave inversions in leads V1-3, (D) Deep  T wave 
inversions extending from V1-V5, assoicated with convex ST segment elvation
B C DA BA C D
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6.2 The Echocardiographic Appearance in Male Subjects (Table 6.3/
Table 6.4)
6.2.1 Athletes vs. Controls (Table 6.3)
With respect to measures of left ventricular size, both cohorts of athletes 
exhibited greater maximal LVWT and LV diastolic cavity diameter when 
compared to the sedentary black male control subjects. (Table 6.3). In 
addition, estimates of left ventricular mass were also significantly greater 
in the athletic groups, compared to sedentary controls. 
Transverse left atrial diameter was also greater in the athletic groups 
compared to sedentary controls, as was aortic root diameter. There was a 
small, but statistically significant difference in measures of early diastolic 
filling velocity (e-wave) across the mitral valve, between the black athletes 
and the black control subjects, but this difference was not seen in the 
white athlete group. All athletes and control subjects exhibited normal 
measures of both systolic and diastolic function. 
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Table 6.3 Comparison of standard echocardiographic parameters in male 



















LA (mm) 35.4 ± 4.5 
(27-45)














10.6 ± 1.6 
(6-16)
















103.7 ± 25.1 98.5 ± 21.8 84.0 ±14.8 <0.001a,
b,c
E-wave (m/s) 0.8 ± 0.2 
(0.5-1.8)













E/A 2.1 ± 0.9 2.2 ± 0.8 2.2 ± 0.6 0.004a
aStatistically significant between black male athletes and white male 
athletes
bStatistically significant between black male athletes and black male 
controls
cStatistically significant between white male athletes and black controls
Abbreviations - A wave - late diastolic mitral valve inflow peak velocity, Ao - 
Aortic annulus diameter, BSA – Body Surface Area, E wave - early  diastolic 
mitral valve peak inflow velocity, E:A – ratio of peak early  diastolic mitral inflow 
velocity  to peak late diastole mitral inflow velocity, LVED - maximal left 
ventricular cavity  dimension in end-diastole, LVM - left ventricular mass, Max 
LVWT - maximal left ventricular wall thickness in end-diastole
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6.2.2 Black vs. White Male athletes (Table 6.3)
Overall, black male athletes demonstrated an significantly greater 
maximal left ventricular wall thickness when compared to white athletes. 
With respect to absolute measures, 112 (12.4%) of black athletes 
exhibited echocardiographic LVH, i.e. a maximal left ventricular wall 
thickness of >12mm. This compared to only 29 (1.6%) of white athletes. 
In no athlete did the maximal observed LVWT exceed 16mm (figure 6.4).
All athletes with left ventricular hypertrophy had correspondingly normal or 
mild dilatation of the left ventricular cavity, along with normal indices of 
both systolic and diastolic function. In no athlete did the difference 
between the septal and posterior left ventricular wall thickness differ by 
more than 1mm. 















Maximal Left ventricular wall thickness (mm)
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Figure 6.4 Histogram demonstrating the distribution of maximal left ventriuclar wall 
thickness at end-diastole as a percentage of the total black athlete (Pink bars) and white 
athlete (Purple bars) cohort, respectively. 12.4% of black athletes had a left ventricular 




6.2.3 The Echocardiogram in black patients with Hypertrophic 
Cardiomyopathy (Table 6.4).
Overall, the echocardiographic appearances of the cohort of patients with 
HCM was consistent with the clinical phenotype. Almost all (98.1%) of 
patients with HCM exhibited echocardiographic left ventricular 
hypertrophy, associated with a non dilated left ventricular cavity, left atrial 
enlargement and impairment of diastolic function. Systolic anterior motion 
of the mitral valve (SAM) was observed in in 23.1%, all of which 
demonstrated an associated left ventricular outflow tract gradient of 
greater than 30mmHg at rest.
6.3 Further Testing
All 350 athletes with T-wave inversions and/or left ventricular hypertrophy 
on echocardiography were invited to undergo further investigations to 
exclude the broader phenotype of HCM. These investigations are 
described in chapter 2, section 3, and include exercise stress testing 
(including  measures of cardiopulmonary function), Holter monitor 




Table 6.4 The Echocardiographic characteristics of black patients with 
HCM
Black HCM patients 
(n = 52)
Ao (mm) 31.3 ± 3.7
LA (mm) 40.9 ± 7.3
LVED (mm) 44.0 ± 6.1
Max LVWT (mm) 17.4 ± 4.9
LVM (g) 279.6 ± 106.5
E-wave (m/s) 0.70 ± 0.18
A-Wave (m/s) 0.67 ± 0.18
E/A 1.11 ± 0.44
SAM (%) 23.1








Abbreviations - A wave - late diastolic mitral valve inflow peak velocity, Ao - 
Aortic annulus diameter, E wave - early  diastolic mitral valve peak inflow velocity, 
E:A – ratio of peak early  diastolic mitral inflow velocity  to peak late diastole mitral 
inflow velocity, LVED - maximal left ventricular cavity  dimension in end-diastole, 
LVM - left ventricular mass, Max LVWT - maximal left ventricular wall thickness in 
end-diastole, LVOT - Left ventricular outflow tract, SAM - systolic anterior motion 
of the mitral valve.
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Of the 350 athletes, 233 (66%) underwent the full complement of 
investigations that were  offered. The remaining 34% either failed to 
attend clinic appointments (n=62, 18%), attended only for some of the 
investigations (n=20, 6%), or moved clubs and could not be traced (n=35, 
10%).
6.3.1 Further Testing Results
All athletes achieved a peak-VO2 of greater than 120% predicted. 
Thirteen athletes exhibited ≥ 100 ventricular or supra-ventricular 
extrasystoles over 24 hours. In no subject did this exceed 0.5% of the 
total number of heart beats. 
One black athlete exhibited asymmetric septal hypertrophy (15mm) on 
cardiac magnetic resonance imaging, that was not apparent on trans 
thoracic echocardiography. There was no evidence of late gadolinium 
enhancement in any subject studied that would be indicative of 
myocardial fibrosis. 
First degree relatives were investigated in only 33 (9.4%) athletes. 
Phenotypic evidence of hypertrophic cardiomyopathy was identified in one 
parent. This case will be discussed in further detail in section 6.4..
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6.4 Determinants of repolarisation changes in athletes
Univariate analyses demonstrated a significant association between ST 
segment elevation and ethnicity, age, body surface area, hours of training 
per week, left atrial size and maximum left ventricular wall thickness. 
Multivariable analysis revealed that black ethnicity was the strongest 
independent predictor with black athletes being four times more likely to 
exhibit ST segment elevation compared with white athletes (OR 3.95; 
95% CI 2.73-5.75, P<0.001). The only other significant predictor of ST 
segment elevation was the number of hours trained per week (OR 1.03; 
95% CI 1.00-1.06; P=0.03). 
With respect to T wave inversions, univariate analysis demonstrated a 
significant association between T wave inversions and ethnicity, age, 
hours of training per week, systolic blood pressure and maximum left 
ventricular wall thickness. After adjustment for all variables, black ethnicity 
was the strongest independent predictor. Overall, black athletes were 
almost six times more likely to exhibit T-wave inversions compared to 
white athletes (OR 5.56; 95% CI 3.55-8.70; P<0.001). The single other 
predictor identified was maximum left ventricular wall thickness (OR 1.18; 
95% CI 1.02-1.35; P=0.02).
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6.5 Clinical Significance of Repolarisation Changes
In total, 2723 athletes underwent cardiac evaluation as part of this study 
cohort. Of these, follow up data was available in 1243 athletes who 
underwent ≥ 2 evaluations either as part of the standard pre-participation 
screening programme, or as a result of on-going clinical surveillance due 
to the presence of marked repolarisation changes and/or LVH. During the 
mean follow-up period of 69.7 ± 29.6 months, three athletes were 
diagnosed with hypertrophic cardiomyopathy. Their ECG and 
echocardiographic findings are summarised in figure 6.5.
Athlete 1, a black soccer player was diagnosed following investigations for 
an abnormal ECG. This showed deep T-wave inversions and ST-segment 
depression in the inferior and lateral leads (Figure 6.5A). Subsequent 
trans-thoracic echocardiography demonstrated asymmetric left ventricular 
hypertrophy, with a maximal septal wall thickness of 15mm, and a non 
dilated left ventricular cavity. This was subsequently  confirmed on cardiac 
magnetic resonance scanning.  
Athlete 2, also a black soccer player, was diagnosed retrospectively 
having been successfully resuscitated from ventricular fibrillation during a 
football match. His initial screening ECG had shown T wave inversions in 
the inferior and lateral leads (Figure 6.5B), which was followed by trans 
thoracic echocardiogram that demonstrated mild concentric LVH with a 
non-dilated left ventricular cavity, a finding confirmed on cardiac magnetic 
resonance imaging. The features were initially  considered to represent 
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athletes heart, based on a peak VO2 max >120% of maximum predicted 
and the absence of the broader HCM phenotype. Subsequent events did 
however confirm the diagnosis of HCM, rather than cardiac athletic 
adaptation.
Figure 6.5 -  12 Lead Electrocardiograms and echocardiographic data of all 
three athletes diagnosed with hypertrophic cardiomyopathy. 
Abbreviations for figure 6.5 A- late diastolic mitral valve inflow peak velocity; E 
- early  diastolic mitral valve inflow peak velocity; IVSd - maximal left ventricular 
septal wall thickness at end diastole; LA - left atrium; LVED - left ventricular 
cavity  diameter in end-diastole; LVM - left ventricular mass; LVPWd - left 
ventricular posterior wall thickness in end-diastole.
Athlete 3, a caucasian triathlete, also exhibited T wave inversions in the 
inferior and lateral leads (Figure 6.5C), but subsequent trans-thoracic 
echocardiography and cardiac magnetic resonance scanning 
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Athlete LA IVSd LVPWd LVED LVM E/A
1 42 15 12 48 302 1.83
2 36 14 14 46 255 2.39
3 34 11 9 49 175 2.4
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demonstrated a structurally  normal heart. The  athlete also had a high 
peak VO2 and a normal Holter monitor recording. The diagnosis of HCM 
was reached after the identification of an apical form HCM in his mother 
followed by  subsequent conformation of a myosin-binding protein C 
mutation in both individuals.  
6.6 Other Significant findings in Male Athletes
In addition to the three athletes diagnosed with hypertrophic 
cardiomyopathy, an incidence of 1 in 908, nineteen further athletes 





Long QT syndrome 3
Brugada Syndrome 1
Structural
Bicuspid Aortic Valve 3
Patent Foramen Ovale 3
Atrial Septal Defect 2
Ventricular Septal Defect 1
Mitral Valve Prolapse 1
Cor-triatritrum 1
Table 6.5 - Other cardiac abnormalities identified at routine pre-
participation screening amongst this cohort of healthy individuals. 
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Chapter 7 – Discussion
7.1 Introduction
Numbers of black athletes that compete at a local, national and 
international level have been steadily increasing since the 1960’s. Initially 
this rise in participation was confined to male athletes – but since the mid 
1980’s female black athletes have emerged to dominate certain sporting 
arenas.  Numbers of female black athletes are predicted to continue 
increase over the coming decades, and sporting organisations have 
begun to specifically target this demographic group.82
In parallel to the increase the numbers of black participants, both male 
and female, in elite sport, governing bodies15, organisers of international 
sporting competitions14 and cardiac societies on both sides of the 
Atlantic17,77, have advocated the adoption of pre-participation cardiac 
screening with a 12-lead ECG and subsequent trans-thoracic 
echocardiography. The aim of these programmes has been the reduction 
in numbers of sudden cardiac death during sporting activity, as is 
discussed in Chapter 1, section 1.5. 
The criteria used to derive the normal range of electrocardiographic and 
echocardiographic parameters in athletes have been derived from studies 
in almost exclusively Caucasian individuals.9,11,77 However, recent studies 
in black male athletes have indicated that they exhibit a higher prevalence 
of left ventricular hypertrophy (LVH) and repolarisation changes compared 
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with Caucasian male athletes.18,19,53,54 The significance of such ECG and 
echocardiographic appearances in male athletes is unclear, as in a 
significant proportion, the appearances observed may be similar to that 
seen in cardiomyopathy, in particular hypertrophic cardiomyopathy 
(HCM)42. There previously has been no data available with respect to 
female athletes. 
This chapter will firstly focus on the data that describes cardiac adaptation 
to exercise in female black and white athletes, examining both the 
structural and electrical changes that occur. Following this, I will discuss 
the data that relates to the significance of the ECG and echocardiographic 
changes that have been observed in male black athletes. Then, by 
applying the results from the data presented in chapters 3 to 6, I will 
suggest a clinical algorithm that aims to facilitate the differentiation 
between physiological cardiac adaptation and cardiomyopathy  in both 
male and female athletes. Finally, I will examine biochemical and 
physiological data that may provide a mechanistic explanation for the 
cardiac changes observed in response to exercise in black individuals.
7.2 Cardiac Structural Adaptation in Black Female Athletes
This study  is the first to specifically examine the adaptive changes in 
response to exercise female international African/Afro-Caribbean athletes. 
Data from both ECG and trans-thoracic echocardiography  have been 




In comparison with the largest published study in Caucasian female 
athletes (n =600),31 only  240 black females were studied. However, when 
one considers that black female athletes currently comprise less than 
10% of all athletes participating at National level in the UK and France, 
the study cohort represents a sizeable proportion of athletes available for 
comparisons and inferences.
7.2.1 Left Ventricular Wall Thickness in Black Female athletes.
Similarly to previous reports examining caucasian athletes31,32, both black 
and white female athletes demonstrated a relative increase in maximal left 
ventricular wall thickness (LVWT), left ventricular cavity size and left 
ventricular mass compared to similar cohorts of sedentary controls. In 
particular, black female athletes exhibited an 11% increase in maximal 
LVWT and a 31% increase in calculated left ventricular mass, compared 
to similar sized black female control subjects. Female white athletes 
exhibited a similar pattern, with a 6% increase in maximal LVWT and 18% 
increase in left ventricular mass, compared to white sedentary  female 
control subjects. There were no statistically  significant differences 
between the respective control groups in measures of left ventricular size. 
As observed in black male athletes19, highly  trained female black athletes 
demonstrated an overall greater maximal LVWT and left ventricular mass 
compared to white female athletes of similar age, size and sporting 
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discipline. Overall, there was a 7% difference in maximal LVWT and a 9% 
difference in left ventricular mass between the two ethnic groups. 
 
7.2.2 Black Female Athletes with Left Ventricular Hypertrophy
Consistent with previous reports, none of the Caucasian female athletes, 
or female control subjects (black or white) exhibited a LVWT >11 mm.5, 
4,32,6 In contrast, 8 (3%) black female athletes demonstrated a maximal 
LVWT >11mm (12-13 mm) that could have been consistent with 
morphologically mild HCM. None of the 8 black female athletes revealed 
any further phenotypic features of HCM on further clinical evaluation 
(Table 4.5). 42
Importantly, since none of the black female athletes exhibited a LVWT 
>13mm, it would be reasonable to infer that an absolute maximal LVWT of 
13mm probably represents the physiological upper limit of LVH in an 
asymptomatic black female athlete outside the context of a family history 
of HCM. A LVWT >13mm may therefore be considered to represent 
pathologic LVH.
Black female athletes with LVH participated in basketball, football, judo, 
netball, sprinting, and wrestling, sports that are not traditionally associated 
with physiologic LVH in Caucasian athletes, indicating that the isotonic 
and isometric stresses of sport induce more cardiac hypertrophy in black 
athletes compared with white athletes. Direct comparisons could not be 
made in sporting disciplines characteristically associated with a greater 
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LVWT in Caucasians such as rowing, canoeing and cycling 4-6 since most 
black female athletes in the UK and France do not usually excel in such 
sporting disciplines. Nevertheless, none of the studies in female 
Caucasians participating in these sporting disciplines have reported a 
LVWT >11mm. 4-6
 
7.2.3 Other Cardiac Dimensions in Black Female Athletes.
In addition to differences in left ventricular wall thickness and mass, black 
female athletes demonstrated a significant increase in left atrial diameter 
compared to similar white female athletes. This difference amount to a 9% 
increase in left atrial size between the respective groups of athletes. The 
distribution of left atrial diameter seen here are similar to that previous 
reported in larger groups of Caucasian female elite athletes,22 with no 
black female athlete demonstrating left atrial dilation that may be 
considered pathological (i.e. >45mm) (Figure 4.2). In particular, no female 
athlete with LVH had evidence of left atrial dilatation,78 and all indices of 
systolic and diastolic function were normal in all subjects studied.70 
Indeed, amongst athletes, diastolic function was enhanced. Absolute 
measures of E and A velocities were slightly  lower amongst athletes vs. 
sedentary controls across the racial groups, but this can be accounted for 
by the relative bradycardia amongst the athletic cohort, reflecting 
improved diastolic filling rather than an abnormality. There were no 




7.3 The Electrocardiographic Appearance in Black Female Athletes 
Racial differences in the resting 12-lead electrocardiogram amongst 
black male sedentary individuals are well recognised100-102.The pattern of 
previously reported data in males is replicated amongst this group  of 
female control subjects, with a longer P-R interval, shorter QTc, and 
shorter QRS duration seen in black sedentary  female individuals.103 There 
was also a small difference in the prevalence of voltage criteria for LVH 
between black and white controls – but these did not reach statistical 
significance. These findings would suggest that the control groups are 
typical of the wider UK female sedentary  population, and comparisons 
made between this group and athletes are valid. 
   
In general, female athletes had lower heart rates and longer PR intervals 
than female control subjects, both black and white. These findings are 
common amongst high level athletes,1 and reflect the quality and intensity 
of training amongst this particular group. Traditionally these alterations 
have been attributed to an increase in vagal tone at rest,1 but in addition 
there may be intrinsic changes in the properties of the SA and AV node 
that contribute to the appearance of the surface 12-lead ECG.43,104
 
With respect to repolarisation anomalies, Black female sedentary control 
subjects demonstrated a small, but non-significant, increase in the 
prevalence of T-wave inversions compared to white female control 
subjects. In addition, there were numerical differences in the prevalence 
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of repolarisation anomalies, both J point ST elevation and T wave 
inversions, between black female athletes and black sedentary control 
subjects – but these differences failed to reach statistical significance 
(p=0.28; and p=0.14 respectively). 
In contrast, white female controls exhibited a higher prevalence of J-point 
and ST segment elevation compared to white female athletes, contrasting 
previously reported data.9 There were no differences in the prevalence of 
T-wave inversions between white athletes and controls. The prevalence of 
J point and ST elevation amongst this particular cohort of white athletes is 
lower than has previously been reported amongst other groups of white 
female athletes, accounting for this difference.  
7.3.1 Differences in Electrocardiographic Repolarisation between 
Black and White Female Athletes
Black female athletes exhibited a greater prevalence of T wave inversions 
compared with white athletes. T wave inversions were present in 14% of 
black athletes compared to 4.5% of white athletes, and confined to the 
anterior precordial leads (V1-V3). Their presence did not appear to be 
determined by age, body size, sporting discipline or cardiac dimensions. 
Deep T wave inversions were only observed in a small number of black 
female athletes (figure 5.2). In particular, athletes with T wave inversions 




In general, there appears to be a racial predilection for the development of 
T wave inversions amongst black individuals, as has been suggested by 
previous larger studies on sedentary male individuals.100 The data in the 
cohort of female sedentary control subjects shows a similar trend, 
although this failed to reach statistical significance. Participation in regular 
physical activity would appear to enhance this effect, with a dramatic 
increase in the prevalence of T wave inversions seen amongst elite 
female black athletes when compared to both white athletes and 
sedentary black controls. In addition, deep  T wave inversions were seen 
only amongst black athletes and not in any white individual or sedentary 
control subject (black or white), suggesting that these are a consequence 
of physical training, rather than simply due to ethnic variation.
T wave inversions amongst black athletes were confined to the anterior 
precordial leads (V1-V3), which differed in distribution pattern from that 
seen in white athletes or black sedentary controls. In both groups, T wave 
inversions were observed in the inferior and anterior leads in similar 
proportions. This would suggest that physical activity induces the 
development of T wave inversions predominately across the anterior pre-
cordial leads, rather than the inferior leads. Lateral T wave inversions 
were not seen in any subject – athlete or control, suggesting that their 
presence is unusual and more likely to be associated with underlying 
cardiac pathology. 
The prevalence and magnitude of these electrical changes in black 
female athletes remains significantly lower than that observed amongst 
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black male athletes,19 but higher than those reported in Caucasian male 
athletes.9,11
The prevalence of ST segment elevation amongst black athletes was 
significantly higher than in white female athletes. This again reflects the 
low incidence of J point ST segment elevation seen amongst white female 
athletes. 
In summary, physical training in black individuals is associated with the 
presence of T wave inversions confined to the anterior precordial leads, 
which in a minority of athletes may be greater than -0.2mV in depth and 
termed “deep”. This would appear to reflect physiological adaptation, 
rather than cardiac pathology.
7.4 Cardiac Adaptation to Exercise in Black Male Athletes
Previous data has described attempted to describe the spectrum of ECG 
and echocardiographic changes that occur in response to regular physical 
activity in black male athletes18,19,53,54. With respect to the 
electrocardiogram, cross sectional studies of black American male 
collegiate football players have indicated that there is a higher prevalence 
of repolarisation changes observed, when compared to similar white male 
athletes. 18,54 In certain cases, these changes may overlap  with the 
phenotype observed in HCM. As yet, there has been little data examining 
the distribution and significance of these anomalies amongst a large and 
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diverse body of athletes, participating in a range of different sporting 
activities. 
The aim of this data was an attempt to elucidate the significance of 
electrical repolarisation changes amongst a large group  of black male 
athletes. The study  population comprised a large group of black elite male 
athletes, numbering 904 individuals, who competed in 25 different 
sporting disciplines. The prevalence and distribution of electrical 
repolarisation anomalies amongst this cohort was compared with that 
observed amongst a group of sedentary black individuals and black 
individuals with HCM. The purpose was to provide data to facilitate the 
differentiation between expressions of simply ethnicity alone, ethnic 
variation in physiological cardiac response to exercise, and quiescent 
cardiac pathology. 
In contrast to studies published in the current literature,18,54 this was the 
first study where all study  participants underwent both ECG and 2D 
echocardiography.  Where repolarisation anomalies were identified, the 
athletes concerned were offered a voluntary, more comprehensive cardiac 
evaluation. This was completed in the majority  (66%) of individuals. In 
addition, this is the first data on the longitudinal assessment of black 
athletes, both with and without repolarisation anomalies, to provide a real 




7.4.1 Ethnic Differences in Repolarisation Changes in Elite Male 
Athletes
Overall, black male athletes demonstrated a significantly higher 
prevalence of repolarisation changes, when compared to both white 
males athletes and sedentary controls (Table 6.1). In total, almost one 
quarter exhibited significant T wave inversions, and nearly two thirds 
showed ST-segment elevation.  With respect to T wave inversions, these 
were observed only in  just under 4% of white athletes, and 10% of black 
control subjects.
7.4.2 The distribution of repolarisation changes amongst  black 
athletes 
Repolarisation changes in black athletes differed not only in their 
observed frequency, but also their distribution across the standard 12-lead 
ECG. 
7.4.2.1 The Anterior Precordial leads
Overall, black male athletes exhibited a significantly greater prevalence of 
T-wave inversions confined to only the anterior leads when compared to 
black male sedentary control subjects. This indicates that the presence of 
anterior T-wave inversions (including deep T wave inversions) is likely to 
represent  an ethnic  response to physiological adaptation to exercise, 
rather than an effect of purely  ethnicity  alone. T-wave inversions confined 
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solely  to the anterior leads were rare amongst black individuals with HCM, 
again indicating that this is likely  to represent a physiological rather than a 
pathological process. Further evidence that this does indeed represent a 
physiological process is the observation that these anterior T wave 
changes may regress, as early as 6 weeks after cessation of exercise 
(Figure 7.1).
The presence of anterior T-wave inversions is also a minor criteria in the 
diagnosis of arrythmogenic right ventricular cardiomyopathy (ARVC)105,106. 
Importantly, none of out athletes demonstrated any further diagnostic 
criteria despite extensive and comprehensive investigations. The precise 
prevalence of ARVC amongst different ethnic groups is unknown, 
however the high prevalence of T –wave inversions in the anterior leads 
amongst black athletes, the co-existence of preceding ST-elevation in a 
large proportion, and the demonstration of regression with detraining 




Figure 7.1 – 12-lead ECGs taken from a 17 year old black male professional 
footballer during peak training (A) and after an 8 week period of detraining (B). 
Panel A demonstrates convex ST segment elevation associated with deep T 
wave inversions in the anterior precordial leads which regress after a period of 
detraining. Echocardiography  and cardiac MRI demonstrated a structurally 
normal heart.107
7.4.2.2 Inferior leads
Overall, T wave inversions in the inferior leads were far less frequent 
across all groups. However, they were again more frequently seen in 
black athletes when compared to white athletes. There was no significant 
difference in the prevalence when compared to black control subjects. 
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Isolated inferior T-wave inversions frequently involving leads III and aVF 
have been reported in a number of studies examining the appearances of 
the athletes ECG. As yet, no data has suggested that their presence is 
associated with a malignant cardiac phenotype. In line with this, within our 
cohort, despite intensive investigation, we failed to demonstrate any 
significant cardiac pathology in any  individual with isolated inferior T-wave 
changes.   
7.4.2.3. Lateral leads 
Overall, the prevalence of lateral (V5, V6, I and aVL) T-wave inversions 
was low across the entire study cohort. However, there were no 
differences in the frequency that these changes were observed amongst 
black male individuals when one compared athletes with sedentary 
control subjects. This is in contrast to white male athletes, where lateral T 
wave inversions were extremely rare and observed in only  0.3% of 
subjects compared to a frequency of 3-4% amongst black individuals. 
This implies that the presence of lateral T-wave inversions may reflect 
ethnic variation amongst the majority of black athletes. 
However, the majority of black patients with HCM, and all 3 athletes 
identified with this condition (of both races) during follow up, exhibited T-
wave inversions in the lateral leads.  Therefore, the finding of lateral T-
wave inversions in an athlete, of any ethnicity, should be viewed with 
caution, since a proportion of these individuals may harbour HCM. 
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This conclusion, that the presence of lateral T wave inversions may 
indicate a cardiomyopathy, is also supported by data from Italy. In a study 
of 81 athletes who demonstrated marked repolarisation abnormalities who 
were followed up for a an average of 9 years, 5 subsequently developed 
phenotypic evidence of a cardiomyopathy. All of these individuals 
exhibited lateral T-wave inversions.108 
7.4.3 ST Segment Shift
ST-segment elevation was a common finding amongst all black 
individuals assess, irrespective of athletic training. Similar findings have 
been previously described amongst black populations and suggest an 
ethnicity related effect.50,100,101
A detailed examination of the ST segment demonstrated a variety of 
different morphologies of ST segment elevation were present amongst 
this cohort (Figure 6.3). Concave /saddle shaped ST segments that 
mimics that seen in acute pericarditis, was a common finding in both black 
athletes and sedentary controls. The pattern of convex ST-elevation 
(Figure 6.3A), akin to that observed in acute ischaemia or the Brugada 
phenotype, was six times more common amongst athletes, indicating that 
this may be the result of a physical response to training in black athletes. 




7.5. Trans-thoracic Echocardiography in Black Male Athletes
All part icipants in this study underwent 2-D trans-thoracic 
echocardiography as part of the standardised cardiac screening protocol. 
This is the largest cohort of elite black male athletes that has been 
examined to date in the current literature.18,19 The individuals assessed all 
competed in sport at a national or international level, and participated in a 
wide range of sporting disciplines. In general, these reflect sporting 
participation amongst this particular ethnic group across the UK and 
France. 
In a similar pattern to that observed amongst black female athletes, black 
male athletes did not participate in the sports that traditionally generated 
the greatest changes in LV wall thickness and cavity size - in particular 
cycling and rowing. This is a reflection of general participation levels world 
wide at both national and international levels. 
7.5.1. Measures of Left Ventricular Wall Thickness
In keeping with other previous studies examining cardiac dimensions in 
black male athletes,19 the mean maximal left ventricular wall thickness 
(LVWT) was significantly greater than in similar white male athletes.  The 
distribution of maximal LVWT is shown in figure 6.5. Calculated left 
ventricular mass was also higher in black male athletes, with a 16g 
average increase when compared to similar white athletes corrected for 
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body surface area. There were no significant observed differences in 
mean maximal LVED between the black and white athletes. 
Both groups of athletes demonstrated significantly greater average 
maximal LVWT, maximal LVED, and calculated left ventricular mass when 
compared to sedentary black control subjects. This suggests that the data 
amongst the athletic cohort truly reflects the physiological process of 
cardiac adaptation to regular physical activity. 
The maximal observed LVWT amongst black male athletes was 16mm. 
The two black athletes that were subsequently diagnosed with HCM had a 
maximal LVWT of 14mm and 15mm respectively. However, this was 
associated with other echocardiographic features in the individuals 
concerned that suggests pathological hypertrophy i.e. a non dilated LV 
cavity  size, enlargement of the left atrium and lateral T-wave inversions in 
12-lead ECG (Figure 6.5). 
In the absence of any further phenotypic features, it would be reasonable 
to infer from this data, that 16mm represents the maximum limit of 
physiological hypertrophy amongst black male athletes. 
Amongst white male athletes, none exhibited a maximal LVWT of greater 
than 13mm, in keeping with previously published large cohort data.4,34 
Importantly, the single white athlete that was subsequently diagnosed with 
HCM had a maximum LVWT of 11mm well within the quoted upper limits 
of normal for his gender and ethnicity. He did however had significant 
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ECG abnormalities (Figure 6.5) - including lateral T wave inversions, 
which would not in general be considered in keeping with a diagnosis of 
athlete’s heart. In this individual, the diagnosis was confirmed after 
identification of HCM in his mother and subsequent genetic testing. This 
highlights the importance of a through and comprehensive assessment of 
athletes with repolarisation anomalies, including a family history, and not 
relying purely upon absolute measures of cardiac dimensions.
Amongst the patient cohort with HCM, the average maximal left 
ventricular wall thickness was 17.4mm. This falls outside the range 
observed in healthy black or white male athletes or controls. Only one 
black patient with HCM had normal left ventricular wall thickness (1.9%). 
Importantly, this data does highlight that that the vast majority of 
individuals with HCM will exhibit LVH in some form. This was reflected in 
calculated left ventricular mass, with the mean LV mass amongst black 
patients with HCM being over 70g higher than in any athlete cohort.
7.5.2 Other measures of cardiac chamber size and function 
Average left atrial diameter was increased in black athletes relative to 
both male white athlete and male black controls. Similarly, there was a 
small but statistically significant difference in aortic root diameter between 
black and white groups of male athletes.  These findings are similar to 
that previously reported amongst smaller cohorts,19 and would seem to 
represent a true ethnic difference in response to exercise. None of the 
158
159
athletes, including those with LVH, demonstrated isolated LA dilatation 
that would be considered pathological (i.e. greater than 45mm).
With respect to other measures of diastolic function (mitral inflow velocity, 
tissue Doppler of the mitral annulus), black male athletes had a slightly 
lower peak E-wave velocity which was reflected in a lower average E/A 
ratio, when compared to both white male  athletes and black male control 
subjects. This again is likely  to reflect the significant bradycardia noted in 
black athletes relative to other cohorts. There were however no 
differences observed in either tissue Doppler velocities nor ratios between 
the respective cohorts. No individual demonstrated any significant 
abnormality of either systolic or diastolic function. Specifically, this 
includes all athletes with LVH. 
7.6 Implications for Pre-Participation Screening 
Overall, these findings have implications for the cardiac pre-participation 
screening of  all black individuals, both males and females. 
Although the relative risk of sudden cardiac death during sport in females 
is considerably lower than in males, female athletes are not exempt from 
cardiac fatalities during sport,12,59,109 therefore, the observation that 
normal healthy black female athletes may demonstrate physiological LVH 
>11mm and T wave inversions that  mimic morphologically mild HCM is a 




With respect to male black athletes, this is the first data presented 
examining the long term significance of repolarisation anomalies and 
echocardiographic LVH. The implications of the findings to pre-
participation screening criteria will be discussed in the following sections. 
7.6.1 Differentiation of Physiological Left  Ventricular Hypertrophy 
from Hypertrophic Cardiomyopathy
Amongst the population of black female athletes in this study, 3% 
exhibited a maximal LVWT of 12mm or 13mm, which falls inside the range 
of values seen in morphologically  mild HCM. Amongst the black male 
population, 12.4% of individuals demonstrated LVH, of up to 16mm. The 
accurate differentiation between physiological and pathological LVH is 
essential due to potentially serious consequences that a diagnosis of 
HCM has for the athlete concerned and their family. If the current 
guidelines,17,77 derived from predominately  Caucasian athletes, had been 
applied to this population, this could have resulted in the unnecessary 
exclusion of these athletes from competitive sport. 
None of the female athletes with LVH demonstrated any further indication 
of HCM on trans-thoracic echocardiography – namely evidence of 
increased left ventricular filling pressures (an increased left atrial diameter 
(>45mm) or impaired diastolic function (an E/E’ ratio of >7), a small left 




Amongst the black male athletic population, 2 individuals were diagnosed 
with HCM – one prospectively with clear echocardiographic evidence of 
HCM, the other retrospectively following a cardiac arrest.  However, 
amongst the remaining male black athletes with LVH, there was no further 
evidence of HCM, other than isolated measures of left ventricular wall 
thickness.
In addition to echocardiography, all individuals with LVH underwent 
extensive investigations to exclude any further phenotypic evidence of 
HCM, including cardiac MRI, 24 hour Holter monitor ECG recordings, and 
standard upright treadmill exercise testing. In particular, there was no 
evidence of myocardial fibrosis on late gadolinium enhancement cardiac 
MRI imaging, a sensitive and specific marker of HCM.75,111The measures 
of LVWT obtained on trans-thoracic echocardiography correlated well with 
that derived from cardiac MRI.
7.6.2 A Bedside Clinical Algorithm for the Differentiation of Left 
Ventricular Hypertrophy in Black Athletes
The application of data derived from this study to the pre-participation 
screening of black athletes will facilitate the differentiation between 
pathological and physiological LVH in such individuals. 
Trans-thoracic echocardiography is the most widely used and available 
means of cardiac imaging and in the majority  of cases will provide the 
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clinician with sufficient information to make the diagnosis at the bedside, 
without having to rely on additional more expensive and complex imaging 
modalities. As has been previously  demonstrated in both white athletes 
and black male athletes, the characteristics of physiological LVH are 
similar in black athletes – namely relative dilatation in the left ventricular 
cavity  size, a normal left atrial diameter, and normal indices of left 
ventricular systolic and diastolic function. The data presented here 
indicates that the upper limit of such physiological LVH should be 13mm 
in black females. In black males, as has been suggested in smaller cohort 
studies,19 the upper limit should be considered 16mm.
The definitive diagnosis of HCM, the commonest cause of exercise 
related sudden cardiac death amongst athletes,28,59 is based on genomic 
analysis and identification of a causal mutation.60 Although there have 
been considerable advances in the methodology for genetic diagnosis, 
routine gene testing in the absence of familial disease is generally  not 
recommended in the UK. The wide genetic hetrogeneity  and high 
prevalence of private mutations does mean that a negative genetic 
diagnosis is not sufficient to exclude this potentially lethal condition.60 
Furthermore, gene testing for HCM is still prohibitive in terms of time and 
may prove costly for the athletes fitness and potential future career. The 
ESC currently recommends that genetic testing should be reserved for 
those cases that remain equivocal, despite extensive clinical investigation, 
and conducted in an expert setting by clinicians experienced in 
interpreting correctly  the results.112 Amongst the 3 male athletes 
diagnosed with HCM amongst this cohort, HCM was diagnosed in a single 
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white athlete using genomic analysis having had a causal mutation 
identified in a first degree relative (his mother) with clear phenotypic 
evidence of HCM.  
At present, a thorough clinical assessment including both 12-lead ECG 
and trans-thoracic echocardiography should underpin the evaluation of 
athletes with left ventricular hypertrophy. Genetic testing does not form a 
part of the routine clinical assessment of athletes, but may have an 
important role in the future, given the advances in technology relating to 
mutational analysis.
7.6.3 Interpretation of the 12-lead ECG in Black Athletes 
This study is the first to illustrate that black female athletes may 
demonstrate T-wave inversions in a resting 12-lead ECG, the appearance 
of which may overlap with that observed in cardiomyopathy, namely HCM 
and ARVC. 
However, unlike HCM, none of the black female athletes in this study 
exhibited deep  T wave inversions in the inferior or lateral leads; therefore, 
the identification of deep  T wave inversions in these leads in a black 
female with LVH would probably be representative of pathology rather 
than physiology. None of the female athletes with T wave inversions had 
any other features on their 12-lead ECG that may be associated with 
HCM, i.e. ST segment depression, extreme left axis deviation, or LBBB42 
With respect to ARVC, on further extensive investigation, none had any of 
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the diagnostic criteria identified by  the European task force in the 
diagnosis of this condition,106 other than T wave inversions across the 
anterior precordial leads. 
Amongst the cohort of black male athletes, T wave inversions were 
present in 22.8% of individuals, and confined to the anterior leads in 
12.8% of individuals. No male athlete with T wave inversions or convex 
ST segment elevation confined to the anterior pre-cordial leads 
demonstrated any  evidence of cardiomyopathy at initial assessment or 
longitudinal follow-up. 
T-wave inversions in the lateral or inferior leads were observed 
significantly less frequently. All athletes with subsequently diagnosed with 
HCM demonstrated T-wave inversions, in all cases with a voltage of 
>0.2mV (i.e. deep), in the lateral leads. Their presence should therefore 
considered to represent pathology, and the athlete should under-go an 
extensive evaluation to exclude the presence of a cardiomyopathy. 
Black athletes in general have a higher prevalence of T wave inversions 
and ST-segment elevation when compared to white athletes, both male 
and female.100 These differences appear to be exaggerated by physical 
training, and when present, usually confined to the anterior pre-cordial 
leads V1-V4 (to V3 in females). Based on this study, T wave inversions in 
leads V1-V3 may be considered a normal physiological finding when 
encountered at a routine pre-participation cardiac screen in an otherwise 
healthy and asymptomatic black athlete. 
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Data on the longitudinal follow up of male white athletes with 
repolarisation anomalies identified cardiac pathology in 11/81 (13.5%) 
athletes studied, None of the athletes that subsequently developed 
cardiac pathology exhibited similar ECG pattern to that observed amongst 
the cohort of female athletes.108 All had extensive T wave inversions that 
extended across the anterior, lateral and (in 54%) the inferior leads. 
Amongst the population of male athletes studied in this cohort, a total of 3 
athletes of the 273 with significant T-wave inversions were eventually 
diagnosed with a cardiomyopathy, all of whom also demonstrated T-wave 
inversions that extended across the  lateral and inferior leads (Figure 6.5). 
These data suggest that athletes with T wave inversions that involve that 
lateral leads, in particular that extend beyond a single territory, should be 
investigated thoroughly  and repeatedly at intervals to exclude the 
presence of an occult cardiomyopathy. Of note, in both our data and the 
previously published work108, 2 individuals were only diagnosed after a 
cardiac arrest, one of which was fatal for the individual concerned. 
None of the female athletes in this particular cohort (black or white) had 
such extensive repolarisation anomalies, which in general, fall outside the 




7.6.4 The Impact on Pre-Participation screening of Black Athletes & 
Recommendations
The use of the resting 12-lead ECG in pre-participation cardiac screening 
is advocated by both international cardiac societies16,17 and major 
international sporting organisations.14,15 The criteria used to define the 
normal range of appearances in the athletes ECG has been derived solely 
from data examining cardiac adaptation amongst predominately 
Caucasian individuals.    
The findings of this study illustrate that black female athletes may exhibit 
repolarisation anomalies – namely T wave inversions in the anterior 
precordial leads – on the resting 12-lead ECG, in a similar pattern to that 
seen in black male athletes.19,54 18 This study has provided  valuable data 
on the significance of such ECG appearances in a large cohort of black 
male athletes. This suggests that the presence of T wave inversions in the 
anterior precordial leads represents physiological adaptation to regular 
exercise, rather than occult cardiac pathology.. The application therefore 
of criteria derived in Caucasian populations may  lead to the generation of 
false positive results, leading to unnecessary investigations with 
subsequent athlete anxiety, physiological distress and potential disruption 
to training schedules.
If the current guidelines are rigorously applied to this cohort of athletes,
16,17 then up to 25% of the black athletes assessed in this study would 
require further investigations based on the presence of T-wave inversions. 
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Application of the criteria that are outlined below – namely attributing the 
presence of isolated anterior T wave inversions in the absence of any 
significant cardiac history – could reduce the numbers of athletes 
requiring investigations to as low as 4%. This represents a significant cost 
saving, particularly in countries with a large proportion of black athletes 
and limited financial resources. 
When screening an individual for cause of sudden cardiac death during 
sport, an appreciation must be taken of an athlete’s ethnicity. In a black 
asymptomatic individual with no family  history of cardiomyopathy or 
sudden cardiac death, the identification of T wave inversions in the 
anterior precordial leads (V1-V3) may be considered normal ethnic 
variation. Contiguous T wave inversions in the lateral or inferior leads 
remain unusual findings amongst black athletes and should therefore be 
investigated further, with a minimum of trans-thoracic echocardiography, 
prior to the athlete being cleared for competition.    
At trans-thoracic echocardiography, this study suggests that the upper 
limit of left ventricular wall thickness in black female athletes should be 
13mm, and in black male athletes 16mm. This measure should not 
however be considered in isolation, but take in context with other 
echocardiographic indices of left ventricular function – including left 
ventricular diameter, left atrial diameter and markers of systolic and 
diastolic function (including TDI).  If any of these suggest any diagnosis 
other than physiological hypertrophy, the individual concerned should be 
asked to suspend physical activity until the results of further investigation 
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are known. If however an athlete is asymptomatic, has no family  history of 
sudden cardiac death or cardiomyopathy, and has no features consistent 
with cardiomyopathy on his/her trans-thoracic echocardiogram, then 
irrespective of whether further investigations are planned, they should be 
allowed to continue sporting activity until the results are known.
In keeping with the current guidelines, an athlete any of the following 
additional features should undergo further investigation to exclude a 
cardiomyopathy or other potential cardiac cause of sudden death during 
exercise. These additional features include:
· Symptoms suggestive of occult cardiac disease e.g. unheralded 
syncope
· A family history of cardiomyopathy or sudden cardiac death
· Any findings on physical examination – e.g. a significant pre-cordial 
murmur
· A 12-lead ECG with additional features suggestive of 
cardiomyopathy i.e:
o T wave inversions in the lateral &/or inferior leads
o ST segment depression
o Left axis deviation
o Left Bundle branch block
o Pathological Q waves
· Findings on trans-thoracic echocardiography consistent with 
structural heart disease or cardiomyopathy. 
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7.7 Potential Mechanisms for Ethnic Differences in Cardiac 
Adaptation 
The precise mechanisms for the exaggerated myocardial hypertrophy and 
ECG appearances in black athletes in response to exercise are complex, 
and remain to be elucidated.   
7.7.1 Structural differences
Regular exercise is associated with an increase in systemic blood 
pressure at peak exercise, as a result of both the increase in cardiac 
output and changes in systemic vascular resistance. There may be racial 
and gender differences in response to these modulations in BP, which 
may account for the relative left ventricular hypertrophy seen amongst 
black individuals, particularly men. 19 However both my own experience of 
exercising both male and female black and white athletes with 
physiological LVH, and the longstanding experience of our research 
group,19 has not demonstrated any significant differences in peripheral 
exercise related BP responses between the ethnic groups. All the male 
and female athletes studied in this cohort had an entirely appropriate 
blood pressure response to exercise, with none having a peak systolic 
blood pressure of >180mmHg. Indeed, if the hypertrophic response to 
blood pressure is the primary mechanism, then one may expect a degree 
of diastolic dysfunction, as may be seen in hypertensive heart disease.113 
This was absent, and indeed diastolic function was enhanced in athletic 
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subjects, as has previously described.23 No athlete or control reported a 
significant family history of hypertension. Given the relative prevalence of 
these conditions in the general population, and the age distribution of the 
study cohort, this would seem unlikely to be correct. A familial response to 
sub-clinical longstanding hypertension may play a role in the development 
of LVH in black athletes, but no relationship between LVH and blood 
pressure was demonstrated in this group.
Systemic vascular resistance and vascular tone play a key role in the 
determination of an individual’s response to hypertension. Racial and 
gender differences in large114 and small115 artery  structure and function, 
endothelial function,116 the renin-angiotensin system,117 and levels of 
vasoactive cytokines,118 are recognised and may partially explain the 
differences in the magnitude of LVH between black athletes and white 
athletes and the greater predilection to LVH in male athletes in both ethnic 
groups respectively.
Mechanisms of physiological hypertrophy are complex, and recent in-vivo 
studies suggest that these are different to that seen in pathological states 
– such as the left ventricular hypertrophic response to systemic 
hypertension. Importantly in murine models of both physiological and 
pathological hypertrophy, there is characteristically the absence of 
myocardial fibrosis amongst mice with a physiological hypertrophic 
response to exercise. 119
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In-vitro and animal studies indicate that physiological LVH is mediated by 
the effects of Insulin like growth factor 1 (IGF-1)120 on the 
phosphatidylinsitol-3-kinase (PI3K)-Akt1119 pathway which appears to 
regulate downstream transcription factor and gene product production.121 
It is possible that potential race related polymorphisms in IGF-1 function 
within the African population may also provide an explanation for the 
greater magnitude of LVH observed in black athletes.
7.7.2 Electrical Differences
It is historically recognised that a significant proportion of normal black 
males and females exhibit T wave inversions in the right precordial leads 
extending to V3 and V4.52,122 Our own experience also suggests that male 
black athletes may acquire such T wave inversions in the right precordial 
leads during physical training (figure 7.1) that are not related to cardiac 
structure and which regress after a six to eight week period of de-
conditioning. Alterations in autonomic cardiac innervation, either reduced 
sympathetic or increased vagal tone, or, recently  identified sodium 
channel polymorphisms amongst the black population123,124 may provide 
some explanation for the variation found within black athletes, however 
more detailed molecular assessment and longitudinal follow up of black 
athletes is necessary to unravel the intriguing manifestations of the black 
athlete’s heart. 
With respect to the differences between male and female athletes, of both 
ethnicities - one potential explanation may lie within variations in 
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reproductive hormones, oestrogen and progestrogen and the female 
menstrual cycle. Vagal tone and baroreceptor sensitivity have both been 
shown to alter during the natural menstral cycle125, and are sensitive to 
the administration of exogenous oestrogen (eg. as the oral contraceptive 
pill)126. These may contribute to the changes observed. However, female 
elite athletes often exhibit wide variation in their menstrual cycle, given the 
demands of their sporting endeavours, that may limit the impact of these 
hormones of the appearances of the resting ECG.
7.8. Conclusion
Systematic physical exercise in black athletes is associated with greater 
LVH and higher prevalence of repolarisation changes compared with 
white athletes of similar age and size participating in identical sporting 
disciplines. However, a maximal LVWT >13 mm in female athletes, and 
>16mm in male athletes, or deep T wave inversions in the inferior and 
lateral leads are rare and warrant further investigation.
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Chapter 8 – Limitations of this Study and Suggestions for Further 
Research
This study has strived to provide information on cardiac remodelling in 
black athletes, both male and female athletes in order to facilitate the 
accurate pre-participation screening of such individuals. Due to certain 
financial, logistical and ethical issues, there are certain limitations that 
should be highlighted. 
The absolute measures of LV wall thickness were not blinded, although 
intra- and inter- observer variability  was within accepted limits. Neither 
was the sonographer blinded to the ethnicity of the individual being 
studied. This in an inherent problem with all large scale observational 
studies of this type. In order to avoid un-intentional measurement bias, 
future studies could make further use of blinding, in particular with the 
use of off-line measurements in order to minimise this potential source 
of error. 
With respect to the data on female athletes, this study is cross sectional 
in design, and as such provides only a limited short term view of cardiac 
remodelling amongst this population. No female athlete was diagnosed 
with a cardiomyopathy or other cardiac disorder over the time period 
that this study  was conducted. Specific longitudinal follow-up amongst 
female athletes is needed to ensure that the observed repolarisation 
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changes and left ventricular hypertrophy do not represent cardiac 
pathology. 
With respect to the data on male black athletes, follow-up data was 
presented here for the first time. The duration of follow-up was relatively 
short however, as event rates in HCM are low. Follow-up data was also 
incomplete, including evaluation of first degree relative, in a significant 
number of athletes. However, follow-up data was available in a 
substantial number of the athletes assessed (n=1243), which suggests 
that valid conclusions can be drawn from the study findings. The number 
of athletes that were assessed on multiple occasions is significant, given 
the practical difficulties in motivating healthy individuals to attend for 
prolonged clinical assessment, given the time involved and the absence 
of perceived benefit relating to athletic performance.
The diagnosis of HCM was established only  in athletes with 
repolarisation changes and/or LVH who exhibited a potentially fatal 
arrhythmia, familial disease or asymmetric septal hypertrophy  with a non 
dilated left ventricle and evidence of left atrial enlargement. Hypertrophic 
cardiomyopathy, however, is a heterogeneous condition, with wide 
variation in its phenotypic expression. Therefore, milder or more benign 
forms of the disorder may not have been identified. Plausibly, athletes 
without repolarisation abnormalities on their 12 lead ECG, or T wave 
inversions in the anterior/inferior leads may harbour a quiescent 
cardiomyopathy. The follow-up data collated did not provide any 
indication that this statement may be correct.
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Similarly, this study is purely observational and makes no attempt to 
provide any physiological explanation for the anomalies observed. As 
discussed, there is a considerable amount of data in the literature 
attempting to provide an explanation for ethnic differences that have 
been observed in response to hypertension. There has been no studies 
do date that relate specifically  to athletes. These is therefore a need for 
specific mechanistic studies in the future, in both animal and human 
models. 
 
There is also the recognition that misuse of performance enhancing 
substances may be associated with LVH and marked repolarisation 
changes,127 however, all athletes  studied were part of national and 
international squads and as such underwent regular testing for the 
presence of such substances. Hence, all subjects where considered 
free from compounds that may adversely affect these results.
Only 52 patients  with a diagnosis  of HCM were included in the analysis, 
which limits the conclusions that can be drawn relating to the 
quantitative characteristics  of black individuals with HCM. However, if 
one considers  that only 2-3% of the UK population is afro-Caribbean/
African origin, then represents a relatively large cohort of individuals. It 
is  important to recognise that the definition of HCM (i.e. the identification 
of LVH in the absence of any other cardiac or systemic cause) per se 
prevents a definitive diagnosis in a many affected black individuals. In 
particular, hypertension is present in up to 50% of the black population 
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aged over 40, and as  a recognised cause of LVH, HCM cannot be 
considered in these individuals.  A multi-centre American study involving 
1986 HCM patients  supports the difficulties  encountered in establishing 
a diagnosis of HCM in black individuals. In this cohort, only 8% of those 
studied were black.63 The HCM cohort was also significantly older than 
the athletic population. However, given that the identification of HCM, in 
relatively asymptomatic individuals, depends upon the level of contact 
with a healthcare system. This increases with age, hence the age 
difference in the identification of this condition. The purpose of this 
cohort however was not to provide a like for like comparison, but to 
allow the identification of key clinical features that may can be used in 
the differentiation between pathological and physiological hypertrophy.
Finally, as per current published guidelines, genetic testing was  not 
available to aid the differentiation of athlete’s heart from HCM outside of 
the context of established familial disease.
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Appendix A - Screening Information for study participants
CRY
CARDIAC RISK IN THE YOUNG
       Unit 7, Epsom Downs Metro Centre, Waterfield, Tadworth, Surrey, KT20 5LR United 
Kingdom
Telephone: +44(0) 01737 363 222 Facsimile +44(0) 01737 363 444
e-mail cry@c-r-y.org.uk  web site www.c-r-y.org.uk
Cardiac Testing – Who are CRY and why is cardiac testing 
important?
CRY are a charity-based organisation whose mission is to raise 
awareness of undetected cardiac abnormalities in young, apparently 
healthy individuals. Although governmental statistics are not available, 
cardiac experts believe that 4-8 young people die each week in the UK 
from undiagnosed cardiac conditions. It is important to stress that the 
majority of these deaths ARE preventable. It is  also important to realise 
that exercise is NOT bad for you, but can act as a trigger for an event if 
the individual already has underlying heart condition.
Individuals  may be tested from the age of 14 until 35.  Individuals may 
make a special request (subject to approval) to be screened before their 
14th birthday.  The reason being that growth changes  during puberty will 
alter results year by year and make valid documentation difficult.  Tests 
performed on pre-pubescent teenagers should be repeated at a later 
date. 
An Electrocardiogram (or ECG for short) is a simple, 
non-invasive and painless electrical test that 
examines the electrical activity within your heart.  As 
you can see from the picture on the left, the ECG 
involves the patient lying down quietly for 5-10 
minutes only.   You should have rested for at least 
30 minutes prior to your ECG. 
Small stickers (known as electrodes) are placed at 
strategic points on your chest. Flexible leads that 
extend from the ECG machine are then attached to these stickers.  The 
electrical rhythm of your heart is recorded and printed out on thermal 
paper. This  part of the process only takes 2-3 minutes to perform and 
after that you are free to go.   As you can see from the picture, the 
technician will have to access your bare chest.  Female technicians  are 
used where possible for female patients, and the ECG can be obtained 
whilst wearing a non-wired sports bra.  
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In addition to this, you will undergo an Echocardiogram (ECHO) whilst 
lying down.  It is an ultrasound scan of the heart that measures cardiac 
dimensions and the flow of the blood in and out of the heart.  Just like a 
sonogram of a pregnant woman, the scan is painless, non-invasive and 
takes no more than 20 minutes.  Please note that all our technicians 
work as ECG/ECHO technicians within the NHS or BUPA, and 
furthermore, all our technicians have been investigated by the Criminal 
Records Bureau and are free to work for CRY.
CRY
CARDIAC RISK IN THE YOUNG
       Unit 7, Epsom Downs Metro Centre, Waterfield, Tadworth, Surrey, KT20 5LR United 
Kingdom
Telephone: +44(0) 01737 363 222 Facsimile +44(0) 01737 363 444
e-mail cry@c-r-y.org.uk  web site www.c-r-y.org.uk
After the ECG and ECHO have taken place, the results are taken to our 
consultant cardiologist, whose speciality is cardiac adaptation in athletic 
individuals.  The consultant reviews each individual with the personal 
and family history questionnaire you would have completed prior to 
examination.  It is  extremely important that you fill in these 
questionnaires to the best of you ability.  Do not guess on history you 
don’t know, instead ask a family member to fill in the missing gaps.  
In the majority to cases, patients will receive an “all clear” letter, but 
sometimes patients will be invited to attend University Hospital 
Lewisham or the CRY Centre for Sports Cardiology for further cardiac 
testing.  
There are a number of reasons why follow up tests are felt to be of 
benefit.  The ECG and ECHO readings taken during the testing MAY 
indicate an athlete’s heart (enlarged heart muscle due to large volumes 
of physical activity), borderline measurements, or imperfect readings. 
In order to properly rule out a cardiac abnormality, a further ECG and 
ECHO may be required.  Additional tests, such as a Holtor monitor (a 24 
or 48 hour ECG) and/or exercise stress test may also be required.  It is 
important to realise that a further review does not necessarily mean you 
have a cardiac condition.  However, further information is required to 
give a full diagnostic evaluation.
The information derived from these tests are strictly confidential and will 
not be disclosed to anyone other than your doctor or others who are 
directly involved within your care, e.g. other consultant cardiologists.  In 
the rare event that a cardiac abnormality is diagnosed you must be 
aware that this may affect certain mortgage applications, particular types 
of life insurance and some careers.  CRY have a comprehensive 
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resource network for affected individuals and family members that 
includes counselling and personal advice.
It must be stressed that undetected heart conditions are rare. Our tests 
are able to detect the majority of cardiac abnormalities most likely to 
affect young people.   In order for you to have an ECG and ECHO, you 
must have fully read the information provided.  If you are unsure about 
anything, please visit our website at: www.c-r-y.org.uk for more 
information.  If you still can’t find the information you are looking for, 
please contact the CRY office and one of us will endeavour to give you 
the answer.
CRY Health Questionnaires and Consent Forms will be distributed with 
this  information letter, but it should be noted that young people wishing 
to be tested, who are under the age of sixteen, must seek written 
permission from a parent or guardian.
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Appendix B - Consent form for study participants
CRY    CARDIAC RISK IN THE YOUNG
CRY, Unit 7, Epsom Downs Metro Centre, Waterfield, Tadworth, Surrey KT20 5LR U.K.
Tel: 01737 363 222   Fax: 01737 363 444  e-mail cry@c-r-y.org.uk  web site www.c-r-y.org.uk
Consent Form for Cardiac Screening
It is extremely important that you have read and understood the 
information sheet provided with this consent form
Please tick the following box to confirm you have fully read and understood 
the screening information on the attached.
Test Procedure:  An Electrocardiogram (or ECG for short) is a simple, non-
invasive and painless test that examines the electrical activity within your 
heart.  Small stickers are placed at strategic points on your chest. Flexible 
leads that extend from the ECG machine are then attached to these stickers. 
The electrical rhythm of  your heart is recorded and printed out on thermal 
paper. Female technicians are used where possible for female patients.  If  you 
wish, a friend or chaperone can accompany you during the procedures.  All 
medical personnel who are linked to CRY are verified and approved by Dr 
Sanjay Sharma and/or Professor WJ McKenna.  All results are treated in the 
strictest of confidence.
Results: It should be noted that the ECG will appear abnormal in a small 
percentage of cases and clients will require follow  up tests to further evaluate 
cardiac health. In some cases you may be requested to have an 
echocardiogram to facilitate the interpretation of the ECG. Echocardiograms 
are not carried out routinely for all clients but only when felt warranted on the 
basis of initial ECG findings or alternatively for research purposes. This may be 
on the same day as the ECG testing or at a later date.  CRY aims to notify you 
(or your parents if  you are under 16) and your GP within 4 working weeks after 
the screening event.
STATEMENT: I have read and understood the implications of further testing, 
outlined in the CRY Information Sheet. I understand that in the rare event an 
abnormality is confirmed, this may affect some types of mortgage and health 
insurance applications and that it may also affect some careers.  Questions 
concerning the testing procedure have been answered to my satisfaction.  I 
also understand that I am free to withdraw  consent and discontinue 
participating in any procedures without giving a reason.  I have also been 
informed that the information derived from these tests is confidential and will 
not be disclosed to anyone other than my doctor or others who are involved 
within my care.  However, I do agree that the information from these tests will 






NAME OF CLIENT (PRINTED)………….…………………………...
………………………………………………...




(Required if individual is under 16 years of age)
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Appendix C - Screening questionnaire





Doctors name and Address:
Phone Number
Date of Birth: Age: Gender: Main Sport(s):
Height: Weight:
Have you been screened before? If so, when and where?
Are you taking any medication: If so, please describe?
Ethnicity (please tick the appropriate box)
White Mixed Black Asian Other
British     White and Black 
Caribbean   
Caribbean    Indian    Chinese   
Irish    White and Black 
African   
East African    Pakistani    Filipino   
Turkish / Cypriot 

White and Asian   

West African   Bangladeshi    Vietnamese   
Greek / Cypriot   

Kurdish   
Other    Other Mixed    Other    Other    Any other ethnic 
group   
If other, please state your ethnic origin:









Seen By Doctor: Follow-up Required: Yes   No
Additional Notes:
          Result:





1. Have you ever fainted?
During Exercise Yes / 
No
How recently did 
this occur?





How recently did 
this occur?





How recently did 
this occur?
Please describe the circumstances:
2. Do you experience dizzy turns?
During Exercise Yes / 
No
How recently did 
this occur?





How recently did 
this occur?





How recently did 
this occur?
Please describe the circumstances:
3. Do you experience palpitations? (palpitations are a fluttering in your chest that you can notice whilst 
resting)
Yes / No If yes, how recently and please describe the circumstances
4. Do you experience chest pain, heaviness or tightness?
During Exercise Yes / No If yes, please describe the circumstances




5. Do you feel that you are more breathless or more easily tired than your team 
mates?
Yes / No If yes, please describe the circumstances
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6. Is there a family history of (please tick):
High Blood pressure □                     High Cholesterol □                          Diabetes 
□
7. Is there a family history of heart disease?
Yes / No If yes, please state the age of onset
8. Has there been an unexplained death or deaths due to heart disease in young 
family members?
Yes / No If yes, please describe the circumstances and at what age did the death 
occur
What sports do you play A. …………………………….. Level: 
…………………………….
and at what level?
    B. …………………………….. Level: 
…………………………….
e.g. International,
National, County,  C. …………………………….. Level: 
…………………………….
Club, Other
What would you consider your main sport?
Approximately, how many days a week are you physically active (playing sport)?
On average, approximately how many hours per week are you physically active 
(playing sport)?
Do you do any other training, e.g. weights, aerobics, circuit training etc?
If so, how often do you do these?
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